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Chapter 1 
Introduction 

1. Genel'al intl'oduction 
DNA is the carrier of genetic information in living organisms. The information stored 
in the nucleotide sequence of DNA is transmitted to the offspring by generating identical 
copies of the parental DNA molecules. Damage in DNA can cause loss of genetic 
information. Nevertheless, the DNA is continuously subject to alterations, and its instability 
is likely one of the major factors in mutagenesis. The structure of DNA can be modified 
spontaneously by hydrolysis, oxidation, or by environmental factors such as ultra-violet (UV) 
light, X-rays, or numerous chemical agents. Replication of unrepaired DNA can cause 
genetic changes, which may affect proper functioning of proteins encoded by that DNA. As 
a result cellular malfunction, onset of carcinogenesis, inborn defects, or even cell death can 
occur. In addition, DNA damage can interfere with other essential metabolizing processes, 
like recombination or transcription, with deleterious consequences for the cell. 
In order to maintain the integrity of DNA, all organisms have evolved a complex 
network of mechanisms to prevent or repair DNA damage. The different pathways known 
are able to handle distillct classes of DNA damage. 
I. Direcl repair of Ihe dall/aged base: Two examples of this mode of repair are the light-
dependent enzyme photolyase (phr), which Illollomerizes specifically cyclobutane pyrinlidine 
dimers, a lesion induced by UV radiation, and the methyltransferase reaction, in which the 
methyl group of a methylated guanine is transferred to Q'-methylguaninc-DNA-
methyltransferase. 
2. Base excisioll repair: Spontaneous DNA lesions which are caused by oxidation and 
hydrolysis, or lesions induced by X-rays and alkylating agents, are examples of lesioI15 that 
are removed by base excision repair (BER). The damaged base is excised by a glycosylase, 
cleaving the N-glycosylic bond between the damaged base and its sugar group. The 
remaining sugar-phosphate is hydrolysed by an abasic endonuclease activity. The main 
pathway of BER replaces a single nucleotide and requires a deoxyribophosphodiesterase to 
remove the 5' terminal deoxyribophosphate residue, a DNA polymerase for gap-filling, and 
a DNA ligase for sealing the newly synthesized nucleotide to the pre-existing strand. An 
alternative, but minor, BER pathway exists, in which a repair patch of two to five 
nucleotides is displaced and DNA synthesis occurs using the non-damaged strand as template, 
like in nucleotide excision repair (Dianov and Lindahl, 1994). 
3. Nucleotide excision repair: This mechanism recognizes a wide variety of stmcturally 
unrelated DNA lesioI15, including various UV-induced photoproducts, cyclobutane pyrimidine 
dimers (CPD) and pyrimidine (6-4) pyrimidone photoproducts (6-4 photoproducts), bulky 
chemical adducts, and certain types of crosslinks. These lesions destabilize severely the 
helical structure of the DNA. Globally, five steps are involved in the nucleotide excision 
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repair (NER) process: recognition of the DNA damage, incision of the damaged strand on 
both sites of the lesion, removal of the damage-containing oligonucleotide, gap-filling by 
DNA synthesis, and finally ligation of the remaining nick (Friedberg, 1985; Hoeijmakers, 
1993a; Hoeijmakers, 1993b). For a subset of lesions, like CPDs, cisplatin intrastrand cross-
links, and benzo[a]pyrene adducts, two sub pathways are recognized in NER: the rapid 
transcription-coupled repair (TCR) of expressed genes, directed to the transcribed strand and 
repair at a slower rate of the genome overall, which is designated here as 'global' genome 
repair (GGR) (Bohr, 1991; Hanawalt and Mellon, 1993). However, the extent of 
discrimination between transcriptionally active and inactive regions varies between species. 
Transcription-coupled repair is more pronounced in rodent cells than in human, since the 
small amount of CPD removal in rodent cells is almost completely targeted to the transcribed 
strand of active genes. 
4. Post-replication daugtller strand gap repair: When the replication machinery is blocked 
by a DNA lesion in the template, replication can restart 3' of the injury, depending on 
whether the lesion occurs in leading or lagging strand. To overcome a blocking lesion in the 
leading strand, replication initiation from a downstream origin can occur. Alternatively, 
translesion synthesis at the expenee of increased mutagenesis can solve the problem. In 
E.coli, the single-stranded gaps, that are left in the newly synthesized DNA strand, are 
repaired by recombinational strand exchange, using the daughter strand as a template, 
allowing complete replication of the DNA. In mammalian cells, this mechanism has not yet 
been elucidated. 
5. Mismatch repair; Another post-replication correction mechanism is the mismatch repair 
pathway. Replication errors occur, due to occasional insertion of a mismatched base, or 
slippage of the DNA replication machinery, in regions of sImple di- or trinucleotide repeat 
sequences. In E.coli, the MutS protein binds the mismatched site, then a dimer of 
MutLiMutH cleaves the non-methylated DNA strand, which is newly synthesized. The DNA 
containing the mismatch is degraded by a single strand-specific exonuclease, followed by 
gap-filling using DNA polymerase III and joining by DNA ligase. Mismatch repair is 
conserved from bacteria to man; MutS and MutH homologues have been identified in human 
cells (Fishel et aI., 1993; Leach et aI., 1993; Parsons et aI., 1993). A remarkable observation 
was the localisation of the human MutS gene to chromosome 2, in the same region where 
the locus responsible for hereditary nonpolyposis colorectal cancer (HNPCC) has been 
mapped. These tumour cells show marked instability of simple DNA repeat sequences, like 
mismatch-deficient mutants in E. coli and yeast. The strongest evidence that the mutation 
responsible for HNPCC affects mismatch repair, is obtained by the fact that extracts of 
tumour cells are deficient in this type of repair (Lindahl, 1994). 
6. Recombinatiollal repair: Double strand breaks and interstrand crosslinks, induced by X-
rays and several crosslinking agents, are severe types of damage, since repair requires both 
DNA strands and the presence of homologous duplex DNAs. The mechanism is intensively 
studied in E.coli. Each end of the double strand break is degraded by an exonuclease, which 
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leaves single-stranded ends. RecA protein binds to these free ends and initiates strand 
exchange with the homologous duplex DNA molecule, forming two adjacent recombination 
junctions. The remaining gaps are filled by DNA polymerase. Then both recombination joints 
are resolved, yielding two intact duplexes. Many other enzymes are required for 
recombinational repair, including RecBCD, RecE, ReeF, RecG, RecQ, RuvA, RuvB, and 
RuvC, but these will not be discussed here (for review, see West, 1992). 
This introduction focusses on the nucleotide excision repair (NER) pathway. First 
evidence that NER plays a significant role in human health was provided in the late sixties 
by Cleaver, who described a defective NER pathway in patients with the human hereditary 
disease xerodenna pigmentosum (XP) (Cleaver, 1968). XP patients show hypersensitivity to 
ultraviolet light and have a predisposition to develop skin cancer in sun-exposed areas of the 
skin. Unravelling of the molecular mechanism of NER requires information about the genes 
involved, and the functions of the encoded proteins in this repair process. NER-deficient 
mutants in various organisms have played an essential role in the elucidation of the NER 
mechanism. Presumably, insights in the NER process shed light upon skin cancer induction 
in general. In the last twenty years, an increased incidence of various types of skin cancer 
has been observed in fair-skinned people. A major reason might be exposure of the skin to 
solar UV -light by sunbathing, especially in the developed countries. Reduction of the ozone 
layer may also enhance the risk of skin cancer, since more harmful ultraviolet-B radiation 
will reach the earth's surface. 
2. Nucleotide excision repair 
2.1 Excision repair in Eschelichia coli 
The NER pathway has been characterized in most detail in Escherichia coli (van Houten, 
1990; Visse, 1994). The key NER proteins are UvrA, UvrB, UvrC, UvrD, DNA polymerase 
I, DNA ligase, and two auxiliary factors: photo1yase (Phr) and Mfd, the product of the 
lIlutationftequency decline gene (also called transcription repair couplings factor, TRCF). 
The first step in the repair process is dimerisation of UvrA molecules in the presence of 
ATP, followed by the association of one UvrB molecule forming a damage recognition 
complex (Lin et aI., 1992). The UvrA,B complex binds to DNA and scans for lesions by a 
weak helicase activity (Grossman and Yeung, 1990). A wide spectlUIll of stlUctural1y 
unrelated DNA lesions, ranging from thymine glycols to bulky adducts as well as inter- and 
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intrastrand crosslinks, are recognized by this UvrA2B complex. Therefore, it is believed that 
the recognition is based on detection of a distortion in the DNA helix, rather than on direct 
sensing of Ihe actual damage. Afler recognition of Ihe lesion, UvrB is linked 10 DNA 
(preincision complex), whereas UvrA, is released (Orren and Sancar, 1989). UvrC binds 10 
the preincision complex and induces a dual incision in the damaged strand. The incision 5' 
of Ihe injury is calalyzed by UvrC, while Ihe 3' incision is made by UvrB (Lin and Sancar, 
1992; Sancar and Tang, 1993). A 12-13 mer oligonucleotide conlaining Ihe adducI logelher 
with UvrC are released by Ihe aClion of Ihe UvrD helicase. DNA polymerase I fills Ihe 
single-slranded gap and releases UvrB from Ihe DNA (Orren el aI., 1992). Finally, Ihe newly 
synlhesized DNA is joined 10 Ihe pre-exisling slrand by DNA ligase I. The scheme depicled 
in Figure 1 represents the NER reaction ill vitro, using naked DNA as a substrate and the 
purified proteins as mentioned above. 
The basic rale of repair can be modulaled and regulaled by auxiliary faclors. The 
regulalory SOS mechanism medialed by Ihe LexA and RecA gene producls promoles Ihe 
expression of a number of NER genes when the cell is confronted with DNA damage. 
Anolher example of a NER modulalor is Phr, which specifically stimulales Ihe repair of 
CPDs by UvrABC endonuclease. Probably Ihe binding of Phr 10 Ihe CPD resulls in a more 
efficienl recognition of Ihis lesion (Sancar and Smith, 1989). 
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Figure 1. A model mechanism for nucleotide excision repair in Escherichia coli. 
Strand-specific repair of active genes has been discovered in E. coli both ill vivo and ill 
vitro, after identification of such a preferential repair in mammalian cells (Bohr, 1991; 
Mellon and Hanawalt, 1989; Selby and Sancar, 1991). Strand-specific repair achieves fast 
and complete elimination of lesions that cause a block in transcription, implying a priority 
for repair of the expressed fraction of the genome compared to non-transcribed regions. 
Strand-specific repair in E. coli requires at least an additional factor for communication 
between the RNA polymerase and nucleotide excision repair. Recently, this transcription-
repair coupling factor (TRCF) has been identified as the product of the lIifd gene (mutation 
frequency decline) (Selby et aI., 1991). When RNA polymerase is stalled at the lesion, it will 
be released from the template by Mfd. The proposed model is that the Mfd protein remains 
bound to DNA and reclUits UvrA,B to accomplish fast repair of the transcribed strand (Selby 
and Sancar, 1993). 
It is obvious that NER in E. coli is a complex process, which requires many repair 
proteins. In eukaryotes, chromatin stl1lcture and dynamics, genome complexity, or cell cycle 
regulation, might further complicate the NER pathway. As a first step on the evolutionary 
ladder from E. coli and man, NER in yeast will be discussed below. The budding yeast 
Saccharomyces cerevisiae has served as a model organism, because of its relatively low 
genome complexity in comparison to higher eukaryotes. 
2.2 Excision repair in yeast 
An extensive collection of repair-deficient yeast mutants has been identified due to the 
versatile genetic system of Saccharomyces cerevisiae. Three epistasis groups, defective in 
DNA repair, have been characterized in yeast: RAD3, RAD6 and RAD52 (Friedberg, 1988). 
Each group is called after one of their representants. The RAD6 group is required for post-
replication repair and is involved in damage-induced mutagenesis, whereas the RAD52 group 
is implicated in recombinational processes. The RAD3 group represents nucleotide excision 
repair. In the RAD3 epistasis group at least thirteen complementation groups (listed in Table 
1) have been identified so far (Hoeijmakers, 1993a; Prakash et a!., 1993). In the distantly 
related fission yeast Schizosaccharomyces pombe also a large set of repair genes have been 
identified, many of which were found to be homologous to members of the RAD3 epistasis 
group of the budding yeast Saccharomyces cerel'isiae (McCready et aI., 1993). These 
homologous genes suggest a conservation of the repair pathway at least in yeast. 
Radl, 2, 3, 4, 10, 14, and rad25 mutants are highly sensitive to UY-light and completely 
deficient in NER. These gene products are indispensable for the incision step. Other mutants, 
including rad7, 16, 23, 24, rad26, ssll, and mllls19, are moderately or even not sensitive 
to UY-light. These mutants are only partially defective in NER, suggesting that the encoded 
proteins serve as accessory factors or act in a specific subpathway of repair, for instance in 
preferential repair of transcribed genes. 
NER in E.coli and yeast share all the basic features: recognition, dual incision, removal 
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of the damage-containing patch, DNA synthesis and ligation. In both cases, a wide spectrum 
of unrelated lesions is substrate for the repair mechanism. Furthermore, the two subpathways 
of repair, transcription-coupled and global genome repair, are present. Although the NER 
mechanism is conserve~, during evolution, E. coli NER genes appear not to have served as 
ancestors for the eukall~'otic repair genes, since repair in yeast and E.coli is exerted by non-
homologous proteins. The properties of the different yeast repair proteins are discussed in 
relation to the five basic steps in NER and briefly summarized in Table I. 
RADI4 is a hydrophilic protein containing a zinc-finger domain. It binds preferentially 
6-4 photoproducts in UV -damaged DNA, but also other types of lesions (Guzder et a!., 
1993). On the basis of these binding properties, it is likely that RADI4 is required for the 
damage recognition step. However, the existence of additional proteins, that recognize DNA 
damage, cannot be excluded. 
Incision in yeast requires at least two endonuclease activities, carried out by RAD2 and 
by the RADlIRADIO complex. Expression of the RAD2 gene is induced by UV-irradiation 
and the protein shows a single strand-specific DNA nuclease activity, independent of the 
lesion (Habraken et a!., 1993). The RADlIRADIO complex (Bailly et a!., 1992; Bardwell 
et al.. 1992) shows low endonuclease activity on both single-stranded and on supercoiled 
double-stranded DNA (Sung et a!., 1993; Tomkinson et a!., 1994). 
Presumably, the DNA around the injury must be locally unwounded to make it accessible 
for the repair proteins, which are involved in incision. Candidates for this role are RAD3 and 
RAD25, since both are helicases. RAD3 has a 5'~ 3' helicase activity on both double-
stranded DNA and DNA-RNA hybrids, but RAD3 is not able to unwind RNA duplexes 
(Sung et a!., 1987; Bailly et a!., 1991; Naegeli et a!., 1992b). The direction of the helicase 
activity of RAD25 is the reverse of RAD3 (park et aI., 1992). In addition, these helicases 
might be involved in recognition of the damage, when the helicases scan the DNA for 
lesions, like the UvrA,B complex in E.coli. Inhibition of the movement of DNA polymerases 
or helicases, which translocate along the DNA, might be important for efficient recognition 
of the damage. For instance, the helicase activity of RAD3 is strongly reduced by DNA 
damage and alterations in the strand to which RAD3 is bound (Naegeli et a!., 1992a). When 
RAD3 remains bound at Of near the lesion, it may enhance recognition by other repair 
proteins. However, the possibility cannot be excluded, that these helicases are involved in 
the strand displacement of the damage-containing patch, like UvrD in E.coli. 
As in E.coli, two NER subpathways exist in S.cerevis;ae: transcription-coupled repair 
and global genome repair. Rad7 and rad16 mutants are deficient in repair of non-transcribed 
DNA, whereas transcribed strands of active genes are repaired at a rate similar to wildtype 
cells (Terleth et a!., 1990; Verhage et a!., 1994). The sequence of RADI6 predicts a helicase 
domain, which demonstrates remarkable sequence homology to a subfamily of putative 
helicases (Bang et a!., 1992; MaIlllhaupt et a!., 1992). Generally, helicases can affect opening 
of the DNA helix. In case ofRAD16, it is believed that this protein serves to make the DNA 
accessible for the repair proteins (Winston and Carlson, 1992). RAD7 interacts with SIR3, 
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a protein that is probably involved in the packaging of DNA into transcriptionally silent 
chromatin (Paetkau et a!., 1994). The function of RAD7 might be remodelling of the 
chromatin structure, to allow NER proteins to remove DNA lesions from these 000-
transcribed regions of the genome. 
In contrast to rad7 and radl6 mutants, the rad26 mutant is defective in transcription-
coupled repair and not in global repair. The RAD26 gene has been characterized only 
recently, based on sequence homology to its human counterpart CSB (Huang el a!., 1994). 
The rad26 mutant is not sensitive to UV-light or X-rays, explaining why it was not identified 
as a repair-deficient mutant before (van Gaol el a!., 1994). RAD26 has also helicase motifs 
of the same putative helicase subfamily as RAD 16. The proteins of this subfamily exhibit 
various functions in repair- and transcription regulation: for example RAD54 
(recombinational repair), RAD5 (post-replication repair), RAD26 and human CSB 
(transcription-coupled repair), and SNF2 and MOTI (transcription regulators) (Clark el a!., 
1992; Johnson et a!., 1992; Laurent et a!., 1992; Schild et a!., 1992; Troelstra et a!., 1992). 
SSLl, TFBl, RAD3, and RAD2S are part of the transcription initiation factor b (Feaver 
et a!., 1993) and will be discussed in the conlext of the homologous human transcription 
factor TFIIH. Several ssll and tjbl mutants display UV-sensitivity, which suggests that these 
mutants are also members of the RAD3 epistasis group (Yoon et a!., 1992; Wang et a!., 
1994b). It appears thaI NER requires proteins which have additional functions in other DNA 
metabolizing processes in the cell. A dual function of RAD3 and RAD25 has been predicted 
previously, as 'null' mutations in these genes were not viable (Higgins el a!., 1983; 
Naumovski and Friedberg, 1983; Park et a!., 1992). Another example of a dual role is 
presented by RADI and RADIO; both are involved in NER and mitotic recombination 
(Schiestl and Prakash, 1988; Schiestl and Prakash, 1990). Little is known about the function 
of proteins encoded by RAD4, RAD23, RAD24 and MMSI9. 
The next question to be answered is to what extent NER in yeast can be related to repair 
in higher eukaryotes, like mammals. The nuclear organisation in mammals is different from 
yeast, this is due to a larger number of chromosomes and the presence of introns in the 
DNA. Presumably. the diversity of tissues in higher organisms can affect the rate of repair. 
Two classes of mammalian mutants have been identified: rodent cell mutants and naturally 
occurring human disorders, in which patients show a genetic defect in NER. Both classes will 
be discussed in the following paragraphs. 
2.3 IVlalllll1alian excision repair 
2.3.1 DNA repair-deficient rodent mutants 
A large number of NER mutants has been obtained from cultured rodent cell lines. 
IS 
0\ Table 1: NER genes in yeast and their properties (the RAD3 epistasis group) 
Gene Homologs Function! Activity Further characteristics 
human S.pombe NER Additional 
RADI ERCC4+ radIo incision recombination complexed with RADIO. endonuclease activity 
RAD2 XPG radI3 incision expression induced by DNA damage. ss-DNA 
endonuclease activity 
RAD3 XPD radI5 helix unwinding transcription 5'-3' helicase. subunit of factor b 
RAD4 XPC ss DNA binding? 
RAD7 repair of non-transcribed DNA gene expression induced by DNA damage 
RADIO ERCCI swilO incision recombination cornplexed with RADI. endonuclease activity 
RADI4 XPA damage recognition preferential binding to damaged DNA 
RADI6 repair of non-transcribed DNA RAD16-subfamily of putative DNA helicases 
RAD23 HHR23A.B ubiquitin-like N-terminal domain 
RAD25· XPB ERCC3" helix unwinding transcription 3'-5' helicase activity. factor b association 
RAD26 CSB transcription-coupled repair RAD16-subfamily of putative DNA helicases 
SSLI p44 transcription subunit of factor b, mutant is UV~ 
!FBI p62 transcription subunit of factor b, mutant is UV~ 
'" rad16 is also designated as swi9: '" RAD25 is also designated as SSL2 
• RADI has sequence homology with ERCC4 ( L. Thompson, personal communication) 
Eleven different complementation groups have been classified by complementation analysis 
based on cell fusion experiments (Busch et aI., 1989; Riboni et aI., 1992; Collins, 1993). 
Representatives of the groups 1-5 and 11 are highly sensitive to DNA-damaging factors, like 
UV-irradiation, and deficient in one of the early steps of NER. Groups 6-10 show only a 
moderate UV-sensitivity. Cross-sensitivity to chemical agents, that produce bulky DNA 
adducts, is a feature of all complementation groups. Mutants of rodent groups 1 and 4 are 
unique, since they display an extreme sensitivity to mitomycin C (MMC) , a crosslinking 
agent (Busch et aI., 1989). Recently, it was found that not all representants of these groups 
are highly sensitive to MMC. Several mutants of group 1 do not exhibit such an extreme 
MMC-sensitivity, whereas the UV sensitivity is retained, and one representative of group 4 
(UVI40) has been isolated with a moderate response to UV and MMC (Busch, manuscript 
in preparation). 
Six human NER genes have been cloned by transfection of the human genomic DNA into 
the rodent repair mutants. A practical reason for this approach is that transfection to rodent 
cells is much easier than to human cells. The correcting genes are designated excision repair 
cross complementing genes (ERCC), ERCCl (Westerveld et aI., 1984), ERCC2 (Flejter et 
aI., 1992), ERCC3 (Weeda et aI., 1990b), ERCC4 (Thompson et aI., 1994) ERCC5 
(O'Donovan and Wood, 1993; Scherly et aI., 1993) and ERCC6 (Troelstra et aI., 1992). 
With the exception of ERCCl and ERCC4, these cloned genes are also involved in human 
NER disorders. Their functions and mode of action will therefore be discussed along with 
the human syndromes. 
2.3.2 Human nucleotide excision repair disorders 
Three rare, inherited human disorders are known, where a defective NER mechanism 
is involved. These are xeroderma pigmentosum (XP), Cockayne's syndrome (CS), and a 
photosensitive form of trichothiodystrophy (TID) also designated as PIBIDS. Of all TID 
patients approximately 50% exhibit photosel15itivity. Patients suffering from the DNA repair 
disorder XP show marked sun(UV)sensitivity, pigmentation abnoIDlalities, and a strong 
predisposition to skin cancer restricted to sun-exposed areas of the skin. Several XP patients 
exhibit also accelerated neurological degeneration (Cleaver and Kraemer, 1994). Both CS and 
TID patients display a broad range of clinical features distinct of XP: including a relatively 
mild UV-scnsitivity, mental retardation, dysmyelination of the neurons, poor physical and 
sexual development and dental caries (Johnson and Squires, 1992; Nance and Berry, 1992). 
In addition, TTD patients show several specific hallmarks such as brittle hair and nails, due 
to a reduced synthesis of a class of cystine-rich matrix proteins, and ichthyosis (scaling of 
the skin), and do not exhibit an increased risk for developing skin tumours (Lehmann, 1987; 
Peserico et al., 1992). However, many parallels have recently been observed between CS and 
TTD. For instance, CS patients show thin hair and ichthyosis, which was found to be a 
pronounced feature of TTD (Nance and Berry, 1992). TID patients may exhibit 
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neurodysmyelination, bird-like facies, cataract and dental caries, which are typical CS 
symptoms (peserico et aI., 1992; McCuaig et aI., 1993). These observations suggest that both 
CS and TTD are part of one broader clinical spectrum. Many of these clinical features of CS 
and TID, besides UV-sensitivity, are remarkable since these symptoms are hard to explain 
on the basis of a deficiency in NER. 
Genetic heterogeneity in these human repair disorders is extensive. At least eleven 
complementation groups have been identified and the characteristics of them are listed in 
Table 2. Seven excision-deficient groups exist in XP, designated XP-A to XP-G (Vermeulen 
et aI., 1991). An eighth XP-group (called XP-variant) is not defective in NER, but impaired 
in daughter-strand repair (Lehmalll et aI., 1975). Two groups have been observed in CS 
(CS-A and CS-B). In TID, three complementation groups have been characterized, one is 
called TTD-A (Stefaninl et aI., 1993), and two other groups coincide with XP-D and XP-B 
(Stefanini et aI., 1992, and Chapter 5). Finally, several individuals show combined features 
of XP and CS. These patients fall into XP group B, D, and G (Johnson and Squires, 1992; 
Vermeulen et aI., 1993; Vermeulen et aI., 1994), suggesting that the disorders XP and CS 
might be related or that both diseases are part of a much broader clinical phenotype. The XP 
groups A-G are defective in NER, although to a variable extent. Most XP groups are 
deficient in both subpathways of NER: in transcription-coupled - as well as global genome 
repair. Both CS-A and CS-B are only deficient in preferential repair of the transcribed strand 
of active genes (Venema et aI., 1990a). The reverse is found in XP group C, in which the 
repair defect is limited to the global genome pathway (Venema et aI., 1990b and 1991). The 
high incidence of skin cancer associated with XP-C and the absence of this risk in CS 
suggests that the efficiency to remove lesions from the genome might be the main 
determinant for the induction of skin tumours. Several XP and CS complementation groups 
display considerable overlap with Chinese hamster mutants. The ERGG2 gene corrects the 
UV-sensitivity of XP-D fibroblasts (Flejter et aI., 1992), while ERGG3 compensates the 
repair defect of XP-B cells (Weeda et aI., 1990b). Recently, ERGG5 has been found to be 
responsible for XP-G (Scherly et aI., 1993), and finally ERGG6 corrects the repair defect of 
CS-B (Troelstra et aI., 1992). This extensive overlap stresses the value of the rodent mutants 
for understanding the molecular basis of NER defects in man; repair-deficient rodent cells 
can be very useful to isolate genes, in which mutations are not compatible with life or proper 
embryonic development in humans. For instance, ERCCl is not affected in any of the known 
human complementation groups of XP, CS or TTD(PIBIDS) (van Duin et aI., 1989b, and 
unpublished results). 
As already indicated in Table 1, nearly all the cloned mammalian NER genes have a 
yeast counterpart. This strong evolutionary conservation between yeast and man suggests that 
no principal differences exist between low and higher eukaryotes. Different versions of the 
same genes in the evolutionary diverse organisms Saccharomyces cerevisiae or 
Schizosaccharomyces pombe might help to isolate the mammalian homo logs by 
characterization of conserved domains. By such an evolutionary walking two human RAD6 
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Table 2: Characteristics of the human NER-deficient complementation groups 
Group Clinical characteristics Repair properties Remarks 
skin neurological relative UV' residual UDS 
cancer abnormalities incidence 
XP-A + ++ high +++ <5% 
XP-B +/- +++/+ very rare ++/+ < 10%/30-40% combined XP/CS and TID patients 
XP-C + high + 15-30% defective in global genome repair 
XP-D +/- ++/+/- intennediate ++/+ 15-50% XP, combined XP/CS and TTD patients 
XP-E +/- rare ± >50% 
XP-F +/- rare + 15-30% slow repair but prolonged 
XP-G +/- ++/+ rare ++ <10% XP and combined XP/CS patients 
CS-A ++ rare + 100% defective in transcription-coupled repair 
CS-B ++ high + 100% defective in transcription-coupled repair 
TTD-A + very rare + -10% typical TID patient. not the same as XP-B 
or XP-D 
-
'" 
homo logs (HHR6A and HHR6B) have been cloned using S.pombe and Drosophila 
melallogaster as intermediates (Koken et ai., 1991a; Koken et ai., 1991b). The RAD6 gene 
plays a role in post replication repair. damage-induced mutagenesis, and sporulation. As an 
example in NER: sequence conservation permitted the isolation of haywire, the Drosophila 
counterpart of XPB. It appears that NER genes of yeast and higher eukaryotes have the same 
ancestor. 
The DNA repair capacity is illost severely reduced in fibroblasts of XP groups A, B, and 
G. XP group A represents one quarter of all the XP cases and displays the severe clinical 
phenotype with both skin tumours and symptoms of accelerated neurological degeneration 
(Cleaver and Kraemer, 1989). The severe phenotype in patients cannot be related to a severe 
type of mutation, such as a large deletion, in XPA. For instance, the characterization of one 
of the mutations, which has been found in several Japanese XP-A patients, has shown that 
only a single base substitution in the 3' splice acceptor site of the third intron causes mRNA 
instability (Satokata et ai., 1990). In the rare group B, four patients have been documented. 
Three of these XP-B patients display simultaneously features of XP and CS, whereas one 
individual manifests the clinical characteristics of TID (Robbins et ai., 1974; Vermeulen et 
ai., 1994 and Chapter 5). Complementation group C represents also a quarter of the total 
number of XP patients. XP-C patients have a high risk for skin cancer, such as in XP group 
A, but they rarely display neurological abnormalities. (Cleaver and Kraemer, 1989). 
Complementation group D is the most heterogeneous, including XP patients with neurological 
problems, rare cases with combined XP/CS features, and individuals with TTD (PIBIDS) 
(Vermeulen et ai., 1991; Johnson and Squires, 1992; Stefanini et ai., 1992). Most individuals 
showing the photosensitive form of TTD belong to XP group D. Patients assigned to XP-E 
display a mild clinical phenotype of XP, which correlates with the high residual repair 
synthesis (50 - 60% in comparison to normal individuals) measured in fibroblasts of these 
patients. XP group F mainly consists of Japanese patients with relatively mild symptoms. 
Although repair in XP-F cells is rather slow, it can reach completion since it continues for 
a longer time (Zelle et ai., 1980). Finally, three XP-G patients demonstrate the combined 
XP/CS phenotype (Vermeulen et ai., 1993). The patient, representing the complementation 
group TID-A, shows typical TID symptoms such as hair-shaft abnormalities with reduced 
sulfur content, ichthyosis, and short stature. Apart from SUIl sensitivity, no clinical features 
associated with XP patients have been found. Pigmentary changes or skin tumours have not 
been observed. 
All the XP fibroblasts show a NER deficiency to a various extent. In these cells 
cyclobutane pyrimidine dimers can be removed by introduction of a CPD-specific 
endonuclease from bacteriophage T4 or Micrococlls Ilitelis. \Vhen the incision is made by 
these exogenous enzymes, the job of repair can be finished, resulting in nearly normal levels 
of CPD repair (Tanaka et ai., 1977; De Jonge et ai., 1985). Therefore, it is suggested that 
NER defects in XP cells are related to early steps of the reaction: recognition or incision. 
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2.3.3 Functions of nucleotide excision repair proteins 
Recognition of the DNA damage. The XPA protein has been purified from NER-
proficient HeLa cells (Robins et aI., 1991). The protein contains a DNA-binding zinc-finger 
domain (Miyamoto et aI., 1992) and has high affinity to bind DNA, damaged by UV or by 
cisplatin (Jones and Wood, 1993). Its yeast homolog is RADI4, which preferentially binds 
6-4 photoproducts in UV-damaged DNA (Guzder et aI., 1993). This implicates a possible 
role for XPA in recognition of the lesions, which is one of the early steps in nucleotide 
excision repair. The main properties of the human NER genes and their encoded products 
are summarized in Table 3 and illustrated in Figure 2. 
Another candidate to recognize DNA adducts is XPE. A polypeptide of 125 leDa was 
purified based on its affinity for UV-damaged oligonucleotides, and an associated 41 leDa 
protein was found in these preparations. A subset of XP-E patients lack a DNA binding 
activity (Chu and Chang, 1988), and microinjection of the purified protein (complex) into 
these XP-E fibroblasts restores DNA repair synthesis to n0l1nal1evels (Keeney et aI., 1994). 
This suggests that the protein (complex) is responsible for correction of the repair defect in 
XP group E. However, mutations in XP-E patients still have to be identified, which is 
possible because both genes encoding the 125 leDa and 41 kDa subunits have been cloned 
(Takao et aI., 1993; Keeney et aI., 1994). No indications for the function of the encoded 
proteins nor any hom.ology to known yeast genes could be found in the sequences. The mild 
repair defect in XP-E cells, even when the binding activity is completely lacking, suggests 
that the DNA damage binding protein has a role as stimulatory or accessory factor. Both 
XPA and XPE proteins show a much higher affinity for (6-4) photoproducts than for CPDs, 
which could be an explanation for the more efficient, about lO-fold, repair of (6-4) lesions 
in humans (Szymkowski et aI., 1993). 
DNA unwinding. Both XPB and XPD exhibit helicase activities; each in opposite 
direction, XPB 3'~5' and XPD 5'~3' (Schaeffer et aI., 1994), like their yeast counterparts 
RAD25 and RAD3. The possible functions of these helicases in the NER process have 
already been discussed (see paragraph 2.2). In XPB both the helicase domains and the 
putative DNA-binding motif are needed as indicated by site-specific mutagenesis (Ma et aI., 
1994). The discovery that XPB and XPD are subunits of the basal transcription factor TFIIH 
is highly important, because it links two distinct processes: DNA repair and basal 
transcription (Schaeffer et aI., 1993; Schaeffer et aI., 1994). TFIIH is required for 
transcription initiation (discussed in detail later) of genes transcribed by RNA polymerase II, 
suggesting that the complex has a vital function in the cell. Mutation analysis of several TTD 
patients deficient in the XPD gene revealed also an additional function for XPD, besides its 
role in NER. \Vhen excision repair activity is abolished> 80%, the growth kinetics remain 
normal in these cell strains (Broughton et aI., 1994). This result is in complete agreement 
with mutations found in the yeast RAD3 gene, especially in the ATP-binding domain, in 
which both helicase and repair activities were fully impaired, but not the viability of the cells 
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Table 3: Main properties of human NER genes 
Group 
XP-A 
XP-B 
XP-C 
XP-D 
XP-E 
XP-F 
XP-G 
CS-A 
CS-B 
TTD-A 
Cloned gene 
XPA 
XPBIERCC3 
XPC 
XPDIERCC2 
XPGIERCC5 
CSBIERCC6 
ERCCl 
HHR23A,B 
Function 
recognition of lesions 
transcription and repair 
global genome repair 
transcription and repair 
recognition of lesions? 
5' incision and mitotic 
recombination? 
incision 3' of the lesion 
transcription-coupled repair 
transcription-coupled repair 
transcription and repair 
5' incision and mitotic 
recombination? 
genome overall repair? 
Further characteristics 
binds preferentially damaged DNA. different from 
rodent group 1-7 
3'- 5' helicase. subunit of TFIIH 
complexed with HHR23B. binds strongly ss-DNA 
5'- 3' helicase, subunit of TFIIH 
binds damaged DNA? 
complexed with ERCCI. 4 and 11. both ERCC4 and 
ERCCll are candidates for deficiency in XP-F 
conserved domains with FENl, a structure-specific ss-
DNA endonuclease 
helicase domains of RAD 16 subfamily 
complexed with ERCC4. 11 and XPF 
ubiquitin-like N-terminal domain. HHR23B complexed 
with XPC 
'" The old ERCC-designation indicates the complementation groups of rodent mutants where the gene is defective 
(Sung et aI., 1988). These findings indicate that the helicase activity of RAD3 and probably 
also of XPD are not essential for their vital function in cells. 
Incision on both sites of the lesion. XPG shows limited but significant homology with the 
yeast RAD2 protein (Scherly et aI., 1993) and with the human FEN I protein (Harrington and 
Lieber, 1994). Although FENI is smaller than XPG, it shares all the domains conserved 
between XPG and RAD2. FEN I is a structure-specific endonuclease and cleaves a DNA 
substrate with a 5' single stranded flap (Harrington and Lieber, 1994). In addition, RAD2 
has single-stranded DNA cleaving properties. XPG demonstrates endonuclease activity on a 
Y -shaped DNA structure, which contains a duplex region and single-stranded tails. XPG 
cleaves specifically the DNA strand with a 5' single-stranded tail and the incision is made 
at the branch point a few bases into the duplex region (O'Donovan et aI., 1994). These 
results suggest that XPG is responsible for the 3' incision in the human NER pathway. The 
conservation between XPG, FEN I and yeast RAD2 inlplicates the existence of a subfamily 
of endonucleases specific for branched DNA. 
Strong evidence exists for a human protein complex carrying ERCCI, and the 
complementing activities of XP-F and the rodent complementation groups 4 and II (Chapter 
2, and Biggerstaff et aI., 1993). The ERCCI complex might be responsible for incision of 
the damaged DNA, and will be discussed in detail in paragraph 2.3.5. 
DNA synthesis and ligation. The final events in the NER reaction are refilling of the gap 
by DNA synthesis and ligation to the pre-existing DNA strand. RP-A (hSSB), which binds 
the non-damaged single-strand DNA template, proliferating cell nuclear antigen (PCNA), 
polymerase 0 andlor polymerase E, all previously discovered as replication proteins, are also 
required for the repair s)'nthesis reaction ill vitro (Cover/e)' et aI., 1991; Shivji et aI., 1992). 
Furthermore, ill vivo, peNA can be detected in repair sites and in replication sites. (Jackson 
et aI., 1994). DNA ligase I is responsible for the final closure of the remaining gap after 
DNA repair synthesis. 
NER genes with a so far unknown junction. The XPC gene has been cloned, but since 
the predicted amino acid sequence did not reveal any known enzymatic domains, no clues 
could be obtained for the role of XPC in repair (Legerski and Peterson, 1992). The XPC 
protein is found to be tightly associated with HHR23B, one of the two human homo logs of 
the yeast RAD23 protein (Masutani et aI., 1994). The complex binds preferentially ss-DNA 
and this binding specificity probably resides in XPC, since no DNA-binding activity could 
be measured using HHR23A or HHR23B alone (van del' Spek, unpubl. results) The predicted 
role of the complex is likely to be restricted to the subpathway of global genome repair 
(Venema et aI., 1990). It is not known whether other repair factors, in addition to the 
XPCIHHR23B complex, are specifically involved in the slower repair of lesions in the non-
transcribed part of the genome. However. a fully inactivated RAD4 gene, which is the 
presumed yeast homolog of XPC based on the sequences of both genes, results in a defect 
in both subpathways (Legerski and Peterson, 1992). In yeast, functional homologs of XPC 
might be RAD7 or RADI6, because the corresponding mutants are only affected in the repair 
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Figure 2. Model for human nucleotide excision repair. 
of non-transcribed DNA (Verhage et aI., 1994). It is possible that this reflects a principle 
difference between the NER processes in yeast and man, which may be related to genome 
organisation of both organisms. 
Mutations in CSB affect the mechanism of strand-specific repair. The protein contains 
the putative helicase domains, characteristic of the RAD16 subfamily (Troelstra et aI., 1992). 
CSB might be the factor that specifically couples NER and transcription, like the Mfd protein 
in E.coli. However, CSB is not found to be associated with any of the well-known 
transcription factors so far, and there is no sequence homology with Mfd (Bootsma and 
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Hoeijmakers, 1993). 
2.3.4 DNA repair ill vitro 
Information about the genes and the gene products involved in NER in mammalian cells 
is accumulating very rapidly. Two fmitful assays to detect repair of DNA damage are 
microneedle injection and cell-fusion. Complementation analysis have been performed using 
cell-fusion experiments, resulting in the identification of at least 10 different human- and 11 
rodent complementation groups involved in NER. Proteins, antibodies, and DNA can easily 
be introduced into fibroblasts by microinjection. The effect on the repair capacity of the cells 
is measured by UV-induced unscheduled DNA synthesis (UDS) (Vermeulen et a!., 1993). 
Both repair assays reflect the entire NER process ill vivo. Therefore, these procedures are 
not very useful to study the biochemistry of excision repair. A powerful ill vitro DNA repair 
assay as developed by Wood et a!. (1988) and independently by Sibghat-Ullah et a!. (1989) 
might help to investigate the components involved, and to dissect the NER reaction into 
discrete steps. 
The ill vitro DNA repair assay is based on defined damaged DNA substrates and cell-free 
extracts of rodent or human cell lines. These cell-free extracts have already been used in ill 
vitro transcription experiments, suggesting that proteins (complexes) still remain active in this 
type of extract (Manley et a!., 1983). In the reaction mixture, the repair enzymes incise the 
damaged DNA on both sites of the lesion and the damage-containing patch is removed. The 
remaining gap is filled by DNA polymerase while ["P]-Iabelled nucleotides are incorporated 
in the newly synthesized patch. As an internal control non-damaged DNA of a different size 
is included in each reaction. Then DNAs are isolated and linearized by restriction enzyme 
digestion prior to gel electrophoresis and autoradiography. The repair synthesis is ATP-
dependent and requires Mg2+ and K+. Extracts of cells representing the different XP 
complementation groups are repair-deficient in this ill vitro assay. Two mixed extracts from 
distinct complementation groups correct the repair activity to normal levels, indicating that 
the assay can mimic the ill vivo cell fusion complementation experiments. 
The ill vilro assay removes not only UV-induced damage like CPDs and 6-4 
photoproducts, but also psoralen and cisplatin adducts. However, the efficiency of repair is 
not equal for all types of lesions. The repair of 6-4 photoproducts is 10-fold faster than CPD 
repair (Szymkowski et a!., 1993). This relates to the situation ill vivo in which the less 
abundant UV-induced 6-4 photoproducts are removed far more rapidly and completely from 
the genome than the main UV-induced CPD lesions. A problem is observed using UV-
irradiated DNA as substrate, since, in addition to CPDs and 6-4 photoproducts, pyrimidine 
hydrates are induced as minor lesions. These pyrimidine hydrates are efficiently recognized 
by a NER-independent endonuclease activity present in all extracts of mammalian cell types. 
As expected, nicks in the DNA induce an aspecific incorporation of labelled nucleotides; 
therefore, it is important that the DNA has its circular closed form before adding to the 
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reaction mixture. The DNA substrate can be cleaned from these pyrimidine hydrates by 
treatment with E.coli Nth protein (Chapter 2, and Wood et aI., 1988). Another method to 
damage the DNA, without such a nuclease problem, is treatment with the chemical agents 
N-acetoxy-2-acetyl-aminofluorene (AAF), which induces almost specific N-(guanine-8-yl) 
adducts (Chapter 2). III vitro, AAF lesions are repaired with an efficiency comparable to 6-4 
photoproducts (Szymkowski et aI., 1993). The ill vitro repair mechanism can easily be 
manipulated by adding antibodies or purified factors. The repair assay represents bona fide 
nucleotide excision repair, although there are some limitations. For instance, the fact that 
approximately 1 % of the damaged DNA molecules undergo a repair event, and only global-
and no transcription-coupled repair can be detected in this in vitro procedure. 
The in vitro repair assay has been used for several approaches: testing purified repair 
factors for their repair capacity, the identification of some replication proteins to be involved 
in repair, and elucidation of the size of the damage-containing patch. In such a correction 
assay purified repair proteins from repair-proficient extracts were found to increase the repair 
synthesis to normal levels in extracts of XP group A (Robins et aI., 1991), XP group G 
(O'Donovan and Wood, 1993), and in XP group C. Purification of the XPC/HHR23B 
complex permitted the cDNA cloning of both components (Masutani et aI., 1994). In this 
case the in vitro assay was modified using UV-irradiated SV40 minichromosomes, a more 
chromatin like stmcture as substrate instead of naked DNA. RP-A (hSSB), proliferating cell 
nuclear antigen (PCNA), and the polymerases band <, previously isolated as part of the 
replication pathway, turued out to be essential for repair ill vitro (Coverley et aI., 1991; 
Shivji et aI., 1992), illustrating an overlap between these distinct processes: replication and 
repair. An excision assay with four defined CPDs in one DNA molecule clearly demonstrates 
that manlllalian NER induces a dual incision in the damaged strand, like in E.coti. The 
incision is made 4-6 base pairs 3' and 21-23 nucleotides 5' of the lesion. An 27-30 mer 
oligonucleotide, containing the damage, is excised (Huang et aI., 1992), which is larger than 
the 12-13 mer found in E.coli. 
The experimental work described in this thesis is centred around this in vitro repair 
assay. Firstly, it was used in complementation analysis of extracts of different rodent 
complementation groups, resulting in the discovery that ERCCI is part ofa functional protein 
complex together with ERCC4, ERCCll, and XPF, and characterization of this complex 
(Chapters 2-3). Secondly, the assay appeared to be crucial for the unexpected discoverly that 
at least three NER proteins are subunits of the transcription initiation factor TFIIH. These 
NER proteins, XPB, XPD and rfDA, function in both transcription and repair, suggesting 
that the entire TFIIH complex plays a role in these two DNA metabolizing processes 
(Chapters 4-6). 
2.3.5 ERCCl resides in a protein complex 
The first human NER gene was cloned in 1984 (Westerveld et aI., 1984). The gene, 
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designated ERCCI corrected the repair defect of rodent complementation group 1 after 
genomic transfection. The gene was isolated and characterized; the encoded protein showed 
sequence homology with the S.cerevisiae RADIO and the S.polllbe swil0 proteins. The C-
terminal part of ERCCI has homology with a UvrA segment and with the C-terminus of the 
UvrC protein (van Duin et aI., 1988). So far, ERCCI is the only NER gene, having 
homology with E. coli repair genes, but the UvrAfC homology of ERCCl was not found in 
the S. cerevisiae counterpart. The C-terminal part of ERCCI is essential for repair, in contrast 
to the N-terminus, since transfection of a eDNA with an N-terminal deletion of 
approximately 113 of ERCCI, still shows correction of the repair defect in rodent 
complementation group 1. ERCC 1 is not associated with a defect in any of the known human 
disorders, since direct transfer of ERCCI cDNA to cells of all XP, CS or TTD 
complementation groups failed to restore the repair defect (van Duin et aI., 1988, 
Vermeulen, unpublished results). 
In yeast, RAD 10 forms a tight complex with RAD 1. This complex is required in both 
NER and mitotic recombination (Schiestl and Prakash, 1988; Schiestl and Prakash, 1990), 
suggesting that also ERCCI might play an additional role in recombination. The 
RAD 1IRAD 10 complex displays endonuclease activity on both single-stranded and 
supercoiled double-stranded DNA (Sung et aI., 1993; Tomkinson et aI., 1994). Recently, 
evidence has been observed that the complex is a stmcture-specific nuclease (Bardwell et al.. 
1994). 
The first indication that EReCl also resides in a protein complex was deduced from 
complementation studies using the ill vitro DNA repair assay. Unexpectedly, mixtures of cell-
free extracts of the rodent complementation groups 1, 4, 11, or the human XP group F, show 
no restoration of the repair activity to normal levels. These data are in contrast to cell 
hybridization experiments bl vivo, in which repair activity was observed when two mutants 
of distinct complementation groups were fused. However, cell-free extracts of rodent groups 
2, 3, 5, and human XP-A are able to complement the NER deficiency of all other 
complementation groups (Chapter 2, and Biggerstaff et aI., 1993). The absence of correction 
is not due to trivial problems of the in vitro repair assay, because other complementation 
groups do increase the repair synthesis of extracts of rodent groups 1, 4, 11, and human XP-
F to normal levels. Lack of correction has been observed using extracts of several 
independent mutants of rodent groups 1 and 4, so allele-specific behaviour is unlikely. This 
observed pattern of non-complementation of NER defects ill vitro between a specific subset 
of complementation groups suggests that the corresponding proteins affect each other. This 
may occur when these proteins form a stable complex, of which the components cannot be 
exchanged under these ill vitro conditions. On the basis of this complementation analysis of 
rodent groups 1,4, 11, and human XP-F, one may conclude that the ill vitro DNA repair 
assay cannot replace cell fusion experiments to identify new NER-deficient complementation 
groups. 
Further evidence for a protein complex concerning ERCC1, 4, 11, and XPF has been 
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obtained from immunodepletion studies. Anti-ERCCI antibodies deplete a repair-proficient 
HeLa extract not only of the ERCCI repair capacity, but also of the repair-correcting 
activities ofERCC4, ERCCll, and XPF. ERCCI protein is significantly reduced in extracts 
of rodent groups 4, II, and human XP-F compared to extracts of other XP groups or wild-
type cells (Chapter 3, Biggerstaff et aI., 1993, and R.D. Wood, personal communication). 
This indicates that complex formation is needed for the stability of its subunits. 
Transfection experiments have already lUled out a direct involvement of ERCCl in the 
NER deficiency of XP group F (van Duin et aI., 1988 and Vermeulen, unpubl. results). In 
addition to ERCCl, only ERCC4 has been cloned as the complementation group 4 correcting 
gene (Thompson et aI., 1994). Unfortunately, sequence data have not yet been published. 
Partial data have revealed homology to the yeast RADl gene (Thompson, personal 
communication). Therefore, both ERCC4 and ERCC1l remain candidates for the gene, which 
is affected in XP-F cells. 
Despite extensive studies (Chapter 3) the composition of the protein complex has not 
been completely elucidated. A tentative subunit of 120 leDa was inmmnoprecipitated 
specifically from "S-Iabelled HeLa extract and not from a labelled XP-F extract by anti-
ERCCI antiselUm. This mammalian subunit might be the human homolog of the yeast RAD 1 
protein, based on the size of both proteins: 120 kDa for the subunit, compared to 126 leDa 
for RADI. The yeast radl and radiO mutants are defective both in NER and mitotic 
recombination (Schiestl and Prakash, 1988; Schiestl and Prakash, 1990). Rodent ERCCl and 
ERCC4 mutants demonstrate also a remarkable similarity. Generally, these rodent mutants 
display hypersensitivity to cross-linking agents, and these lesions are thought to be repaired 
by a recombinational event. Rodent group II and human XP-F cells do not show such an 
extreme sensitivity to MMe, which is maybe due to subtle mutations in these genes. In nOll-
denaturing gels the protein complex has a molecular mass of - 250 kDa, which is much 
larger than the - 120 leDa previously found in glycerol gradient sedimentation (Chapter 2, 
Biggerstaff et aI., 1993). The larger size of the protein complex found by gel-electrophoresis 
would better accommodate the presence of ERCC1, a protein with a predicted weight of 33 
leDa, a 120 leDa subunit, which is an ERCC4 candidate, and at least one unidentified protein 
in the complex. 
Purification of the EReCt complex to homogeneity could not be achieved so far using 
classical chromatography columns. Qne complication to purify the ERCCI complex is the 
low expression level (van Duin et aI., 1989a). The ERCC1 complex shows partially co-
elution with the transcription initiation factor TFIIH over four chromatography columns, but 
this co-elution is incidental, since no co-depletion of ERCCI and TFIIH was found by anti-
ERCCI antiserum or anti-p62 antiserum, a subunit of TFIIH. In addition, innnunodepletion 
of a repair-proficient extract using anti-EReCl antisemm does not remove the repair capacity 
to correct rodent groups 2 and 3 extracts (Chapter 2), while both correcting proteins reside 
in TFIIH (Chapters 4 and 5). Although an interaction between ERCCI and XPA was recently 
described (Li et aI., 1994a; Park and Sancar, 1994) association studies failed to disclose a 
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stable interaction between both proteins, but transient affinities during the NER process 
cannot be excluded. Presumable, another approach via a tagged ERCCI protein might be 
necessary to purify the ERCCI complex. 
It is expected that the ERCCI complex is the human homolog of the yeast RADlIRAD10 
complex, based on the homology of ERCCI and ERCC4 with RAD10 and RADI 
respectively. The ERCC 1 complex might have an additional function in recombination, like 
the yeast counterpart. Very recent data showed that the yeast RADlIRAD10 complex cleaves 
ill vitro a splayed-arm DNA structure, at the border of the single-stranded and double-
stranded area, only in the strand with a single 3' end (Bardwell et aI., 1994). When this is 
also true ill vivo, the RADlIRAD10 complex is likely to be responsible for the 5' incision 
in NER. By analogy to yeast, the ERCCI complex is predicted to exhibit incision activity, 
which would be in line ,vith the additional function of the ERCCt complex in recombination, 
since both processes imply a DNA incision step in their reaction mechanisms. However, the 
incision activity of the ERCCI complex still has to be confirmed. Recently, XPG was found 
to display endonuclease activity on similar splayed-arm DNA structures with 5' single-
stranded tails, implicating that XPG is required for the 3' incision (O'Donovan et aI., 1994). 
No human disorder has been observed yet to be due to an ERCCI-deficiency. Perhaps 
the additional involvement of ERCCl in recombination is responsible for clinical symptoms 
in patients that are not directly associated with NER. Presumably, a mouse model can give 
more indications of an ERCCl-deficiency in man. Mice have been generated in which both 
ERCCI alleles were inactivated (McWhir et aI., 1993, and Weeda, unpublished results). The 
homozygous ERCCI-deficient mice (-1-) show retarded growth in comparison to the 
heterozygote (+1-) or the wild-type (+1+) litter mates, and die at an age of4 to 10 weeks. 
In addition to growth deficiency, liver and kidney abnormalities have been observed in (-1-) 
mice. Homozygous mice are underrepresented, suggesting that these mice might have a 
decreased viability. Embryonic fibroblasts of homozygotes display both UV-sensitivity and 
hypersensitivity to the cross-linking agent MMC, confirming the expected NER-deficiency. 
If a human disorder due to an ERCCI-deficiency exists, and if the phenotype is related 
to these homozygous mice, patients may die very young due to liver problems before they 
can be clinically recognized as having a defect in NER. Pigmentation abnormalities or UV-
sensitivity are often not noted in very young XP patients. Alternatively, a defect in ERCCI 
might not be viable in man, since no expected segregation of ERCCl-deficient alleles has 
been observed in mice. More subtle mutations in ERCCI, rather than a complete inactivation 
of the gene, will hopefully result in a longer lifetime of the (-1-) mice. This will allow to 
study the role of ERCCt in carcinogenesis, since skin tumour induction by carcinogenic 
agents usually requires several months. A series of mouse models lacking different excision 
repair genes will be generated in the future, which is important to study the clinical aspects 
of a NER-deficiency in more detail. 
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3. DNA repair: link to the process of transcription 
3.1 Transcription initiation by RNA polymerase II 
One of the basal initiation factors, TFIIH, is required for transcription initiation and is 
involved in nucleotide excision repair. Therefore, the process of transcription initiation by 
RNA polymerase II (pol II) will be discussed briefly. In eukaryotes, transcription of protein-
encoding genes is carried out by RNA pol II. Two classes of transcription factors are 
observed: general initiation factors, essential for initiation of a basal level of transcription 
from many core promoters, and regulatory factors, mediating the action of activators, 
silencers, and enhancers. 
Transcription initiation by RNA pol II requires at least six basal transcription initiation 
factors. The assembly of these transcription factors on the promoter has been extensively 
studied ill vitro (Conaway and Conaway, 1993). Promoters recogItized by pol II often have 
a TATA-box, which is located -30 bp upstream of the transcription start site, and an 
iItitiation motif at position + 1. As an iItitial step the TATA box-binding protein (TBP), a 
subunit of TFIID, binds to the promoter. Hmvever, a subset of promoters Jacking this TAT A 
clement is also recognized by the protein. In addition to TBP, TFIID contains several TBP-
associated factors (TAFs), which are probably mediating transcriptional activation. 
Subsequently, TFIIA binds THP, thereby stabilizing the TFIID-DNA interaction and acting 
as a binding site for TFIIB. TFIIF appears to associate with RNA pol II and delivers it to 
the pre-initiation complex. 
Eukaryotic pol II is composed of 10 different subunits. The largest subunit of pol II 
contains an unusual C-terminal domain (CTD) comprised of multiple repeats of the heptamer 
consensus sequence Tyr-Ser-Pro-Thr-Ser-Pro-Ser. This CTD is specific for eukaryotic pol 
II enzymes. The length of the heptapeptide repeats correlates with the genomic complexity 
of the organism; it occurs 26-27 times in yeast, 42-44 times in Drosophila, and 52 times in 
mouse and man (Young, 1991). As a result of this high content of serine and threonine 
residues, the CTD can be extensively phosphorylated. The function of CTD phosphorylation 
has been analyzed: the nonphosphorylated (IIA) form of the polymerase stably associates with 
the preinitiation complex, whereas the phosphorylated (110) form is isolated from actively 
elongating complexes. The conversion of IIA to no occurs prior to the formation of the first 
phosphodiester bond (Laybourn and Dahmus, 1990). Phosphorylation of the CTD might be 
the trigger for transition from the initiation- to the elongation phase. 
The association of the basal factors TFIIE and TFIIH completes the assembly of the pre-
initiation complex (Zawel and Reinberg, 1993). An ATP-dependent step is required during 
the initiation step of transcription (Sawadogo and Sentenac, 1990). So far, TFIIH is the only 
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factor displaying known catalytic activities. Its activity phosphorylates the large subunit of 
RNA pol II. In addition, TFIIH shows DNA-dependent ATPase and helicase activities (Lu 
et aI., 1992; Schaeffer et aI., 1993). Most of the tral15cription initiation factors are 
multisubunit protein complexes. and these factors have been characterized by purification. 
after which the corresponding genes could be isolated. 
Transcription ill vitro from the adenovims major late promoter (AdML) requires all the 
described general initiation factors, but only a subset of basal factors is necessary for 
transcription of the inlluunogJobulin heavy chain (IgH) promoter. The transcription appears 
to be dependent on the topology of the DNA; negatively supercoiled DNA obviates the need 
for the factors TFIIE and TFIIII. Probably, melting of the DNA for the formation of an open 
complex is facilitated by negative superhelical twists (Parvin and Sharp, 1993; Timmers, 
1994), suggesting that the configuration of the DNA template is an important parameter 
determining initiation in vitro. There is evidence that TFIIH has a stimulatory effect on 
transcription of supercoiled templates. The effect is more pronounced on HIV type 1 than 
on the AdML promoter, implying a possible promoter specificity. Whether this is the case 
ill vivo remains to be proven, since all data have been obtained using in vitro nlT1-off assays 
and a linlited number of promoters. Only a 'minimal initiation complex' containing TBP, 
TFIIB, TFIIF, and pol II, is sufficient for the production of transcripts up to 70 nucleotides 
(Tyree et aI., 1993). 
It is not yet clear how many subunits reside in the TFIIH complex. In the most purified 
fraction five predominant subunits are observed, including pS9, p62, p44, p41 and p34, and 
at least three more loosely associated components: p80, p55 and p38 (Gerard et aI., 1991). 
The function of the p62 protein is unknown, although the gene was cloned some years ago. 
Suprisingly, the pS9 subunit was found to be identical to the XPB protein described 
previously by Weeda (Weeda et aI., 1990a; Schaeffer et aI., 1993). Both 3'~5' helicase 
activity and at least part of the ATPase activity appear to be associated with the XPB subunit 
ofTFIIH (Schaeffer et aI., 1993; Roy et aI., 1994b). The pSO subunit has been identified as 
the equivalent of the repair protein XPD, and a 5'--»3' helicase activity is attributed to this 
subunit (Schaeffer et aI., 1994). The pSO subunit could hardly be detected in the most 
purified TFIIH fraction, suggesting that either a small portion of the complex is in an active 
conformation or the different subunits are not available in stoichiometric amounts in TFIIH. 
In addition to XPB, XPD and p62, the genes encoding the subunits p44, the homolog of the 
yeast SSLl, and p34 have been cloned. Putative Zn-finger domains suggest that both proteins 
are involved in DNA binding (Chapter 6). The subunit responsible for the kinase activity is 
recently identified as MOl5, a cyclin-dcpendent kinase, which is involved in cell cycle 
regulation (Feaver et aI., 1994; Roy et aI., 1994a). This exciting discovery will be discussed 
in more detail in paragraph 4. 
In addition to human cells, transcription initiation factors have also been isolated from 
yeast and rat liver cells. The yeast factor b, homologue of TFIIlI, consists of five 
polypeptides: pS5 (RAD3), p75 (TFB1), p55, p50 (SSLI), and p3S. Although, the less 
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tightly associated component of p 105 (RAD25/SSL2) stimulates the transcription activity ill 
vitro (Fe aver et a!., 1993) and indications have been found for a holocomplex in yeast 
showing three additional subunits p47, p45 and p33 (Svejstrup et a!., 1994). Previously SSLI 
and SSL2 have been identified as suppressors of an artificial stemloop structure in the 5 'UTR 
of His4 mRNA, which blocks translation initiation (Gulyas and Donahue, 1992; Yoon et a!., 
1992), one assumes tacitly that both proteins are subunits of the transcription initiation factor 
b. In factor D, the rat homolog of TFUH, at least eight subunits have been identified 
(Conaway and Conaway, 1989). These transcription initiation factors from man, rat and yeast 
and their subunits are summarized in Table 4. The distinct composition of TFIIH in diverse 
organisms is probably due to different purification schemes to isolate these transcription 
initiation factors, and variable dissociation of more loosely associated components during 
purification. 
3.2 Role of TFIIH in transcription. 
The function of TFIIH in transcription is not completely clear. The initiation factors 
TFUE and TFUH are not required for transcription of certain promoters on supercoiled DNA 
templates. while these factors are necessary in the case of the same promoters on linear 
templates (Parvin and Sharp, 1993; Timmers, 1994). The p5G subunit ofTFUE mediates the 
recmitment of TFUH by binding the XPB(p89) subunit (Serizawa et a!., 1994); ill vitro this 
interaction is sufficient to purify transcriptionally active TFIIH complexes (Maxon et at.. 
1994). In addition, TFUE interacts also with pol UA, TBP, TFUD, and TFUF. TFUE 
stimulates the TFUH-associated kinase activity in the presence of DNA at a late stage of the 
assembly of the preinitiation complex. TFUH phosphorylates the CTD of RNA pol U and, 
in addition, several other factors, like TFIlD, (TBP) , TFUE. (p5G), and TFUF. (RAP74) can 
be phosphorylated (Ohkuma and Roeder, 1994). Probably TFUE regulates the 
phosphorylation activity of TFIIH, resulting in cOIlversion into the active initiation complex. 
Recently, data have been obtained that TFIIH is involved in promoter clearance, rather 
than in the initiation or the elongation phase of transcription (Goodrich and Tjian, 1994). 
Association of TFUE and TFUH to the minimal initiation complex completes the formation 
of an active transcription complex. The complex requires ATP to produce extended 
transcripts. suggesting an intermediate phase between initiation and elongation. TFIIH is not 
necessary for open complex formation, because initiation can occur without TFIIH on 
supercoiled DNA templates and in abortive initiation assays, wherein a trinucleotide abortive 
transcript is formed. Probably the helicase activity of TFUH extends the melted region of the 
DNA, when this region reaches a sufficient length the RNA pol U looses contact with the 
promoter and enters the elongation phase. TFUE and TFUl! are not required during 
elongation (Goodrich and Tjian, 1994). However, it caIUlOt be excluded that TFUH is also 
involved in early elongation, because transcriptional pause sites in 5' regions of a subset of 
Drosophila heat-shock genes are found to be associated with pol U (A) molecules (Ohkuma 
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Table 4: Human transcription initiation factors and their homologs in rat and Saccharomyces cerevisiae. 
Human Subunits Rat Subunits Yeast Subunits 
TFIIA' p34. p19. p14 
TFIIB p33 
'" 
p35 e 
TFIID p38(TBP) and TAP's 7 d p27(TBP) 
TFllE p34, p56 , p58. p34 g' plOS. pS4. p30 
TFllF p30. p74 By p67. p31 a' p66. p43 
TFIIH p89(XPB). p62. p44. p41, p34. 
" 
p94. p85. p68. p46. p43. b p85(RAD3). p75(TFBl). p55, 
[P80(XPD). p50. p38. p32] p40. p38, p35 pSO(SSLl). p38. 
[Pl05(SSL2). p47. p45. p33] 
, 
-- --
I) The human TFllA has been purified as a subunit of 43 kD. as 38 kD and as a heterotrimer composed of the subunits 34. 19 and 14 kD (Conaway and Conaway. 1993). 
§ It is not clear yet how these factors are related to mammalian initiation factors 
[1 indicates more loosely associating components 
I 
, 
and Roeder, 1994). This suggests that pol II has to be re-phosphorylated before efficient 
read through of a pause site. 
Chromatin structures, like loops, decondensed, and condensed domains, are important, 
since these can influence the processing of transcription, replication and recombination. How 
these stmctures affect gene expression is largely unknown. Transcription may require at least 
a transient unwrapping of the nucleosome-bound DNA. The proteins of the high mobility 
group (HMG), chromatin-associated proteins, are known to bind and bend linker DNA 
(Travers, 1994). It appears that the HMG2 protein represses basal transcription ill vitro after 
linkage of the second and before addition of the fifth nucleotide. The effects of HMG2 are 
completely relieved by adding purified TFIIH fractions, suggesting an essential role for 
TFIIH in removing DNA-bound repressors (Stelzer et a!., 1994). Fine-tuning of different 
regulatory mechanisms, like transcription activation, promoter specificity or chromatin 
stlUcture has to be elucidated. 
3.3 Role of TFIIH in repair 
The identification of XPB as a subunit of TFIIH suggests a possible function of this 
transcription factor in repair. Chapter 4 presents data showing that purified fractions of 
TFIIH correct the XPB-deficicncy ill vivo as well as ill vitro. In addition, micro injection of 
the same TFIIH fractions into XP-D and TID-A fibroblasts induces repair synthesis to 
normal levels. These results could be confirmed hi vitro by adding these fractions to extracts 
of rodent complementation group 2 or human TTD-A cells: again a clear correction of the 
repair defect lVas observed (Chapter 5). lnmmnodepletion studies, using antibodies raised 
against the subunits p89 or p62, show the removal of the repair-correcting activities of XPB, 
XPD and TTDA from a repair-proficient extract. In contrast, repair-correcting activities of 
XPA and XPG remain in the depleted extract. These results suggest that all three subunits 
reside in a TFIIH configuration. The subunit responsible for the correction of the TTD-A 
defect is not yet known. The three complementation groups XP-B, XP-D and 'fTD-A are 
defective in both subpathways ofNER: global genome - and transcription-coupled repair. The 
requirement of XPB(p89) and XPD(p80) in transcription initiation was deduced from ill vitro 
results (Schaeffer et a!., 1993; Schaeffer et a!., 1994). To verify that both subunits XPB and 
XPD are also directly involved in transcription bl vivo, antibodies against these proteins were 
injected into normal fibroblasts, The NER activity as well as RNA synthesis were 
significantly decreased. In contrast, anti-EReCl antisemm reduces only the repair activity, 
whereas RNA synthesis remains normal. The dual functions of XPB and XPD in NER as 
well as in transcription strongly suggest that the entire TFIIH complex is essential for both 
DNA metabolizing processes. Evidence for this multifunctional role of TFIIH is extended by 
data observed in yeast. The SSLl and TFBI mutants show hypersensitivity to UV and the 
NER defect of these muta.nts can be corrected by purified factor b (Wang et a!., 1994b). 
Evidence that XPC is associated with TFIIH as described previously (Drapkin et a!., 
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1994) is difficult to reconcile with the notion that XPC is implicated only in the transcription 
independent mechanism of global genome repair. The connection between XPC and TFIIH 
could not be confirmed in our experiments. In the first chromatography step the repair 
activities of XPB and XPD, both subunits of TFIIH, and XPC are already separated 
(Vermeulen, unpuhl. results), However, the global genome repair requires most of the repair 
proteins, which are also involved in the transcription-coupled repair pathway. These include 
the damage-recognition proteins. as well as the incising and helix-unwinding components. A 
transient interaction between TFIIH and XPC/HHR23B cannot be excluded during the repair 
process in the non-transcribed genome. 
Transcription is impaired by DNA damage, since RNA pol II is arrested at the site of 
the lesion in the transcribed DNA template. Pol II covers the lesion, because photolyase can 
no longer cleave a CPD that blocks the DNA polymerase (Donahue et aI., 1994). Thus the 
polymerase has to be displaced from the lesion to allow access for repair enzymes. 
Presumably, this is accomplished by a backward movement of pol II and cleavage of six 
nuc1eotides from the 3' end of the nascent transcript, because the 3' incision in NER is made 
6 base pairs upstream of the lesion (Huang et al., 1992). Both the polymerase and the nascent 
transcript remain stably associated with the DNA (Donahue et aI., 1994). This stability 
contrasts with the situation in E.coli, where the transcription repair coupling factor (TRCF) 
removes the polymerase from the DNA. TRCF remains bound as a signal to recmit the 
UvrA,B complex (Selby and Sancar, 1993). In this way the damage is rapidly repaired by 
the transcription-coupled repair process. When the eukaryotic polymerase is displaced and 
the repair proteins are recl1lited, the TFIIH factor might unwind the DNA helix around the 
lesion by its helicase-associated activity. After the lesion has been repaired, the transcription 
factor TFIIS may probably help to restart elongation using the nascent transcript. Normally 
TFIIS assists the process of elongation through transcriptional pause sites, which are 
sequence-specific sites, where transcription can be arrested (Reines et aI., 1989). 
The CSA and CSB proteins also playa role in transcription-coupled repair, although it 
is not known whether these proteins interact with one of the transcription factors. Perhaps, 
CSB functions in scanning the transcribed DNA strand for lesions and is involved in the 
recmitment of the repair proteins. Alternatively, the developmental abnormalities found in 
CS patients might be the result of a repair defect in expressed genes rather than a deficiency 
in transcription. Ionizing radiation induces lesions through oxidation by free radicals that 
damages the DNA. Normally free radicals are produced as by-products of oxidative 
metabolism in the cell, and the damage generated by these radicals is repaired mainly by base 
excision repair (BER). CS patients are also deficient in transcription-coupled repair of X-ray 
induced lesions. This suggests that certain lesions induced by free radicals are repaired by 
NER, or that other repair pathways, such as BER, might be coupled to transcription. Cells 
that proliferate rapidly during development or cells with a high metabolic activity produce 
a high level of free radicals. This might be the reason that these cells are very sensitive to 
defects in transcription-coupled repair (Hanawalt, 1994). More detailed studies are necessary 
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to elucidate this complex mechanism of transcription-coupled repair and its biological 
relevance. 
3.4 Clinical consequences of mutations in subunits of TFIlli. 
The disorders related to mutations in subunits of TFIIH show a very broad spectlUm of 
clinical symptoms. XP group D displays three classes of patients. Patients with a classical 
XP phenotype, patients with combined XP/CS features, and several individuals with TTD 
symptoms. In contrast, XP group B is very rare and displays two classes of patients, XP/CS 
and TID. Within groups Band D, the severity of the biochemical NER defect cannot be 
related to the clinical symptoms in patients. A higher level of residual repair activity is 
observed in XP-D cells compared to XP-B, but the clinical features are similar in both 
groups. Even within one complementation group differences in the clinical phenotype occur. 
Two patients of XP-B: XP IlBE and XPlBA, display the same low level of residual repair 
activity (0; 10%). However, patient XPllBE is severely affected, showing skin tumours at 
early age. while only mild skin lesions at an age of > 40 years and no skin tumours have 
been observed in XP1BA (Vermeulen et aI., 1994). Several peculiar symptoms of CS and 
TID. like mental retardation due to dysmyelination of neurons, impaired sexual development 
and brittle hair and nails, can hardly be explained on the basis of a NER-deficiency. Probably 
transcription is to some extent affected in these patients. in addition to the NER defects. The 
defects in transcription must be subtle, because severe deficiency in transcription is probably 
not compatible with life. These defects might occur when mutations in TFIIH subunits affect 
only the transcription of a subset of genes or when overall transcription is slightly decreased. 
The effect might be that the level of mRNA or translated proteins is below a certain critical 
threshold. The reduced cysteine content in brittle hair in TID patients may be due to a 
decreased synthesis of a group of high sulphur proteins. Since transcription of the myelin 
basic protein is rate-limiting (Read head et aI., 1987), its reduced transcription may cause 
dysmyelination of the neurons in CS and TID. Combined XP/CS features have also been 
recognized in patients of XP group G (Johnson and Squires, 1992; Vermeulen et aI., 1993), 
suggesting that possibly XPG affects basal transcription as well. Perhaps XPG influences 
RNA pol II, that has to move backwards to make the DNA accessible for the 3' incision in 
case of a lesion in the DNA. 
If the hypothesis that mutations in TFIIH subtly affect transcription is correct, it should 
be possible to detect transcriptional defects without a repair involvement. Indeed, patients 
have been identified displaying clinical characteristics of TID and CS, but no evidence of 
photosensitivity or a NER deficiency (LehmaIlll, 1987; Lelunann et aI., 1993). The 
hupothesis would be strengthened when patients exhibiting mutations in transcription factors, 
that do not affect NER, can be identified. The non-photosensitive TID patients are good 
candidates, harbouring partial mutations in XPB or XPD genes. which only disturb the 
transcription function of TFIIH. This has to be established by further experimental studies. 
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Presumably, a much wider class of human disorders call be regarded as " transcription 
syndromes". A search in the OMIM database (McKusick, 1992) reveals several syndromes, 
like Rothmund-Thompson, OTD, IFAP, ICE, CAM(F)AK, Sjogren-Larsson, RUD and KID. 
All these syndromes share at least four pronounced clinical features of CS or TTD, and even 
some of them display the occurrence of skin cancer. 
4. Evidence for interactions between DNA repair and cell cycle 
regulation 
Interactions between different DNA metabolizing processes like repair, transcription, and 
replication have been observed. Remarkably, the process of cell cycle control can also affect 
NER. The tumorsuppressor gene p53 plays an important role in stressed cells. Its expression 
is significantly increased in response to a variety of DNA damaging agents. As a 
consequence, the cells are arrested in their cell cycle until the damage is repaired (Vogelstein 
and Kinzler, 1992). The importance of its ability to an'est cell growth is shown by the fact 
that alterations of the p53 gene appear to be involved in the majority of human malignancies. 
In response to UV irradiation P53 has at least one additional function, it initiates the process 
of apoptosis, also named progranmled cell death. Apoptosis might prevent the development 
of skin cancer, because unwanted cells are eliminated, for instance those that have an 
increased amount of mutations. P53 is also a transcription factor, which regulates the activity 
of other genes. Enhanced p53 levels stimulate the expression of p21 and GADD45, which 
causes growth arrest. P21 is an inhibitor of the cyclin-dependent kinases (cdk), key enzymes 
needed for cell cycle progression. The p21 induces a Gl arrest to allow repair of DNA 
damage before replication. A remarkable observation is the fact that p21 inhibits specifically 
the role of PCNA in replication, but does not block the PCNA-dependent NER reaction (Li 
et ai., 1994b). Gadd45 is found to be associated with PCNA, it enhances the repair activity 
ill vitro and inhibits cells to enter the S phase (Smith et ai., 1994). It is not clear yet whether 
Gadd45 has a direct role in repair, or that Gadd45 suppresses cell growth through another 
mechanism. In addition to the fact that p53 indirectly stimulates rcpair through Gadd45, there 
is evidence for a direct role of p53 in repair, since p53 might be associated with XPB ill vitro 
(Wang et ai., 1994a). However, veq little is known about how p53 binds XPB and affects 
NER. These data suggest that the arrest of cell cycle progression regulates NER before the 
cell enters S or M phase. 
More evidence in favour of a correlation between cell cycle regulation and NER is 
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recently found by the isolation of the gene that encodes the kinase activity of TFIIH both in 
human and yeast (Feaver et aI., 1994; Roy et aI., 1994a). These genes are homologous to 
the previously isolated Xenopus M015. M015 has been identified as the catalytic subunit of 
a CDK-activating kinase (CAK) , a cyclin-dependent protein kinase that phosphorylates p34,dd 
and p33'dk2, which has a key function in cell cycle control (Poon et aI., 1993; Solomon et aI., 
1993; Fesquet et aI., 1993). M015 requires cyclin H as its partner, which enhances the 
kinase activity (Makela et aI., 1994). In addition to MOI5, cyclin H could be observed in 
the most purified TFIIH fractions. M015 was shown to interact with XPD, a subunit of 
TFIIH. Phosphorylation of the CTD of RNA pol II requires not only the presence of M015, 
but also certain key subunits of TFIIH. Presumably the cell uses the CAK activity in two 
independent processes: cell cycle regulation and transcription. It appears that there are fOlms 
of TFIIH complexes, that differ in their subunit composition. This suggests that the various 
functions of TFIIH in transcription, repair, and possibly in cell cycle control need different 
TFIIH compositions. 
5. Conclusions and future perspectives 
Information about the excision repair pathway increased rapidly in the last few years. 
Genetic analysis using repair-deficient mutants have revealed nearly all the repair genes 
corresponding to the different complementation groups in rodents and human. Properties of 
the encoded gene-products have been found by purification and biochemical studies of most 
enzymes. Very soon it will be possible to reconstitute the entire NER process in vitro using 
the purified and/or recombinant repair factors. Details concerning the interactions of the 
distinct repair proteins with each other or with DNA have to be elucidated, and mechanisms 
regulating DNA repair response are largely unknown. 
The first indication that transcription and repair were linked to each other has been 
provided by the discovery of a mechanism designated as transcription-coupled repair. Certain 
types of DNA lesions, for instance CPD, are repaired by such a pathway. This preferential 
repair of expressed genes is very complex, since differences in repair exist between rodent 
and human cells. In rodent cells CPDs are rapidly removed from the transcribed strand of 
active genes, although this represents only a small fraction of the total amount of CPDs in 
the genome. In contrast, human cells repair CPDs very efficiently both from expressed genes 
and the genome overall. In spite of this difference in repair efficiency of total genomic DNA 
rodent and human cells are equally resistant to UV. This paradox might be explained by the 
fact that rodents remove dinlers from regions that are immediately essential for UV -survival. 
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Alternatively, CPDs are not as mutagenic as other lesions, although the high rate of 
spontaneous transformations in rodent cells might be explained by the presence of many 
CPDs in the genome overall. 
Another link between the processes of repair and transcription was found by the 
remarkable observations that the repair enzymes: XPB, XPD, and TTDA are subunits of the 
transcription initiation factor TFIIH. and function in both repair and transcription. Many 
clinical symptoms in CS and TID patients, which might not be related to a NER-deficiency, 
can be explained as subtle defects in transcription, suggesting the existence of 'transcription 
syndromes' in which patients suffer from transcriptional defects without any NER deficiency. 
but tllis hypothesis has to be confirmed. An alternative explanation as suggested by Hanawalt 
(Hanawalt, 1994) that growth abnormalities found in CS and TTD patients are probably due 
to the accumulation of free radical damage in expressed genes, thus by a DNA repair defect, 
cannot be excluded. Perhaps highly proliferating or metabolic active cells are very sensitive 
to deficiencies in transcription-coupled repair. 
The influence of chromatin structure on DNA metabolizing processes like replication, 
transcription, and repair is far from understood. Loosening of the chromatin stlUcture is 
necessary to allow transcription. In these open chromatin domains, not only active genes are 
repaired more rapidly, but this rapid repair extends beyond the entire region. The 
nucleosomes in the DNA stlUcture have to be removed before transcription can be initiated, 
since RNA polymerase II complex is even larger than the nucleosomes. Presumably, this 
nucleosome removal promotes also excision repair of DNA damage. The observation that 
preferential repair varies between genes, even when the same lesion is studied, might be 
explained by the high stability of some nucleosomes inside transcribed regions. 
The very exciting results recently observed that cell cycle control might affect excision 
repair and probably also transcription, require more detailed studies to elucidate the precise 
role of proteins like M015 in these processes. Is M015 the trigger to initiate cell cycle 
arrest, after transcription is blocked by DNA lesions? Is the same kinase used in both distinct 
processes: transcription and cell cycle regulation? Does the possible interaction between 
M015 and XPD indicate that M015 is involved in sensing DNA lesions or changing the 
configuration mode of TFIIH from transcription into repair? Several other genes are induced 
in response to X-ray irradiation, like p53, GADD45 and p21, enhancing directly or indirectly 
excision repair. 
In the future, NER defects in humans will be mimicked in animal models by gene 
replacement of the gene of interest. The generation of repair-deficient mice would provide 
more insight in the distinct clinical features observed in NER-deficient patients and in the 
processes of mutagenesis and carcinogenesis. Mice defective in the genes ERCCl, XPC, or 
XPA have already been developed (McWhir et al., 1993; G. Weeda and E. Friedberg, both 
personal communication; Tanaka, submitted). XPC-deficient mice might give clues about the 
role of global genome repair in carcinogenesis, whereas CSB-deficient mice will shed light 
on the contribution of transcription-coupled repair to the clinical symptoms observed in these 
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NER syndromes. The example of XPA-deficient mice (Tanaka, submitted), which closely 
imitate the phenotype of XP-A patients, is very promising in this respect. 
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Chapter 2 
Evidence for a repair enzyme complex involving ERCCl and 
complementing activities of ERCC4, ERCCll and xeroderma 
pigmentosum group F 
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and complementing activities of ERCC4, ERCC11 and 
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Nucleotide excision repair (NER), one of the major 
cellular DNA repair systems, remOl'CS a "ide range of 
lesions in a mwti-enz)nlC reaction. In man, a !\'ER defect 
d~e to a mutation in one of at le-astH distinct genes, can 
gl\'C rise 10 the inherited repair disorders xerodenna 
pigmentosum (XP), Cockayne's syndrome or PlBIDS, a 
photosensitiyc form of the brittle hair disease tricho-
thiodystrophy. Laboratory-induced NER-deflclenl 
mutants of cultured rodent cells ha\'e betn classified Into 
11 complementation groups (CGs). Some of these ha\'e 
been shoun to correspond with human disorders. In ceH-
free e.\1racts prepared from rodent CGs 1-5 and 11 but 
not in a mutant from CG6, we find an impaired r~pair 
of damage induced in plasmids by UV light and N-
acetoxy-acetylaminofluorene. Complementation analysis 
ill ~'iIrO of rodent CGs Is accomplished by paimise mixing 
of mutant extracts. The results show that mutants from 
groups 2, 3, 5 and XP-A can complement all other CGs 
tested. Howewr, selecth'e non-complementation ill },jiro 
was obsened in mutual mixtures of groups 1, 4, 11 and 
XP-F, suggesting that the complementing aclh'ities 
inml\'ed somehow affect each other. Depletion of \\ild-
type human extracts from ERCCI protein using spedfie 
anti-ERCCI antibodies concomitantly remo\'ed the 
correcting acthities for groups 4, 11 and XP-F, but not 
those for the other CGs. Furthermore, we find that 
33 kDa ERCCI protein sediments as a high mol. \\t 
species of -120 kDa in a nath'e glycerol gradient. These 
results strongly suggest the presence of a pre-existing 
enzyme complex in mammalian cell extracts, harbour-
ing at least the products of the ERCCI and ERCC4 genes. 
TIlls complex also carries complementing activites of XP 
group F and rodent CGll. We postulate that the com-
plex, like the one in Saccharomyces cere~'jsilJe ill\'olving 
the RAOl and RADIO proteins (the latler being the 
homologue of ERCC1), functions in both NER and 
recombinational repair. 
Key words: Chinese hamster mutant/complementation 
analysis/damaging agents/nucleotide excision repairlrepair 
complex 
Introduction 
Nucleotide excision repair (NER) is a DNA repair system 
that has evolved in aU living organisms for the removal of 
lesions inflicted on DNA by mutagenic radiations (notably 
UV light) or numerous chemical agents. It is a muIti-enzyme 
process involving specific recognition and dual incision of 
the damaged strand. followed by lesion removal, gap-
refilling and strand ligation (Grossman and Yeung, 1990; 
Selby and Sancar, 1990; Hoeijmakers. 1991). In man 
g.enetic defects in ~ER of UV+induced DNA damage giv~ 
nse to the severe disorders xerodenna pigmentosum (XP) 
Coc~~y'ne's syndr~me (C~) or PIDlDS. Besides hyper: 
sensItIVity of the skin to sunlight and progressive neurological 
dysfunction, a dramatically increased risk of skin cancer (XP) 
or developmental abnormalities (CS) entail the clinical 
hallmarks of these disorders (Cleaver and Kraemer, 1989; 
Nance and Berry, 1992). prnlDS is a photosensitive form 
of the brittle hair disorder lrichothiodystrophy (Lehmann 
1987). Somatic cell hybridization studies have revealed 
extensive genetic heterogeneity: in XP, at least seven 
NER-defectiye complementation groups (named A to G) 
exist whereas in CS two (CS-A and CS-S) have been iden+ 
tifled so far (Lehmann, 1982; Venneulen et al., 1991) and 
two complementation groups have been found in PIDIDS 
patients (Stefanini et af., 1992, 1993). 
In a~dition to these naturally occurring mutants, a large 
collec~lOn of laboratory-induced, UV-sensitive. NER+ 
defecuve mutants have been obtained from Cultured rodent 
cells, By reSI~}fation of UV resistance in cell hybrids. II 
complementalton groups (CGs) were discerned among these 
mutant cell lines (for recent overviews see Thompson el al., 
1988; Busch et al., 1989; Stefanini et al., 1991; Zdzicnicka 
ela~.: ~991; Ribo~i etlJf., 1992; Collins, 1993). Cross-
sensitIvity to chemlcals producing bulky DNA lesions is a 
feature of tJ:te UV -sensitive mutants in all groups. However, 
representatIves from groups 1 and 4 are unique with regard 
to the property of extreme sensitivity of DNA crossiinking 
agents. such as mitomycin C (Busch et af .• 1989). 
A number of excision repair cross-compiementing (ERCq 
genes, capable of correcting the NER defects in the rodent 
CGs have been isolated using gene transfer strategies. 
Characterization has provided clues to the function of their 
gene products and their involvement in human disease (for 
reviews se.'~ Hoeijmakers and Bootsma, 1990; Friedberg, 
1992; Hoeljmakers, 1993). For instance. based on sequence 
motifs, both the genes ERCC2 and ERCC3 are expected to 
encode proteins with helicase activity. These genes are now 
known to be involved in XP-D and XP-B, respectively 
(Weeda el al., 1990; Flejter el al., 1992; Weber, cited in 
Lelunann el al., 1992). A third putative helicase encoded 
by ERC;:C6. is required for preferential NER of actively 
transcnbed DNA segments and is defective in CS group 8 
(froelstra el al., 1992). The ERCC5 gene was recently found 
to be responsible for XP-G (O'Donovan and Wood, 1993; 
Scherlyet at., 1993). The ERCC1 protein is not associated 
wi~ the defect in any of the XP, CS or PIDIDS groups (Van 
~Uln 1.:'1 al.: 1989). On the other hand, the XPAC protein 
IS affected In XP-A (Tanaka et ai" 1989). but in none of 
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the rodent COs [-7 or CO 11 (our unpublished results). 
As another outcome of the characterization of NER genes 
it has become clear that they are highly conserved in 
evolution. Thus, homologues for most cloned manunalian 
NER genes could be identified in lower eukaryotes, 
particularly in yeast. As examples, the ERCC1, 2, 3 and 
5 genes share extensive sequence homology at the protein 
kwel with the RAD10, RAD3, RAD251SSL2 and RAD2 genes 
of Sacclmromyces cerevisiae, respectively (Van Duin et al., 
1986; Weber et al., 1990; Oulyas and Donahue, 1992; Park 
etal., 1992; Scherly elal., 1993). Therefore. it is likely 
that the basic features of the NER mechanism are conserved 
from yeast to man as well and that the homologues have 
functional equivalence. Both yeast and mammalian studies 
indicate that some NER genes playa role in other cellular 
processes. Far instance. RAD1 and RADIO are required for 
mitotic recombination (Schiestl and Prakash, 1988, 1990) 
and recently a direct involvement of the ERCC3 protein in 
transcription initiation was found (Schaeffer el al., 1993). 
A cell-free ill \'ilro assay of mammalian NER is another 
important tool to elucidate the functions of the NER gene 
products at the enzymological level. The ill \1tro system 
mea~ures repair synthesis in UV-irradiated plasmid DNA 
mediated by isolated human cell extracts (Wood el af., 
1988). The assay can mimic in \1tro complementation 
analysis of XP extracts (Hansson et al., 1991; Coverley 
et af., 1992) and can detect repair of bulky lesions induced 
by chemical agents (Hansson et af .• 1989; Sibghat-Ullah 
et af., 1989; Sibghat-Ullah, 1990). It has served to assess 
the topology of the early endonudeolytic step of human NER 
(Huang et af., 1992), the involvement in NER of additional 
protein factors such as PCNA and SSBIRP-A (Coverley 
et af., 1991, 1992; Nichols et al.. 1992; Shivji et al., 1992) 
and the purificalion of XPAC protein from calf thymus 
(Robins el af., 1991). 
Here, we report the results of a systematic study of NER 
in UV-sensitjve mutants of various rodent COs using the 
ill vitro assay. In anempting ill ~1tro complementation 
analysis, we encounter selective absence of correction, when 
cell extracts from representatives of groups I, 4 and II are 
mixed. Results from antibody depletion experiments and 
sedimentation analysis indicate that these specific patterns 
of in vitro non-complementation can be explained by the 
presence of a high mol. wt repair enzyme complex, 
comprising at leasl the products of the ERCCi and ERCC4 
genes. In addition, the factors able to complement XP group 
F and COli are associated with this complex. 
Results 
In vitro repair activity in Chinese hamster cell extracts 
Two cell-free extracts, prepared from wild-type Chinese 
hamster cells (CH09) and from a NER-deficient strain 
belonging to COl (43-3B), were compared with respect to 
their ability to mediate repair synthesis ill \'i1ro using UV-
irradiated plasmid DNA (450 lId) as a substrate. As 
shown in Figure lA, UV-dependent repair synthesis was 
observed ill vitro, with only a very slight incorporation of 
J1P_labelled dATP in the non-damaged plasmid. With these 
substrates no significant difference in repair synthesis was 
detected between a wild type (CH09) and a CO 1 mutant 
extract (43-3B). 
Besides pyrimidine dimers and 6-4 photoproducts UV 
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Fig. I. Damage-<.lep"ndent incorporation of [l2pJdATP into yarious 
DNA substrates. Plasmid DNAs Wefe incubated with 200 I'g of wild· 
ty~ (CH09, lanes 1) or COl (43-3B, 1l!leS 2) e.\tract in the repair 
assay. After incubation isolated plasmids were liil<".lrized and separated 
on agaro,e gels, Upper panels ~how ethidillfil bromide-stained gels and 
lower panels are autoradiogl1!.lIls of the dried gels. The positions of 
non.(lmuged and dmuged substrates are indicated by a minus (-) 
and a plus (+). (A) Plasmids exposed to 450 Jlm2 of UV light; (8) 
plasmids e~posed to 450 Jlm2 UV and further pnxessed using Nth 
protein; (C) plasmids e~posed to AAF. 
Table I. Residll.1] a.:ti\ity of the NER mutants In litre 
co CeU strain Residual activity 
(% of wild type)' 
43~3B 27 -* 4 (n = 13) 
UV85 22 ± 4 (n '" 10) 
2 UV5 21 ± 3 en '"' II) 
) 27·1 23 ± 3 (II = 20) 
4 UV4l 28 ± 7 (n = 5) 
UV47 17 ± 3 (II = 6) 
5 UVI35 24 ± 4 (n '"' 9) 
6 l4.{i(}..23B 116 ± 19 (n = 3) 
" 
UVSl 24 ± 4 (II = 6) 
XP-A XPI2RO-SV 15 ± 5 (II = 5) 
xp·p XP2YO 16 ± 9 (II '" 3) 
'Mean ± SEM (II '" number of nperiments). 
induces oxidative thymine species as a minor UV lesion, 
which is efficiently recognized by a NER-independent 
endonuclease activity present in human extracts. Plasmids 
can be cleared from such damage by trealment with the 
Escherichia coli Nth protein (Wood el af .• 1988). Using a 
'cleaned' UV-irradiated substrate [UV(nt")! a clear 
difference between the repair activities of wild-type CH09 
and mutant 43-3B extracts became apparent (Figure IB). 
Similar results were detected with plasmids damaged by 
N-acetoxy-2-aeetyl-aminofluorene (AAF) (Figure IC), 
which causes almost exclusively N-(guanin-8-yl) adducts 
(Landegent et al., 1984). Apparently, the endonuclease-
triggered activity is very potent in CHO extracts, necessi-
tating the use of AAF or UV(nt!!) substrates to measure NER 
activity. The observed levels of repair synthesis of human 
and Chinese hamster repair-proficient protein extracls, when 
expressed as fmol np incorporated per ng plasmid. were 
in the same range and linearly dependent on the amount of 
extract added (data not shown). 
As in CO I, a clear defect in ill ~'itro NER is present in 
the tested rodent CG2, 3, 4, 5 and 11, as well as in XP-A 
and XP-F (fable I), in agreement with their inability to incise 
UV damage in V;\'O. In an extract derived from CG6 a 
normal response was observed. in line with the near nomal 
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f1g. 2. Complementation of repair actioity in mixtures of eGl wnus C02 (Al and COl wrsus CO) (D and C). In both mixtures OV(nth) danugo:! 
plasrnids were used. £uracts were mlled in different ratios totalling 200 1'8 of protein. irKrem.:nlS were 25 and 30 1'& in {Al and (BIC), respeo>til'ely. 
Cell extracts used are in (A) 43-3B (COl) and UVS (em) and in (Btc) 4J-JB (COl) and 27-1 (em), e.,tracts I and 2, respectively. First lane.; in 
e.1ch ~I contain 200 ,,8 of CH09 nlract {Wn. Because tho:: amounts of reoJwred DNA in (B) are not wmplelely equll in all lanes, a bar grap.'l 
of Ihls nperiment is ~ho\"n in (C), repres<:nting normalized data obtained after liquid scintillation coonting of the IIp inoJrporation and scanning of 
the DNA fluorograms. 
leyel of unscheduled DNA synthesis and incision in cultured 
cells (fhompson et al., 1988). Some variation of residual 
activity in separate extracts of these NER·deficient mutants 
was found, ranging from 15 to 30% of the wild-type 
response. We conclude that NER can be detected readily 
ill vi/ro using rodent cell-free. extracts and that this repair 
requires the active presence of the products of the ERCC1, 
2, 3, 4, 5 or Il genes, in addition to those of XPAC and 
XPFC. 
In vitro complementatIon analysis 
Since ill vitro complememation with human extracts can be 
achieved by mixing representatives of different COs of XP 
(Wood el af., 1988), it is expected that mutant extracts from 
various rodent CGs should complemcnt each other as well. 
To determine the complementation patterns of the various 
Chinese hamster COs in more detail, COl, 2, 3, 4, 5 and 
II were tested, togcther with human COs XP~A and XP-F. 
In view of the nonnal levels of repair activity ill VilfO, CG6 
could not be used for analysis. 
First, extracts from COl and 2 or COl and 3 were 
combined in various proportions and ill \';lrO NER was 
measured. A substantial. ratio-dependent increase of repair 
synthesis was found with ma'dmal repair activity around a 
mixing ratio of t: t (Figure 2). Restoration of repair synthesis 
was obsen'cd in the damagcd plasmids only. Some variation 
in diffcrent experiments was experienced, but the presence 
of correction was unequivocal. 
Then, proportional mixing experiments were conductcd 
with other COs. The results from a number of typical tests 
are shown in Figure 3 and the complete data set is 
summarized in Table II. Clcar complementation was 
observed in any mutual combination of C02, 3, 5 and XP-A 
and in combination with extracts from COl, CG4 and COil. 
Unexpectedly, pairwise mixing of representatives of CO I, 
C04 or CO 11 did not yield levels of rcpair synthesis 
significantly different from those in the deficient extracts 
alone (Figure 3). Similarly, XP-F extracts failed to 
complement CO I, 4 and 11, whcreas clear corrcction was 
obsen'ed with C02 and C03. This pattern of non-comple~ 
mentation was consistently obsen'ed using independent 
isolates and with different representatives of CO I and CG4 
(Table II). These results indicate absence of correction in 
all combined extracts of CGl. C04, CGll or XP~F. 
App8rent molecul8r weight of EReC1 protein on 
glyc8ro/ gradi8nts 
The consistent pattern of non-complementation ill \1tro 
between groups I, 4, 11 and XP~F suggests that the 
corresponding proteins somehow affect each other; the 
presence of a defect in one has an effect on the activities 
of the others. Such a situation may oe<:ur, for instance, when 
these gene products fonn a protein complex ill \1\'0, of which 
the subunits cannot exchange under the conditions of the 
ill vitro assay. To investigate this possibility, a NER-
proficient HeLa extract was size-fractionated on a 10-30% 
glycerol gradicnt. To minimize effects of buffer and salt the 
gradient was run in the conditions of the repair assay together 
with internal mol. wt markers. The presence of ERCCt 
protein in gradient fractions was monitored by SOS-PAGE 
and immunostaining with a specific anti-ERCCI antiserum 
{for characterization of the antiserum see below}. ERCCI 
runs on SOS gcls with an apparent mol. \\11 of39 kOa, which 
1S larger than the calculated mo\' wt of 33 kDa. This is 
probably due to the proline-rich N-terminus, since truncated 
ERCCI missing the N-tcrminal segment migrates at the 
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Flg. J. /" I'itro complementation analysis, Substrate pla.smids are 
damagoo (+) ..... ith AAF (8. <:: and F-K) or ..... ith UV(llIh) (A. D and 
EJ. Panels consist of an ethidilUD bromide Iluorogram (top) and an 
autoradiogram (bottom). Each fim lane (left) represents wild·type 
e.\tract. either Hela (E) o[ CH09 (other panels), uken as an internal 
(ontro1. Sewnd and last lanes are mutant e,tracts alone (200 I'g). The 
bnes in between are mhtures of cxtraill in different ratios of e'tract 
I (left) and e.'tract 2 (right). with a total of 200 jJg of protein. 
E.\lracts 1 \"ersus 2 are; (A) UV5 (CO2) versus 27-1 (COl); (B) 27-t 
(CG3) venus UV47 (C04): (C) UV41 (CG4) wrws XPI1RO 
(XP'A); (D) UVS5 (COl) versus UV4l (CG4); (E) XP2YO (XP-f) 
versus UV47 (C04): (F) UVS5 (CGn W[SUS UVSI (Cm!); (0) UV5 
(CO2) versus UV135 (COS); (H) 27-1 (COl) versus UV135 (C05); 
(I) UVSI (COli) versus UV135 (CG5); OJ UV5 (CO2) versus UVSI 
(COlI); (Kl UV41 (CG4) mrus UVSI (COli). 
Table II. Summary of i~ lilro comp!em<:ntation data' 
XP-F XP-A II 
predicted position (data not shown). The profile of the 
glycerol gradient depicted in Figure 4 showed that. under 
native conditions, the protein sediments as a unifoml band 
between the 67 and 149 kDa mol. wt markers, peaking on 
the position corresponding to -120 kDa. Although non-
specific aggregation of the ERCCl protein cannot be 
completely excluded, the overall protein patterns analysed 
on SOS - PAGE did not show any indication of this. These 
results are consistent with the idea that ERCCt resides in 
a complex . 
ERCC1 proteIn produced by E.co/l fails to correct 
CG 1 extracts in vitro 
Human ERCCt, overproduced in E.coli as a ubiquitin~ 
ERCC 1 fusion protein, was tested for ill \1lro complemen-
tation. Details of the overexpression constructs will be pub-
lished elsewhere (M.H.M.Koken, H.Odijk, M,Van Ouin, 
M.Fomerod and J.H.J.Hoeijmakers, in preparation). The 
ubiquitin moiety can be removed either by a specific ubiquitin 
lyase (UOPI protein) from S,cere\1siae (Tobias and 
Varshavsk.")', 1991) or by ubiquitin-specific lyase activity 
present in Manley-type extracts incubated under the condi-
tions of the repair assay (Figure SA, lanes 1-6). The free 
full-length ERCCI protein migrated at 39 kDa in SOS-
PAGE (Figure SA) at the same position as ERCCt protein 
synthesized in a reticulocyte lysate ill \1lro (Figure 5C, 
lane 6). 
Purified cleaved EReCl protein or fusion protein (either 
crude or partially purified) was added in excess to CO 1 
extracts. In none of these cases was significant correction 
observed, The presence of inhibiting factors in the ERCCI 
protein preparation was ruled out by adding these proteins 
also to repair-competent extracts. It appears that in these 
ill \1170 conditions ERCCI protein on its own cannot 
participate in the repair reaction. 
Characterization of anti-ERCCt antibodies 
To study the possibility that ERCCl is involved in a 
complex, we needed to do experiments at the enzymological 
level. Therefore a polyclonal antiserum was raised in rabbits 
against the ubiquitin-ERCCI protein and affinit)'~purified 
on a column carrying immobilized fusion protein. The 
antisera were characterized in the following ways. First, 
Western blot analysis visualized a protein band with the exact 
mol. \\11 of ERCCI on SOS-PAGE in crude lysates and 
!Vlanley-type extracts of HeLa cells (Figure 5D, lanes 4. 5, 
7 and 8). This band was not recognized by the preimrnune 
serum (Figure 50, lanes 1 and 2) and the reaction could 
be competed by partially purified EReCt fusion protein. 
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No cross-reaction was observed with ubiquilin or with the 
ERCC I protein from bovine or Chinese hamster origin 
(Figure 50, lanes 6 and 9)_ Secondly, the antiserum was 
able to inununoprecipitace J5S_labelled ERCCI protein, 
synthesized in \1'rro by reticulocyte lysate (Figure 5C, 
lanes 2~5). Finally a complete abolition of UV-induced 
unscheduled DNA synthesis was observed after micro-
M-67 
I 
M-147 
ERCC1! 
-
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FIg. 4. Mol. ~1 determin:ltion of ERCCI by =limentation analysis. 
ActiYe Heta cxua« was layered, together \\ith mol. \\1 sundards. on 
a non-deMturing gIy~rol gradient and ~imenU:d. 1he markers are 
(hymotrypsinogen A (25 Wa), albumin (67 Wa) and aldolase (147 
kOa). Gradient fra~tioM were analrsed on SDS-PAGE to determine 
the marker positions and immUIlOl)lotted to assess !he position of 
ERCCI. 
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234567m 
lOJecllOn of the antibodies into repair-protlcient human 
fibroblasts, whereas the preimmune serum did not have any 
effect (data not shovro). These results indicate that the 
antibodies are able to react specificaUy with ERCCI ill vi\'o 
as well as in ~ilro. 
ERCC1 antiserum depletes a repair-competent HeLa 
extract Irom fRCC1, 4, 11 and XPFC 
In view of the species specificity of the antiserum, a NER-
competent extract from HeLa cells was used to study the 
effect of removal of ERCCt protein in the ill vl'lro repair 
reaction. To this end antiserum was immobilized on protein 
A ~Sepharose beads prior to incubation with the HeLa 
extract. After removal of the beads by centrifugation the 
supernatant exhibited a Significantly decreased in }'ilro NER 
activity (Figure 6A), No such effect was detected when 
preimmune serum was used even at a SOx higher concen-
tration (Figure 6B). We conclude that ERCCt protein can 
be removed from a human wild-type extract using specific 
antibodies, resulting in a lowered repair activity comparable 
with the level of a CG I mutant. 
The HeLa extract depleted ofERCCI (HeLa-ERcct) was 
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Fig. 5. Produ('tion of ubiquitin-ERCCI fusion protein and chara«eri..ution of anti-ERCCI antibodies. (Al SOS- PAGE analysis of crude wluble 
\y$.1te of ERCCI-oyerprodudng E.c<)fi incubated with increasing amoonl$ of Hela Manley-type extract. Lanes 1-6, I)'sate rea«ro for 2 h with 0, 
15. 30. 45, 60 or 7S pg of Heta extract: lane 7, 75 I'g of Hela nira('t alone: lane m, mol. \\t ntMkers: phosphorylase b (97 Wal, albumin 
(67 kDa), ovalbumin (43 Wa), carbonic anhydrase (30 kDa), tr}'psin inhibitor (20 kOa) and a-lactalbumin (l4 kDa). (NB the released ubiquitin of 
8 kDa has run off the gd.) (8) 50S-PAGE amIy5is of lysate from ERCCI fusion protein. pani.aIly purified by 33% saturated arnnlOruum sulfate 
precipitation. Lane, [-2, not treated \\ith lyase, 0.7 and 35 1'8 of lysate: lanes 3-4. pre-treated with purified UBPI-Iyase. 0.7 and 35 I'g of lysate. 
(C) 50S-PAGE and autoradiography of immune-precipitated f.lS]ERCCI lraIl5lated in \;110. Lane I, preimmune serum, undiluted: lanes 2-5, 
('rude immune serum. dilute.:! ] x. lOx, IOOx and 1000X, wpecth'ely: lane 6. input amount of [l.lS}ERCCI. (D) SpecifICity of ERCCI antiserum 
on immunoblots of different cell e.\tram. Lanes ]-3, preimmune serum; lanes 4-6, ('rude immune serum: lanes 7 -9, afflnity·purified anti·ERCCI 
.1J\libodJes; amounts used are equi~'alent to lanes 4-6. The e~uam anaJ~'~ are total Heta cell wnicate (lane:s 1.4 and 7), Manley-type ext:ra<:ts of 
lIeLa {lanes 2, 5 and 8] or CH09 {lanes 3. 6 and 9). 
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Fig. 6. IXpletion of Hela extract using anti-EReCt antJOodies. Serom 
"'015 immobiliud on protein A -Sepharo>e beads; after incubation with 
repair.wmpctent HeLl e~\{;Ict and centrifugation, the rupenutant was 
tested for repair ~ctivity ill IltrO. (A) \0 p.1 of $e/Uffi was used for 
depletion of 150 I'g HeLa e-'trTh:t. Lane 1, undepleted ewact (I00 
1'8): lane 2, C\trTh:l tre.1ted with empty protein A beads (90 1'8); 
lane 3, extraCt depleted "'ith pre-immune serum (SO "z); lane 4, 
e.\tract depleted Vrith immlJlle serum (110 pg). (B) Various 
concentrations of >era were used to deplete 150 1'8 of HeLa e.\trac\. 
Lanes 1-4, anti-ERCCI serom (50, IS, .5 and I pi respoxtiYcly); 
J:uw; 5-8, pre-immune serum (SO, 15,5 and 11'1 respoxth·dy). 
then tested for the ability to correct NER-deficient Chinese 
hamster mutants in mixing experiments. As expected, no 
complementation was detected when HeLa-ERCCl was 
mixed with a representative of COL However, when an 
extract of C02. C03, C05 or XP-A was added to 
HeLa-ERCCI a significantly higher repair synthesis was 
observed (Figure 7A and C), indicating that the antibodies 
cannot remove the correcting activities of these groups. In 
contrast, HeLa-ERCCI failed to restore repair in mixtures 
with extracts of CG4, CGll and XP-F (Figure 7B, A and 
D), showing that in addition to ERCCI protein, correcting 
activities of CG4, CGlI and XP-F are concomitantly 
removed from the wild-type extract. Both crude and affinity-
purified anlisera were equally capable of depleting HeLa 
extract from ERCC I, 4, 11 and XPFC. 
Discussion 
In vitro (ep8i( studies in Chinese hamster NER· 
deficient mut8nts 
In agreement with findings of others (Biggerstaff and Wood, 
1992) we have observed that extracts isolated from cultured 
Chinese hamster cells can support NER of DNA damage 
ill \·itro. DNA substrates with a well-defmed and narrow 
damage spectrum can be used in this assay, provided they 
are extensively purified. Clearance of UV -damaged p!asmids 
from oxidative thymine species by pretteating with bacterial 
Nth protein proves to be an absolute requirement when 
Chinese hamster cell extracts are used, due to an apparently 
high endonuclease Ill-like activity in these cells. 
The NER deficiency of CGl, 2, 3, 4, 5 and 11 ill \1tro 
agrees with the low unscheduled DNA synthesis levels (Van 
Duin et af., 198B) and low incision capabilities of these cell 
strains in culture. In CG6, which is only moderately sensitive 
to UV, the repair activity is in the range ofNER-proficient 
extracts. The ERCC6 gene is defective in CS-B (Troelstra 
et al., 1992), where preferential repair of actively transcribed 
strands is impaired, but overall genome repair, which is 
responsible for the bulk of repair synthesis. is unaffected 
(Venema el af., 1990). The nonnal in vitro repair rates are 
likely to reflect overall repair, since transcription is not taking 
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fig. 7. Complem<:ntatioo. analy.lis with ERCCI..:Iepl««I Bela e~trnct. 
7.5 "I of anti·ERCCI serum U.lW for depletion. Different panel. 
represent independent e~periments. P!.!.$mhl re.;:owries are 5imilar 
lIithln 10% in each e~periment. (A) !..Me I. BeLa-ERCCt ;lion;:; 
lane 2. 1:( mU with UV85 (CGl): lane 3. UV85 alone; Ill!<! 4, mh 
\\ith UV5 (CO2); lane 5, UV5 alone; lane 6, mb: v.;th UV135 (CGS); 
bne 7, UVt35 ;lIorK:; lane 8, mi., v.ilb XPI2RO (XPA); lane 9. 
XPI2RO ;lIone; lane 10, mil v.ith UVSI (CGlI); lane II, UVSI 
alone. (H) Lane I, BeLa-ERCCt ;lIone; lane 2.1:1!1li.>; with UV47 
(C04); lane 3, UV47 alone. (C) Lane I, HeLa-EReCt ;lIone; lane 2, 
1:1 mix with 27·1 (C03); lane 3, 27·' alone. (D) Lane I, 
Hela- ERCCI ;lion.:; lane 2, 1:1 mil with XP2YO (XP.F); lane 3, 
XP2YO alone. In (8) and (C) controls for positive compiem<:l1tatioo. 
taken ;lIong in these e.lperiments are not shown, but ga\'e results 
identical to lanes A4 and 02. 
place in the reaction conditions. Our fmding that. in vitro, 
human and hamster repair activities are similar, contrasts 
with the low activity of overall repair in cultured rodent cells 
in comparison with human cells (Bohr and Hanawalt. 1987; 
Lammel and Hanawalt, 1991). It follows that the factors 
responsible for this difference do not play a role in the 
ill I'itm reaction, perhaps because they are related to 
chromatin structure. 
Extracts of C02, 3 and 5 are able to complement each 
other and representatives of all other CGs tested. This 
suggests that the proteins which are missing or defective in 
these CGs are available in the complementing extracts and 
can freely interact to ensure restoration of nonnal repair 
activity. The findings that XP-F can correct CG2 and CG3 
and that XP-A complements CG3 and CG5 show that human 
and Chinese hamster repair proteins are sufficiently 
conserved and interchangeable in I'itro. This is in line with 
the correction ill 11\'0 by transfection of human genes into 
the Chinese hamster mutants. 
Evidence for 8 repair enzyme complex 
Mixtures ofCGs 1,4, II and XP-F do not show restora· 
tion of repair activity in 11tro, whereas they do ill \11'0 after 
cell hybridization. Since non-complementation occurred with 
independent mutants from CGI and CG4, this unexpected 
phenomenon is unlikely to be related to an allele-specific 
behaviour. Our data indicate that the normal gene products 
needed for correction arc either unable to exchange ill vl'fro 
or are not present in the mixtures. Such a situation can occur 
when these correcting proteins are part of a pre-existing 
stable complex. Depletion of a wild-type extract using 
specific anti·ERCCI antibodies not only results in the loss 
of CG I complementing activity, but concomitantly removes 
the activity which is capable of corre<:ting C04 and CO 11 
or even XP-F. This strongly suggests that such a complex 
does exist in wild-type extracts. This is further supported 
by the finding that human ERCCI protein, which has an 
apparent mol. wI of 39 kDa in denaturing SDS gels, 
sediments in glycerol gradients as a much larger species. 
The absence of complementation in some combinations 
indicates that the ill ~1tro assay cannot replace classical cell 
fusion as a system for complementation analysis, To 
explain these non--complementation patterns ill \1tro, several 
mechanisms can be envisaged, (i) Reconstitution of a 
complex from its components may not be possible under 
ill \ltro conditions, An inactive complex harbouring a tightly 
bound defective protein in one mutant extract will be unable 
to complement another mutant, in which the same complex 
is crippled by the presence of another inlpaired component, 
(ii) Alternatively, or in addition, dependent on the type of 
mutation in the cell strain, the complex may be required for 
stability of its components ill vil'O. In that case cell-free 
extracts from CO 1 lacking ERCCI would be also deficient 
in ERCC4 and the other proteins, and vice versa, Indirect 
support for this idea comes from studies with 41D, a COl 
cell strain containing an amplified correcting hwnan ERCCi 
gene. Whereas at DNA and mRNA levels ERCCi is 
amplified in this strain 100- to lOoo-fold, the amount of 
ERCCI protein is enhanced only by a factor of three and 
many degmdation products become apparent on immunoblots 
with anti·ERCC antibodies, In addition, micro-injection into 
human fibroblasts of an excess of ERCCI protein, over-
produced in E,coli. results in unusually rapid « I h) 
degradation ill vtm as judged by inununofluorescence (our 
unpublished results). These data suggest that ERCCt protein 
on its own may not be very stable in the cell, which is in 
agreement with our observation that addition of an excess 
of purified ERCCI protein fails to restore repair activity in 
CO I extracts. 
Involvement of the xeroderma plgmentosum group F 
gene product 
Extracts from a human XP-F cell strain fail to complement 
Chinese hamster extracts of CO I. C04 and CO II ill vitro. 
This pattern of non-complementation is group specific, as 
efficient correction of repair is found with other COs, In 
addition, the XP-F extract is not able to correct the 
ERCCt-depleted HeLa extract, indicating that the XPF-
correcting activity is also part of the postulated complex. 
Welkontrolled cell fusions in \1m between human XP-F 
cells and Chinese hamster NER-deficient mutants, being 
complicated by poor interspecies fusion and chromosome 
loss in the resulting hybrids. have not been done so far, so 
there is no ill \'im correlation of our ill vitro results, Direct 
involvement ofERCCI in XP-F is ruled out by the inability 
of the ERCCI gene to carre<:! XP-F cells ill dvo (Van Duin 
et al., 1989). Therefore, ERCC4 and ERCC1! are possible 
candidates for the gene defective in XP-F. This would 
represent another overlap benveen Chinese hamster mutants 
and hwnan rcpair disorders. Alternatively, XPFC might also 
encode a distinct protein, which may be less likely in view 
of gradient sedimentation data. 
The relstlon betwsen fRCC4 and fRCe 11 
The complex bern'cen the ERCCI and ERCC4 proteins also 
contains the correcting activities of COIl and XP-F, The 
latter two mutants do not show the extreme sensitivity to 
DNA crosslinking agents characteristic for representatives 
of COl and 4, However, absence of mitomycin C sensi-
tivity has also been noted in some ERCCI mutants, whereas 
the sensitivity 10 UV has been retained (I,Van de Berg and 
],H,],Hoeijmakers, unpublished results), It is possible that 
such relatively mild mutations are present in CO It and XP-F 
as well. Since the strain UVSI is the sale representative of 
CO II isolated so far. one has to consider also the theoretical 
possibility that the complementation in cell hybrids of COL! 
with CO I or C04 mutants is of the intra·allelic type, Our 
(unpublished) observation that transfected ERCCi eDNA is 
unable to correct UVS~ 1 cells defmitely rules out invoh'e-
ment of ERCCI. On the other hand, complementation has 
been shown after cell fusion with UVSl and the two indepen-
dent C04 mutants UV47 (Hata et af .• 1991) and UV41 
(D,Busch, personal communication), which makes intra-
allelic complementation less likely. Although such patterns 
of complementation have never been observed in the 
numerous fusions between either Chinese hamster or human 
(XP) repair--deficient mutant ceils, a defmitive answer must 
await the isolation of the ERCC4 or ERCCii gene and its 
transfection into the reciprocal mutants. 
Possible functions of tho compfox 
The homologue of ERCCi in S.cemisiae is the RADiO gene 
(Van Duin et ai" 1986), This protein can fonn a very stable 
complex with the RADi gene product, both ill dm and 
ill vitro (Bailly el at., 1992; Bardwell et al., 1992), 
explaining the similar phenotypes of the yeas! RADI and 
RADiO mutants, having a defect in NERas well as in mitotic 
recombination (Schiestl and Prakash, 1988, 1990), Also 
ERCCi and ERCC4 mutants share unique features, such as 
extreme sensitivity to crosslinking agents. Therefore. it is 
conceivable that the RAD1-RADIO complex and the 
manunalian repair comple.'( identified here are equivalent and 
have similar functions, The studies in yeast do not exclude 
the possibility that additional proteins are part of the 
RADI-RADIO complex. which is relevant in view of our 
ftndings that ERCClt and/or XPFC correcting activities also 
appear to be present in the mammalian complex. In this idea. 
the yeast RADl gene becomes a good candidate for being 
the homologue of one of the mammalian genes ERCC4, 
ERCCii or XPFC. 
Combining these data, we postulate that the manunalian 
enzyme complex has a dual function, as has its homologue 
in yeast, Deficiency of the NER function results in a -5-
to to-fold increased sensitivity to UV light and other 
chemical agents inducing bulky DNA adducts, Such a 
sensitivity is also found in XP-A cells. where NER is fully 
impaired due to the complete inactivation of the XPAC 
protein (Tanaka et af" 1990), On top of the moderate 
sensitivity for crosslinks (such as found in XP-A cells), the 
additional participation of ERCCI and ERCC4 proteins in 
a recombinational repair pathway might explain the extreme 
(80- to loo-fold) sensitivity of the corresponding mulants 
to crosslinking agents, Obviously. interstmnd crosslinks may 
require additional recombination steps for their removal, 
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Note added 
In the course of manuscript preparation we became 
aware of recent resuits obtained by M.Biggerstaff, 
D.E.Szymkowski and R.D.Wo<XI, indicating an association 
between COl, C04 and XP·F correcting activities and 
showing non-compiememation in extracts mixtures obtained 
from these COs (Biggerstaff et al .• 1993). 
Materials and methods 
Plssmld DNA 
Pla.s.mids pBluescript KS+ (pBKS. 3.0 kb), pTZl9R (3.0 kb), pHMl4 
(J.7 kb) and pSLM (4.3 kb) were isolated from E.(of/ R~A - hosts by 
alkaline I}'sis and purified twice on a CsO gradient. pBKS and pTZl9R 
,Hre eithu nposed to 450 J/m2 of UV light of pred<:lmiruntly 254 nm or 
treated with 0.1 mM ,\'·a.:-eto~r-2-acetylaminofluore(l¢ (MF) (a kind gift 
of R,Bam, !NO, Rij~wijk), inducing N-(glWlin-S-yl) AAP adduo;ti. pBKS 
plasmld ",,-as treated with Nth protein from E.(oli (generous!y proyided by 
C.J.lones, ICRF, london) after UV irradiation and extensively purifioo 
as closed circular DNA on neutral soxrose gradients as descnl»:! by Wood 
el al. (1988) and Biggerstaff etal. (1991). 
AAF·modified plasmids were collocted by repeated dkthyl-ether 
extractions and ethanol procipi!.1tion (Landegent (/ al., 19&4) and also 
repurified on a soxrose gradient. In both cases pHMI4 or pSLM plasmids 
were mock-treated in parallel. The awnge numbers of lesions perd.1ma.ged 
pIa.!.mId mo!~e were 10-12 pyrimldined.imers and IS-lOAAF-guanine 
adducts, re5pe.;tive1y. 
Cell lines end ex/tacls 
Mutant Chinese hlrrl5ter cells, hypemnsitio .. e to UV irradiation or other 
mU!.1genic agents, wue isolated from either the I'oild-t)pe CHO strains 
AA8 (Busch d aL, 1980) orCH09 (Wood and Burid, 1982). Th!semutanlS 
have been assigned to compkmen!.1tion group I (43-3B, UYBS), group 2 
(UYS), group 3 (21-1), group 4 (UV41, UV47), group 5 (UVI35) (Busch 
(/ al., 198'9), group6 (IHO .. 23B) (D.Busch, p:rw!ll! communication) and 
group II (UYS1) {Hau (/ al., 1991; Riboni n al., 1m; Nwnau (/ 01 .. 
1993). XPI2RO(SV4{l) and XP3YO(SV4{l) are SV4{l·transformOO lines 
belonging to XP CGs A and P, Iespocti.'d)·. HeLa and CH09 (elli $u\"ed 
as repair-competent controls. 
Cells were cultured in 8SO cm2 plastic roller bottles or in 265 cm2 glass 
Pem dishes ina 1:1 mhture of Ham's FlO and DMEM medium (Gibeo) 
supplemer«<f with 10% fetal ca!fsei\lIJl.m:i annbiOOcs. CeUs I'o~re harY~w 
by trypsinization and wash.:d with phosp/1ale-bulfered saline (PBS). E.,1r.hlS 
were prepared from 2-5 ml of packed (ell pellet by the method of Manley 
(/ aL (1983) as modified by Wood (/ al. (1988), dialysed in buffer A and 
stored at -W·C. Buffer A rontained 25 mM HEPESIKOH pH 7.8,0.1 M 
KCI, 12 filM MgCl1, I mM EDTA. 2 m.\1 dithiothreitoi (DTD and 17% (vtv) gl)·cero!. 
In vitro repaIr assay 
The standard reaction mi,ture (50 "I) (()ntained 250 ng damaged pBKS 
and 250 ng pHMI4 plasmid DNA, 45 m.\f HEPES-KOH (pH 7.8), 70 m.\1 
KCI, 7.4 mM MgO" 0.9 mM DIT, 0.4 mM EDTA, 20 "M eaeh of 
dCTP, dGTP and TIP, 8 I'~l dATP, 74 kBq of [u)2PldATP, 2 m.\l 
ATP, 4{l mM phosphocreatine, 2,5 I'g creatine phosphokinase. 3.45% 
glycerol, 18 "g bovine $erum albumin and 100 "g of ceil·free e~lra". The 
mhrures were iocubated for 3 h al 30·C. Pll>mid DNAs were isolated, 
lineariZed by restriction and electrophoresed on an agarow gel. Data were 
arulysed by autoradiography and quantified by scintill;;tioo counting of DNA 
bands e.'l:dscd from dried gel. 
Ant/·fReC1 antibodies end Immunob/ottlng 
Human ERCCI protein was owrprodLJo;ed as a ubiqultin-ERCCI fusion 
protein in E.cofi. The ubiquitin part is thought 10 protect the N-terminal 
partofthe ERCCI protein against ckgrad.:;tioo. The pETIJBI..ERCCI \"OCtOr 
contai.oo:I a strong inducible 17 prom:>ter and was transformed to the baaerial 
host $Ullin BL2I(DE3)LysS (M.B.M.Koken el al., submitted). 
A po\ydonaJ anti-ERCCI antisemm was raised in rabbits by inje.:tion 
of gel·purified ubiquitin-ERCCI fusion protein. For immunoblot analy~is 
protein samples were wparated on 11% SDS-polyacryJarnide gel and 
traJUfelTed to a PVDF membT1lfl¢ in 2S mM Tris-HO, pH 8.3 «Intaining 
10% mcthanol and 0.2 M glycine. The membrane~ were treated I'oith non· 
fat milk conWning 0.1 % Twe.en 20 and so::Iium azide for at kast I hand 
then incubated for 16 h with l()(X}x diluted antiserum at 4·C. Then the 
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blots were washed ""ith PBS containing 0.5% Tween 10 and ill{ubaled for 
2 h at room temperature with alkaline phosphatase-conjugated goat anli-
rabbit IgG. The blots were washed. again and del'eloped \',ith the coloured 
rubltrates nitroblue tetrarolium and 5-br0m0-4-chJoro-Hnoolyl phospb.lte. 
The ERCCI antiserum was affmity·puri&d using a protein A-Seph.lrow 
column for isolating the /gO fractiooofthes.:i\lIJlaOO an Affigel~ iOcollllllll 
(Bio-Rad) C.1IT)'ing immobilized purified fusion protein. 
In vitro I,ensfe/lon and fmmunQPfac/pi/etion 
ERCCI protein was translated in \1"ITO using a rabbit feticul0C)1e 1}'S.J.te 
s~'slem as described by the manufacturer (Promega) using 50 pCi of 
[ SSlmethionine (I mCilmmol). Antiwrum was incubated I'oith ERCCI 
protein for2 hat4·C in 100 mMNaCl, SOmMTri.;-HCI pH7.5, 5 mM 
Na2EDTA and 0.5% Triton (NETT buffer). The 10% protein 
A-Se¢"m:<se beOOs in I\'EIT bufferoontaining 1% BSA and 0.02% $Odium 
azide were added and tumbled for I h at 4'C. After centrifugation and 
washing four times in NEll buffer the immunopredpi!.1te was separated 
on [I % SDS- PAGE and the gel was dried and exposed to X-ray fIlm.. 
Gfycelol grsdlenl sedjmente/ion 
The mokcuhr weight of ERCCI was determined on a 10-30% non-
denaturing glycerol gradient in buffer A. N£R·proficient HeLa (.,tract 
(650 I'g) I'o-as loaded, together I'oith three markers: aldolase (i47 kDa), 
albumin (67 kDa) and chymotrypsinogen A (25 kDa) and sedimented in 
a Beckman SW41 rotor at 280 ()(X) g a14·C for 24 h. After fra"ionation 
the pIeseoce ofERCCI protein was monitored on immuooblots ming ami-
ERCCI antibodies and horseradish pero.tidase-conjugated second antibody, 
using a phosphoresc.!oce detoction methoo. 
Antibody deplef/on of NfR-proficfent extlecl 
HeLa cdl extract was tm1ted with JX>Iydorul anti-ERCCI antiserom. Protein 
A-Sepharose CL4B be<tds (protA) (70 "g) were washed three times in 
PBS and incubated with 10 1'1 anti-ERCCI antibodies Or preimmune serum 
for IS min at O'C. Then the beads were washed. three times in buffer A 
and add¢:! to a rep.tir-competent HeLa e.'tract for 30 min at O'C. The super-
natant ob!.1ined after spinning dOllTI the lx'<tds was uled as a depicted BeLa 
Utract and tested in the ill \llro repair assay. 
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Abstract 
The nucleotide excision repair (NER) protein EReC1 is part of a functional complex, which harbours in 
addition the repair correcting activities of ERCC4, ERCCll and human XPF. ERCCI is not associated with 
a defect in any of the known human NER disorders: xeroderma pigmentosulll, Cockayne's Syndrome or 
trichothiodystrophy. Here we report the partial purification and characterization of the ERCCt complex. 
Immunoprecipitation studies tentatively identified a subunit in the complex with an apparent MW of -120 kDa. 
The complex has affinity for DNA, but no clear preference for ss, ds or UV-damaged DNA substrates. The 
size of the entire complex determined by non·denaturing gradient gels (-280 kDa) is considerably larger than 
previously found using size-separation on glycerol gradients (-120 kDa). Stable associations of the ERCCt 
complex with other known repair factors (XPA, XPC, XPG and TFIIH complex) could not be detected. 
Key\\'ords: nucleotide excision repair; ERCCt protein complex; 120 kDa subunit; immunoprccipitation; 
purification 
1. Introduction 
Environmental agents such as UV and X-rays 
or chemical compounds can induce a wide range 
of lesions in the DNA. Persisting lesions can 
interfere with essential processes like transcrip-
tion or replication, which might cause cell death 
or lead to mutations. To protect the genetic infor-
mation in the cell a network of DNA repair 
mechanisms has evolved in all living organisms. 
In nucleotide excision repair (NER), a major 
repair pathway, five steps can be identified: 
recognition of the DNA iI~ury, dual incision on 
the damaged strand (Huang et a1., 1992), remo-
val of the damaged-containing patch, gap refil-
ling by DNA synthesis and finally strand liga-
tion. (Grossman and Thiagalingam, 1993; Hoeij-
makers, 1993a; Sancar and Tang, 1993). 
A NER deficiency can give rise to three geneti-
cally heterogeneous human disorders: xeroderma 
pigmentosum (XP) (seven genetic complementa-
tion groups: XP-A to XP-G), Cockayne's syn-
drome (two groups: CS-A and CS-B), and a 
photosensitive form of the brittle hair disease 
trichothiodystrophy(TTD) (Hoeijmakers, 1993b). 
Patients suffering from this SUbtype of ITD have 
been classified in three complementation groups: 
TTD-A (Stefanini ct al.. 1993), XP group D 
(Stefanini et aI., 1992), and one TTD family is 
assigned to XP group B (Vermeulen et a1., 
1994). In addition to cell lines of these patients, 
a large collection of UV-sensitive mutants has 
been obtained from rodent cell cultures, in which 
cleven complementation groups have been identi-
fied. A number of correcting human genes has 
been isolated by gene transfer experiments, 
designated as excision repair cross-complemen-
ting (ERCC) genes (Busch et a1., 1989; Riboni et 
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aJ., 1992; Collins, 1993). Most of these ERCC 
genes have been found to be involved in the 
human NER disorders as well: ERCC2 is identi-
cal to XPD (Plejter et aJ., 1992), ERCC3 is XPB 
(Weeda et aI., 1990), ERCC5 is XPG (O'Dono-
van and Wood, 1993; Scherly et aI., 1993) and 
ERCC6 is identical to CSB (Troelstra et aI., 
1992). However, ERCCl is not affected in any 
of the known human complementation groups 
(van Duin et aI., 1989). 
The eukaryotic NER genes are highly conser-
ved during evolution. As an example, ERCCI 
shares sequence homology with the Saccharomy-
ces cerevisiae NER gene RADJO. The RADlO 
gene product forms a stable complex with the 
yeast RAD 1 protein (Bailly et aI., 1992; Bard-
well et aI., 1992), which is required for both 
NER and mitotic recombination (Schiesll and 
Prakash, 1988; Schiestl and Prakash, 1990). The 
complex lllay perform the 5' incision in the NER 
process, since it has a stmcture-specific endonu-
clease activity that cleaves a splayed arm DNA 
structure only in the strand with a 3' single end 
(Bardwell et aJ., 1994b). Manllllalian ERCCl, 
like its yeast homolog, is also part of a protein 
complex, which harbours the correcting activities 
of the rodent groups 1, 4, 11 and human XP 
group F, as observed by co-purification and co-
imllmnodepletion of these repair activities (Big-
gerstaff et aI., 1993; van Vuuren et aI., 1993). 
Cosmid clones harbouring the functional 
ERCC4 gene have been recently described, 
(Thompson et aI., 1994), although no informa-
tion is available on the encoded gene product. 
Also the ERCCll and XPF genes have not yet 
been cloned. Therefore, an enzymological ap-
proach has been chosen to characterize the 
ERCCI-complex. Here we report its partial puri-
fication from BeLa celis, the tentative identi-
fication of a 120 kDa subunit, and the possible 
associations with other repair factors. 
2. IHaterial and :Methods 
Gel-electrophoresis, immunoblotting and re-
striction enzyme digestion were performed accor-
ding to standard procedures (Sambrook et ai., 
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1989). The purification scheme was prepared 
according to Gerard et a1. (1991). 
2.1 Cel/lilles alld extracts 
Repair-competent cell lines: HeLa and Chinese 
hamster ovary (CH09) as well as rodent NER 
mutants of complementation groups 1 (43-3B, 
UV20), 2 (UV5), 3 (27.1, UV24), 4 (UV41, 
UV47), 5 (UV135), and 11 (UVSl) and human 
XP group F (XP3YOSV) were cultured in a mix-
ture of Ham's FlO and DMEM medium (1: 1), 
with 10% fetal calf serum and antibiotics (strep-
tomycin and penicillin). Cells were harvested and 
extracts were prepared from 2-5 ml of packed 
cell peliet by the method of Manley as modified 
by Wood (Manley et aJ., 1983; Wood et aJ., 
1988) dialysed in buffer A and stored at - 80°C. 
Buffer A contains 25 mM Hepes-KOH pH 7.8, 
0.1 M KCI, 12 111M MgCI" 1 111M EDTA, 2 
mM DTT and 17% glycerol. Primary fibroblasts 
of XP-P (XP3YO) and XP-C (XP2IRO) were 
cultured for microinjection in Ham's FlO me-
dium supplemented with 12% serum and antibio-
tics. 
2.2 In vitro DNA repair 
Plasmid pBKS was treated with 0.1 mM N-ace-
toxy-2-acetylaminofluorene (AAF) and closed 
circular forms were isolated as described earlier 
(van Vuuren et aI., 1993). Each reaction contai-
ned 250 ng of AAF-modified plasmids and 250 
ng of non-damaged pHM14 plasmid as a control 
in 45 mM HEPES-KOH (pH7.8), 70 mM KCI, 
7.4mM MgCI" 0.9mM DTT, 0.4 mM EDTA, 
20 I,M each of dCTP, dGTP, and TTP, 8 pM 
dATP, 74 kBq of ["P]adATP, 2mM ATP, 40 
mM phosphocreatine, 2.5 p.g creatine phosphoki-
nase, 3.5% glycerol, 18 Jtg bovine serum al-
bumin, and 100 or 200 J(g protein of the cell-free 
extracts. Samples were incubated 3 h at 30°C, 
then the DNA was isolated, linearized by BamHl 
digestion and separated by electrophoresis on 
0.8% agarose gel. Incorporation of [31p]dATP in 
damaged and undamaged plasmids was detected 
by autoradiography and quantified using a B&L 
Phosphor-Imager and a LKB Densitometer. 
2.3 Microilljectioll 
Microinjection ofXP fibroblasts was performed 
as previously described (Vermeulen et aI., 1986). 
After injection cells were irradiated with UV-
light (254 mn, 15 Jim'), incubated for 2 h in 
[3H]-thymidine-containing culture medium (10 
JlCi/ml; s.a.: 50 Ci/mmol) and fixed. Repair ac-
tivity was detected by autoradiography. The 
number of silver grains above the nuclei is a 
measure for the level of unscheduled DNA syn-
thesis (UDS). 
2.4 Alltibodies 
Polyclonal antibodies were raised in rabbits 
against an E.cofi overproduced human ubiquitin-
ERCCt fusion protein (Koken et aI., 1993; van 
Vuuren et ai., 1993) and against a C-terminal 
peptide of XPA. Anti-ERCCI antiserum was pu-
rified OIl protein A-sepharose followed by an 
Affi-Gel 10 column carrying purified ubiquitin-
ERCC I fusion protein. Immunoblots were incu-
bated with either crude anti-ERCCl antiserum, 
crude anti-XPA antiserum, affinity purified anti-
ERCCl antiserum or with monoclonal antibodies 
(M3C9) against the p62 subunit of TFllH. As a 
second antibody horse radish peroxidase- or alka-
line phosphatase-conjugated goat anti-rabbit or 
goat anti-mouse Ig were used. These antibodies 
were detected by a chemiluminescent substrate 
ECL (Amersham) or nitroblue tetrazoJiulll and 5-
bromo-4-chloro-3-indolyl phosphate. 
2.5 Immrmoprecipitatioll e.\perimellts 
HeLa cells were cultured I It in DMEM medi-
um lacking methionine, supplemented with fetal 
calf serum (dialysed against phosphate-buffered 
saline (PBS», and labelled with [35S]-methionine 
(20~Cilml; s.a. I mCilmMol) for 16-20 h. Cells 
were harvested and washed twice with PBS and 
stored at -SO°C. For il11munoprecipitation the 
pellet was dissolved in IPB7 buffer (20 mM 
Triethanolamine pH 7.S, 0.7 M NaCI, 0,5% 
NP40 and 0.2% natrium deoxycholaat) and the 
solution was centrifuged for 15', Afterwards the 
supernatant was incubated with anti-ERCCt anti-
body beads for 16 h at 4°C with agitation. The 
beads were extensively washed in IPB7 buffer 
and PBS, dissolved in loading buffer, heated for 
5' and the soluble proteins were separated on a 
11 % SDS-polyacrylamide gel. Protein bands 
were visualized by autoradiography of the dried 
gel. 
2.6 Purification of ERCCl complex 
Chromatographic materials were tested batch-
wise or in colunms. The following materials 
were used: Heparin-UItrogel A4R, DEAE-Sphe-
rodex M, Phosphor Ultrogel-P A6R, and ss 
DNA Ultrogel A4R (IBF); Sulfopropyl SP-5PW, 
and TSK gel Heparin 5PW, and TSK gel HA-
100 Hydroxylapatite (TosoHaas); Phenyl Sepha-
rose, Octyl Sepharose, Sepharose CL-4B, Sepha-
cryl-S300, and Q-sepharose Fast Flow (Pharma-
cia); ds DNA Cellulose, and ATP Sepharose 
(Sigma); Red Sepharose CL-4B, Blue Sepharose 
CL-4B, and UV-irradiated-DNA cellulose; 
Cellulose phosphate Pll (Whatman); Hydroxyl-
apatite Spheroidal beads (Fluka). Hela extracts or 
partially purified ERCCI fractions (Hep 10 or 
Sulfopropyl) were loaded. 
2.7 NOli-denaturing gel-electrophoresis 
A 4-15% polyacrylamide gradient gel in TBE 
buffer and 12% glycerol was prepared (TBE: 90 
111M Tris, SO mM boric acid and 2.5 111M 
EDT A). The gel was prerun for 30 min at 70 V, 
loaded with samples and run for 2 h at 70 V and 
for 16-20 h at 150 V. Proteins included as mole-
cular weight markers were ferritin (440 kDa), 
catalase (232 kDa), lactate dehydrogenase (140 
kDa), and albumin (67 kDa). BeLa extracts or 
partially purified ERCCl fractions were loaded 
and immunoblotted. The Westernblot was stained 
with Ponceau-S to visualize the molecular weight 
markers for determination of the apparent M\V of 
the ERCCI complex. There was a good relation-
ship between the migration and the known MW 
of the markers. The ERCCt comples was detec-
ted by antibodies. The ERCCl-containing band 
was cut out from the gel and incubated 30 min in 
0.1 % SDS, 50 mM boric acid pH 8.0, and elec-
tro-eluted for 16 h in 30 mM Tris and 200 mM 
glycine. The eluted proteins were concentrated 
on a Centricon-lO filter at 4°C. 
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2.8 Endonuclease assay 
Partially purified ERCCt fractions were incu-
bated with different DNA substrates: 200 ng ss-
DNA (MI3), d,-DNA (pHMI4) or damaged 
DNA (pUR288-AAF) under ill vitro repair condi-
tions for 30 min at 37° C. Heparin 5P'V fraction 
10 with or without prior depletion of ERCCI by 
inmmnobeads was used in a range of 1 to 30 p.g 
protein. After the reaction, samples were treated 
with proteinase K, SDS and phenol extracted to 
de-proteinize. The DNA was isolated and sepa-
rated on 0.8% agarose gels. 
3. Results 
3.11mmulloprecipitatiotl studies 
Affinity-purified anti-ERCCl antiserum descri-
bed previously (van Vuuren et al. , 1993) recog-
nizes ERCCt as the only band on a \Vestern blot 
of a HeLa cell-free extract, (prepared according 
10 Manley el aI., 1983) (Figure lD, lane 7). 
Antibodies were immobilized on proteinA-sepha-
rose beads and washed prior to incubation with 
a total [35SJ-methionine labelled HeLa extract. A 
protein band, migrating at the position of ill vitro 
translated ERCCt protein (39 kDa in SDS-
PAGE), was precipitated by crude or affinity-
purified anti-ERect antiserum among a number 
of aspecific polypeptides, but not by preimmune 
serum (Figure lA). ERCCt appeared as a minor 
band on the autoradiogram, presumably due to its 
low expression level (van Duin et aI., 1986) and 
the low specific labelling due to the presence of 
only two internal methionines in the protein. 
Background bands could not be reduced signifi-
cantly by pretreatment of the antibodybeads with 
a non-labelled HeLa extract (Figure IC; lane 1). 
In addition to ERCCI, at least one polypeptide 
with an apparent molecular weight of - 120 kDa 
was co-precipitated by the ERCCt inmlUl10beads 
(Figure IA; lane 2 and 3 indicated with *). This 
band as well as the ERCCI band disappeared 
when the imlllunobeads were preincubated with 
an excess of purified ubiquitin-ERCCI fusion 
protein overproduced in E.coli (Figure IB; lane 
2). Further evidence in favour of the 120 kDa 
protein being a subunit of the ERCCt complex 
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Fig. I. Immunoprecipitation using anti-ERCCI 
antibodies of a total p5S]-labelled protein extract of 
HeLa cells and detection of ERCCI in different XP cell 
strains. A: HcLa extract was precipitated with pre-
immune serum (pre), with crude anti-ERCCI antibodies 
(aEI) or with affmity-purified anti-ERCCl antiserum 
(affi-El). Both lane t (pre) and 2 (aEI) show a 
migration effect of the large amount of IgG in the 
samples, the heavy chain is indicated by an arrowhead. 
The ERCCt protein is indicated as an arrow, the 
presumed 120 kDa subunit with an aslerix. B: 
Competition experiment using aftt-EI beads which were 
pretreated with non-labelled recombinant ubiquitin-
ERCCt fusion protein (lane 2) in comparison to affi-EI 
immunoprecipitation of HeLa extract (lane I). C: 
Immunoprecipitation with labelled HeLa using aEI 
competed with non-labelled HeLa extract to reduce 
aspecific binding (lane I). Lane 2 shows a [35SJ-labelled 
XP-F extract that was precipitated with ERCCI-
immunobeads. D: 10 Ilg protein of the cell-free extracts 
of respectively XP-A, XP-B, XP-C, XP-D, XP-F, XP-
G and HeLa cells were analyzed for the presence of 
ERCCt protein on immunoblot using affinity-purified 
anti-ERCCI serum. Protein staining with Coollllllassie 
Brilliant Blue (CBB) indicated that similar amounts of 
protein were loaded in each lane (not shown). 
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Fig. 2. Co-elution of (he EReCt complex with transcription initiation factor TFJIH over the first 
chromatography columns. EReCt is visualized by immunoblot analysis. A: Purification scheme of TFIIH 
(Gerard et ai., 1991), In panels B - E 30 pi of each fraction was loaded or 10 pg protein when the protein 
concentration is known, B: Heparin column. EReCt is present in the 0.4 M KCI elution fraction, C: DEAE 
column, EReCt is found predominantly in the 0.2 M KCI elution fraction, a minor amount in the 0.35 M 
fraction D: SulfopropyJ 5PW column, EReCt is detected in both 0.28 and 0.45 M KCI elution fractions 
(TFIIH is present in 0.45 M KCI fraction), E: Heparin 5PW coiunm, the peak of EReC1 is observed in 
fraction 8-10, whereas the peak ofTFIIH is found in fraction 1O-l4. 
was obtained by analysis of an XP-F extract. 
InmlUnoblot analysis of ceB-free extracts from 
XP complementation groups A to D and G sho-
wed that ERCCl is significantly reduced only in 
XP-F (Figure ID). These results are in agree-
ment with earlier findings (Biggerstaff et al., 
1993). After precipitation of a ["S1-labelled XP-
F extract using ERCCt immunobeads both 
ERCC1 and the 120 kDa band were no longer 
detectable, whereas the aspecific bands remained 
(Figure IC; lane 2). These data suggest a close 
association between ERCCI and the 120 kDa 
protein and might identify the latter as a subunit 
of the complex. 
3.2 Partial purification of the ERCCI complex. 
An elaborated purification scheme, designed 
for isolation of active protein complexes, has 
been developed for the purification of mammali-
an basal transcription factors, including the 
multisubunit TFIIH complex (Gerard et ai., 
1991). TFIIH accommodates the repair-correct-
ing activities ofXPB, XPD and TTD-A (Drapkin 
et ai., 1994; Schaeffer et aI., 1994; van Vuuren 
et aI., 1994; Vermeulen et aI., 1994), illustrating 
that this procedure can be used for the purifica-
tion of (repair) complexes. From this purification 
scheme (Figure 2A), which starts with a large 
amount of repair-competent HeLa extract, frac-
tions of several chromatography steps were tested 
for the presence of ERCC1. Immunoblot analysis 
indicated that ERCCI and TFIIH eluted in the 
same fractions on the first two chromatography 
columns: Heparin-UJtrogel (0.4 M KCI) and 
DEAE-Spherodex (0.2 M KCI) (Figure 2B-C). 
On SulfopropylSPW ERCCI was detected in the 
0.28 and 0.45 M KCI fractions (Figure 2D). The 
latter contained the TFIIH complex and was 
loaded on a Heparin 5PW column. Gradient 
elution achieved an incomplete separation of 
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Fig. 3. Correction of the repair defect by ERCCl~containing Hcparin 5PW fractions using an ill vitro DNA 
repair assay. In all cases 6.2 ltg of Heparin fraction 10 was added to 100 Jig cell-free extract of rodent group 
I, 4, 11, human XP group F or HeLa (even numbered lanes), no fractions were added in odd numbered 
lanes. The same amount of Heparin fraction 8, 9 or 10 was added to a rodent group 3 extract (lane 14-16). 
AAF-damaged plasmid is indicated as '+' and the non -damaged plasmid as '-'. The upper panel shows the 
ethidium bromide stained gel and the lower panel the autoradiogram. 
ERCCI and TFIIH. The peak of ERCCI resides 
in fractions 8 to 10, just in front of the TFIIH-
containing fractions 10 to 14 (Figure 2E), see 
also (Gerard et ai., 1991). 
The biological activity of the ERCCl-contai-
ning fractions was investigated utilizing the ;,/ 
vitro DNA repair assay based on cell-free ex-
tracts (Wood et ai., 1988). The Sulfopropyl 0.28 
M KCI elution containing ERCCI but no signifi-
cant fraction of TFIIH, induced complementation 
of the repair defect in extracts of rodent group 11 
and human XP-F. Correction of the repair defect 
was also observed after administration of Heparin 
5P'V fractions 8-10 to extracts of rodent groups 
1,4, 11 and human XP-F, but not when added to 
a group 5 extract (Figure 3, showing the results 
of fraction 10). Addition of these fractions to a 
repair-proficient extract did not influence its 
NER activity, demonstrating that the stimulation 
of repair observed in the above mentioned extract 
was not due to an aspecific effect. Furthermore, 
the level of correction achieved was similar to 
that observed in the above mentioned extracts 
was obtained when the same extracts were mixed 
with a rodent complementation group 2 extract 
(data not shown, see van Vuuren et aL, 1993). A 
slllall part of the TFIJH activity (known to peak 
in fraction 12 and 13 (Gerard et aI., 1991» was 
detected in fraction 10 and to a lesser extent in 
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fraction 9, as measured by the ability to correct 
extracts of rodent group 3 (Figure 3, lane 14-16). 
These data were in agreement with inmlUnoblot 
analysis and indicate again that ERCCl and 
TFUH complexes become separated in this stage 
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Fig. 4. Hydroxylapatite chromatography of ERCC1 
containing Heparin 5PW fraction 10_ The upper panel 
shows the presence of ERCCl in fractions 20-24 (0.26 
M phosphate buffer) by immunoblot analysis_ The lower 
panel shows the protein profile of a CBB-stained gel. 
of the purification, but an overlap of both activi-
ties was found in fraction 10_ As an independent 
test for functionality ill viva, the Heparin 5P\V 
fractions 8-10 and the 0.28 KCl fraction of Sul-
fopropyl were microinjected into XP fibroblasts_ 
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Fig. 5. Absence of a physical association between EReCl and TFIIH or XPA. A: HeLa extract (lane 1 and 
4), HeLa extract depIcted for p62 (H-r61) (lane 2 and 5) and HeLa extract depleted for EReCt (aEI ) (lane 
3 and 6) were loaded on SDS-PAGE, immunoblotted and analyzed with anti-EReCt antiserum (lane 1-3) 
or with anti-p62 antiserum (lane 4-6). Arrowheads indicate IgG bands. B: Hela extract was depleted for 
EReCt and the non-bound fraction (n), protein fraction bound to the ERCCI-immunobeads (b), and 
untreated HeLa extract (ll) were analyzed by immunoblotling with anti-EReCt antiserum (lane 1-3) or with 
anti-p62 antibodies (lane 4-6). EReCt is bound to the anti-ERCCt immunobeads (lane 2), while binding of 
p62 was not detectable (lane 5). Note: the samples in lane 1 and 4 were lOx diluted compared to lane 3 and 
6. C: HeLa extract tested for the presence of XPA protein after ERCCI depletion: lane I, non-bound 
fraction; lane 2, proteins bound to the ERCCI-immunobeads (b) and lane 3 untreated HeLa extract (u) as 
a control and analyzed by polyclonal antiserum against XPA. 
Correction of the repair defect was clearly 
observed in XP-F cells as an increase in unsche-
duled DNA synthesis (UDS) to wild-type levels 
within 2 h after injection. No correction was 
found in XP-C fibroblasts, included as a negative 
control. These results indicate that at this stage of 
purification both ill vitro and ill vivo active 
ERCCt complex is present and that the repair-
correcting activities of ERCCt, ERCC4, 
ERCCtt and XPF remain associated. 
The Heparin fractions still contain many pro-
teins as detected on Coommassie Brilliant Blue 
(CBB) stained SDS-polyacrylamide gels. There-
fore, the behaviour of the ERCC 1 complex on a 
wide range of chromatographic mate-rials was 
analyzed, using extracts of HeLa cells as well as 
partially purified Sulfopropyl 5PW and Heparin 
5PW eluates. A strong hydrophobic interaction 
with Phenylsepharose and Octylsepharose caused 
irreversible binding of ERCCt, which could only 
be eluted using a denaturing detergent solution 
(0.5 % SDS). Application to the weoldy hydro-
phobic unsubstituted sepharose carrier resulted in 
binding in the presence of 40% anulloniumsul-
phate solution, but ERCCt eluted with the bulk 
of proteins between 35-20% auulloniumsulphate. 
ERCCt was found to bind at low ionic strength 
to the colullm materials: Q-, Blue-, Red-, 
Heparin-sepharose, ATP-agarose, Phosphocel-
lulose, DEAE, Sephacryl S-300, ss-DNA agaro-
se, ds-DNA cellulose, UV-irradiated DNA 
cellulose and Hydroxylapatite. Generally, the 
complex eluted between 0.2 and 0.4 M salt. 
However, with none of these column materials a 
significant additional purification of the ERCCl 
complex could be achieved. The best purification 
was observed using Hydroxylapatite. ERCCt 
eluted at 0.26 M phosphate buffer (fractions 20-
24), but the CBB-stained profile still showed 
many protein bands (Figure 4). Neither CBB-
nor silver-stained protein profiles revealed promi-
nent SDS-PAGE bands at he MW of 39 or 120 
kDa, indicating that the ERCCl complex is 
present as a minor component at this stage of 
purification. However, the elution fractions of 
the Hydroxylapatite column, containing ERCCl, 
still induced potent correction indicating that they 
are biologically active. 
To investigate DNA-binding activity of the 
ERCCt complex Heparin 5PW fraction to was 
loaded on ss-DNA agarose, on ds-DNA cellulose 
and on UV-irradiated DNA cellulose. In all three 
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cases ERCCl eluted between 0.2 and 0.4 M 
KCI, indicating that the ERCCt complex binds to 
DNA without pronounced preference for ss-, ds-
or damaged DNA. This observation together with 
the finding that the homologous yeast 
RA D I/RAD 1 0 complex exhibits ss-specific endo-
nuclease activity (Sung et aI., 1993; Tomkinson 
et aI., 1994), may imply that the ERCC1 com-
plex has such an activity as well. Heparin frac-
tion 10 contained nuclease activity for both 
single- and double-stranded DNA under the 
conditions used in the ill vitro repair assay, but 
the fraction was not pure enough to unequivocal-
ly demonstrate an association of a nuclease with 
the ERCC1-containing protein complex. 
3.3 Possible interactions with other repair Jactors 
Since NER requires many enzymes during the 
reaction, the possibility of specific association of 
ERCCI and other NER factors was investigated. 
At first, TFIIH seemed a good candidate, be-
cause ERCC1 co-eluted at least partially with 
TFIlH in the initial four purification steps. 
However, separation occurred in Sulfopropyl and 
Heparin 5PW chromatography, arguing against 
such an interaction. This result was confirmed by 
antibody depletion studies. Monoclonal antiserum 
against the p62 subunit of TFIIH and polyclonal 
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anti-ERCC1 antiserum were immobilized on 
protein A sepharose beads prior 10 incubation 
with repair-proficient cell-free extracts of HeLa 
cells. After removal of the beads, the non-bound 
fraction (supernatant) displayed a strong decrease 
in NER activity measured in the in vitro repair 
assay, consistent with the removal of at least one 
essential NER component (van Vuuren el aI., 
1993; van Vuuren et a!., 1994). HeLa extracts 
depleted of ERCCI (HeLa-ERCC ') or p62 (HeLa-
1">2) were loaded on SDS-page and immunoblot-
ted. A clear reduction of ERCCI was found in 
HeLa-ERCC1 , whereas no significant decrease in 
the amount ofERCCI was observed in the HeLa-
p61 (Figure SA, lane 2 and 3). The reverse pattern 
was detected in HeLa-p62: a decreased amount of 
p62 was found in this extract in comparison to 
normal levels of p62 in the BeLa-ERCCl extract 
(Figure SA, lane 5 and 6). To exclude the possi-
bility that only a smaH fraction of TFIIH is 
associated with ERCC1, the proteins bound to 
the ERCCl-iIlllllunobeads were analyzed. This 
bound fraction showed clearly ERCCt as ex-
pected, while no p62 could be observed (Figure 
58, lane 2 and 5). It appears that no significant 
stable association between the ERCC1 and the 
TFIIH complexes exists in repair-competent 
extracts of HeLa cells. 
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Fig. 6. The size of the EReCl complex determined by non-denaturing gel-electrophoresis. The immunoblots 
were analyzed with anti-ERCCI antiserum. A: lane 1: Heparin 5PW fraction 10 (100 JIg), Jane 2: 
SuJphopropyl5PW fraction 0.45 M KCI (120 Ilg), lane 3 DEAB fraction 0.2 M KCl (10 Ilg), lane 4 Heparin 
Ultrogel 0.4 M KCI. (20) B: lane 5 Hela extract, lane 6 XP-F extract, and lane 7 ERCCI-depleted HeLa 
extract (REI), in all cases 100 jtg protein was loaded. C: the region corresponding to the position of the 
ERCCl complex was cut out of the non-denaturing gel, the proteins were electro-eluted and analyzed by 
SDS-PAGE and Western blotting: lane 8 HeLa extract and lane 9 ERCCI-depleted HeLa extract (H-E1). 
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In the first chromatography step ERCCt co-
eluted neither with XPC nor with CSB, whereas 
XPA and XPG were found in the same Heparin 
fraction as ERCCl (van der Spek, van Goal, 
A.P.M.E., unpub. res.). XPG correcting activity 
became separated from ERCCI on the second 
DEAE column using the iI/vitro NER assay (data 
not shown). This is consistent with our previous 
findings in which no close association of XPG 
with TFIIH was found (van Vuuren et aI., 1994). 
Interaction of ERCCI with XPA was recently 
suggested by Li et al. (I 994) and Park and 
Sancar (1994). After depletion of BeLa extract 
by ERCCI-immunobeads the presence of XPA 
was analyzed in the different fractions using XPA 
specific antiserum. The XPA protein was found 
in the ERCCI depleted HeLa extract, whereas no 
XPA was detected in the fraction bound to the 
ERCCI-imIllunobeads (Figure SC, lane 1 and 2), 
indicating that XPA was not co-depleted by anti-
ERCC 1 antiserum. 
3.4 MW of the ERCC1 complex ul/der !/Oll-
denaturing conditions 
Previously, the size of the ERCCI complex 
was estimated to be approximately 120 kDa using 
size-separation on glycerol gradients (Biggerstaff 
et aI., 1993; van Vuuren et aI., 1993). This size 
is quite small considering the fact that the com-
bined tvIW ofERCCl (33 kDa) and the ERCC1-
associated factor ( - 120 kDa) tentatively identi-
fied in this paper exceeds 150 kDa even without 
a third possible subunit. Therefore we examined 
the size of the ERCCI complex by an indepen-
dent method using non-denaturing 4-15% poly-
acrylamide gradient gel-electrophoresis. To 
investigate whether during purification the size of 
the complex had changed due to dissociation of 
loosely bound factors, the apparent MW of the 
complex was analyzed in unfractiollated HeLa 
extract and in partially purified ERCCt fractions 
(see Figure 2A). After immunoblotting ERCCI 
was found to migrate at a position corresponding 
with an apparent MW of 280 kDa ± SD 36 
(Figure 6A and B, lane 5). This signal was 
absent when HeLa·ERCCI or XP-F extracts were 
analyzed (Figure 6B, lane 6 and 7). To further 
establish that the detected protein band is 
ERCC1, part of the gel containing ERCCt was 
cut out and the polypeptides were electro-eluted 
and analyzed using SOS-PAGE. After immuno-
blotting the anti-ERCCt antiserum clearly 
detected the ERCCt protein as a 39 kDa band. 
In contrast, the HeLa·ERCCI extract did not contain 
any detectable ERCCI after electro-elution and 
blotting (Figure 6C, lane 8 and 9), No XPA 
could be observed by polyclonaJ anti-XPA anti-
bodies in this eluted protein fraction (data not 
shown), confirming the results described above 
that under our conditions XPA is not detectably 
associated with ERCCI. 
4. Discllssion 
4.1 Composition and size of the ERCC1 complex 
The ERCCt complex contains the correcting 
activities of ERCC1, ERCC4, ERCCll and 
XPF, although the latter might be identical to 
either ERCC4 or ERCCll (van Vuuren et aI., 
1993). These findings support the idea that the 
ERCCI complex contains a minimum of three 
subunits, ERCCI (predicted molecular weight of 
33 kDa), a subunit of 120 kDa and at least one 
unidentified subunit. Immulloprecipitation studies 
revealed co-precipitation of the 120 kDa compo-
nent. This is not due to cross-reaction of the 
antiserum: competition experiments prevent the 
precipitation of both ERCCl and the 120 kDa 
protein. ERCCI is specifically reduced in XP-F 
extracts and after inullunoprecipitation neither 
ERCCI nor this 120 kDa protein band could be 
observed. These data strongly suggest that the 
120 kDa protein represents a component of the 
ERCC 1 complex and that the complex is proba-
bly required for stability of ERCCI. The latter 
conclusion is consistent with the findings of 
Biggerstaff et ai., who also noted reduced 
ERCCI amounts in rodent group 4 and II (Big-
gerstaff et aL, 1993 and R.D. Wood, pers. 
cOllun.). 
The yeast RADI and RADIO Illutants show 
similar phenotypes distinct from other RAD3 
group mutants, both have a defect in NER and, 
in addition, in mitotic recombination (Schiestl 
and Prakash, 1988; Schiestl and Prakash, 1990). 
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Mammalian ERCCI and ERCC4 mutants share a 
unique characteristic as well; unlike mutants of 
other complementation groups they are extremely 
sensitive (50-100x) to crosslinking agents. Repair 
of these crosslinks is thought to require recombi-
national events. Based on the fact that ERCCl is 
the homologue of the yeast RAD 10 one might 
suggest that the human ERCC4 gene is the COUll-
terpart of the yeast RADI. The MWs of the 
mammalian subunit (-120 kDa), found in the 
iUlll1uuoprecipitation studies, and RADI (126 
kDa) fit well in this prediction. These data 
suggest that the 120 kDa subunit might be 
ERCC4. No such extreme sensitivity for cross-
linking agents has been observed in ERCCIl or 
XPF mutants, possibly due to partial mutations in 
these genes. 
It appears that at least one subunit has escaped 
detection in the inllllulloprecipitation studies and 
remains to be identified. It is possible that the 
ERCCI antibodies competes with binding sites 
for ERCC4 or ERCCII. This explanation seems 
unlikely, in view of the immunodepletion studies 
(van Vuuren et al., 1993), but cannot be comple-
tely ruled out. A second possibility is that the 
complementation found between mutants of 
groups 1, 4 and 11 is due at least in one of the 
combinations to intragenic complementation. 
However, transfection of functional ERCCl 
cDNA and gene to mutants of rodent group 4 
and 11 as well as to XP group F have excluded 
a possible involvement of this gene in any of 
these mutants (van Duin and Hoeijmakers, 1989 
and ,V. Vermeulen, 1. de Wit and I.H.I.H. un-
publ. res.). Furthermore, intragenic complemen-
tation between the sole representative (UYSl) of 
rodent complementation group 11 and several 
independent mutants of groups I or 4 is rather 
unlikely, since correction of the repair defect was 
found in all cases in different laboratories (Hata 
ct aI., 1991; Busch ct aI., 1994). In addition, 
cosmid clones containing the ERCC4 gene failed 
to complement the repair defect in group 11 (L. 
Thompson, pers. comn1.). The most likely expla-
nation is that the missing subunit has escaped 
detection due to a low methionine content or 
because it is hidden behind background bands. 
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These arguments further support the idea that the 
ERCCt complex consists of at least three sub-
units: ERCCl, ERCC4 and ERCCII. Experi-
ments in yeast concerning the RAD lIRAD 10 
complex (Bailly et aI., 1992; Bardwell et aI., 
1992) have not excluded the presence of addi-
tional proteins. 
Non-denaturing gel electrophoresis shows an 
ERCCI complex with an apparent molecular 
weight (MW) of - 280 kDa bOlh in Hela extracts 
and in partially purified ERCCt fractions, much 
larger than the -120 kDa previously observed 
by glycerol gradient sedimentation experiments 
(Biggerstaff et aI., 1993; van Vuuren et ai., 
1993). The larger MW obtained in non-denatu-
ring gels would better accommodate the presence 
of ERCCI (predicted as 33 kDa), a subunit of 
120 kDa and at least one additional polypeptide. 
In general, MW estimations from these two 
methods must be taken with caution, and may 
strongly depend on the conformation of the 
complex. 
4.2 Purification alld activity of the ERCCI 
complex 
Purification of the ERCC 1 complex to homo-
geneity from mammalian cells is very difficult by 
classical methods. After initial purification most 
of the chromatographic materials showed elution 
of ERCCI together with the majority of the 
remaining proteins. In our experience the Hy-
droxylapatite colunm yielded the best purifi-
cation, but even after this step ERCCI could not 
be unequivocally identified on protein-stained 
gels. The protein complex must be present in 
relatively small amounts in this stage of purifica-
tion. Unfortunately, immunodetection of ERCC4 , 
ERCCII or XPF during the different chromato-
graphy steps is impossible at the moment, since 
antibodies are not available yet. The ERCCI 
complex has affinity for DNA but no strong 
preference for binding ss, ds, or UV-irradiated 
DNA. This suggests that the ERCCI complex 
does not have a direct role in recognition of the 
DNA lesion,likeXPA and XPE, which preferen-
tially bind 6-4 photoproducts and other NER 
lesions (Jones and Wood, 1993; Reardon et aI., 
1993). Very recently, the RADIIRADIO COIll-
plex has been found to cleave a splayed~arm 
DNA structure (Bardwell et aI., 1994b). By 
extrapolation the EReCl complex might be 
involved in the 5' incision, whereas XPG has 
been shown to be responsible for the 3' incision 
(O'Donovan et aI., 1994). However, no S5 or ds 
endonuclease activity specific for the EReCt 
complex could be demonstrated due to contami~ 
nating nucleases. Absence of EReCt endonu-
clease activity was found by Park and Sancar 
(1994). Further purification of the complex and 
the use of structure-specific DNA substrates 
(such as splayed-arm Of bubble-containing DNA 
molecules) may be required for disclosing the 
enzymatic function of the EReCt complex. 
4.3 Association of ERCCl complex with other 
NER faclors 
A coordinated action of many repair proteins 
is required in the NER process. This might 
indicate binding affinities between different 
repair factors. For instance, evidence has been 
reported that XPC associates with TFIIH (Drap-
kin et aI., 1994). In addition, RAD2 and RAD4, 
yeast homologs of XPG and XPC res-pectively, 
were claimed to interact with factor b, the yeast 
equivalent of TFllH (Bardwell et aI., 1994a). In 
case of the ERCC I complex no specific stable 
interactions are observed with any of the known 
repair proteins (complexes). Depletion of a 
repair-proficient extract with antibodies against 
the p62 subunit of TFIIH or against ERCCI 
failed to reveal co-depletion. Also XPA did not 
show a stable association with the ERCCl com-
plex in unfractionated HeLa cell-free extracts. An 
ERCCl-depleted HeLa extract still contains the 
repair-correcting activities for XPB, XPD (both 
subunits ofTFIlH) and XPA, while the activities 
to complement the defect of ERCCl, ERCC4, 
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Communicated by D.Boc>tsma 
ERce3 was initially Identified as a gene correcting the 
nucleotide excision repair (NER) defect of xeroderma 
lligmentosum complementation group B (XP-B), The 
recent finding that its gene product is idenllcal to the 
p89 subunit of basal transcription factor BTF2(TFIHn, 
opened the possibility that it is not direclly inyoh'ed in 
NER but that it regulates the transcription of one 
or more NER genes. Using an ;/1 ~'im microinjeclion 
repair assay and an in l'i!ro NER system based on 
cell·free e:dracts we demonstrate that ERCC31n BTF2 Is 
directly implicated in excision repair. Antibody depletion 
experiments support the idea that the p62 BTF2 subunit 
and perhaps the entire transcription factor function in 
NER. MicroinjcctioJl experiments suggest that exogenous 
ERCC3 can exchange with ERCC3 subunits in the 
complex. Expression of a dominant negath'e K436 - R 
ERCC3 mutant, expected to ha\'e lost all hellcase 
aethity, completely abrogates NER and transcription and 
concomitantly induces a dramatic chromatin collapse. 
These fmdings establish the role of ERCC3 and probably 
the entire BTF2 complex in transcription ill l'jl'O which 
was hitherto only demonstrated ill l'i!ro. The results 
strongly suggest that transcription itself is a critical 
component for maintenance of chromatin structure. The 
remarkable dual role of ERCC3 in f'o.'ER and transcription 
prm'ides a clue in understanding the complex clinical 
features of some inherited repair syndromes 
Key words: BTF2/chromatin structure/ERCC3/nucleotide 
excision repairlrepair syndromes 
Introduction 
An intricate network of DNA repair systems protects the 
genetic infonnation from continuous deterioration due to the 
damaging effects of environmental genotoxic agents and 
inherent chemical instability of DNA. Thus these systems 
prevent mutagenesis leading to inborn defects, cell death 
and neoplasia, and may counteract the process of ageing. 
Nucleotide excision repair (NER) is one of the major, cellular 
repair pathways. It removcs a wide range of structurally 
unrelated lesions (such as UV·induced pyrimidine dimers 
and chemic.al adducts) in a complex multi·step reaction. The 
mechanistic details of this process in eukaryotes are-in 
contrast to Escherichia coli-poorly understood, but a 
general picture is emerging. After recognition of the DNA 
injury by a process not yet resolved, the damaged strand 
is incised on either side of the lesion, 27 - 29 nucleotides 
npart (Huang et al., 1992). Excision of the patch, which 
appears to require one or more single strand binding proteins. 
such as HSSB (RP·A) (Coverley et at., 1992) is followed 
by gap-filling, mediated by DNA polymerase 0 and/or f. in 
a reaction dependent on PCNA (Nichols and Sanc.ar, 1992; 
Shivji et af., 1992). Finally, ligation is required to seal the 
newly synthesized repair patch to the pre-existing DNA (for 
recent reviews see Grossman and Thiagalingam, 1993; 
Hocijmakers, 1993a,b; Sancar nnd Tang, 1993). In fact, in 
most, if not all, organisms at least two NER sub·pathways 
exist. Special factors allow for the rapid and emcient 
removal of lesions in the transcribed strand that interfere 
with ongoing transcription (transcription·coupled repair). 
The other sub·pathway deals with the slower repair of 
the rest of the genome (genome overall repair; Hanawalt 
and Melton, 1993). 
The dramatic consequences of impaired NER are illustrated 
by three distinct, inherited diseases characterized by 
sun (UV) hypersensitivity, elevated genetic instability 
and a striking clinical and genetic heterogeneity. These 
are the prototype rcpair disorder xerodenna pigmentosum 
(seven complementation groups: XP-A - Xp·G), Cockayne's 
syndrome (two groups: CS·A and CS·B) and PIBIDS (at 
least two groups, one of which is equivalent to XP·D) 
(Stefanini et af., 1986, 1993; for a review see Hoeijmakers, 
1993b). XP is marked by severe cutaneous abnomlalities, 
including a strong predisposition to skin cancer, and frequently 
progressive neurological degeneration (reviewed in Cleaver 
and Kraemer, 1989). es exhibits poor general development 
and neurodysmyelination. No increased frequency of skin 
cancer is noted in this disorder (Lehmrum, 1987; Nance and 
Berry, 1992). The repair defect in CS is limited to the 
sub-pathway of transcription·coupled repair (Venema eJ af., 
1990). Patients with PIBIDS manifest most of the es 
symptoms and, curiously, the hallmark of another disease 
c.alled trichothiodystrophy; ichthyosis and brittle hair and 
nails (the latter may be due to a reduced synthesis of a 
cysteine·rich matrix protein) (Peserico el af., 1992; Bootsma 
and Hoeijmakcrs, 1993). In exceptional cases individuals 
-display a combination of XP and es. These have been 
assigned to XP complementation groups B, D and G 
(Vermeulen et ai., 1991, 1993, 1994). 
Recently. the gene responsible for one of these, the XP·8 
gene: ERCeJ (Weeda et ai., 1990), was unexpectedly found 
to be identical to the pS9 subwut of basaitrallscription factor 
BTF2 (TFIIH) (Schaeffer et al., (993). Human TFIIH, its 
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rat counterpart factor 0 and its yeast equivalent factor b are 
one of the seven or so components required for proper 
transcription initiation of RNA polymerase II;II ritro from 
a number of model promoters (Conaway and Conaway, 
1989; Feaver et of., 1991; Gerard et 01., 1991; Flores et 01., 
1992). The fonnation of an elongation--{:ompetent initiation 
complex involves a highly ordered cascade of reacliG .oS 
(reviewed in Sawadogo and Sentenac, 1990; Roeder, 1991; 
Gill and Tijan, 1992; Drapkin et ai., 1993), initiated by the 
binding of factor TFIID to the TAT A box and completed 
by binding of TFIIJ. The multi-subunit BTF2 consists of a 
minimum of five proteins: pS9, p62, p43, p41 and p35. The 
role of this factor is at least 2-fold. First, the human 
BTF2/TFID-l as well as the rat 0 factor are associated with 
a protein kinase activity that specifically phosphorylates the 
C-terminal domain of the large subunit of RNA polymerase 
II (Lu et of., 1992; Serizawa et 01., 1993b). Second, it 
exhibits a DNA helicase activity (Schaeffer et ai., 1993) that 
is functionally required for ATP-<lriven local denaturation 
of the transcriptional start site. The foonation of an open 
configuration precedes the catalysis of the first phosphodiester 
bond of the transcript. Experimental evidence renders it 
likely that the ERCe3 gene product participates in the 
essential unwinding reaction (Schaeffer et 01., 1993). This 
is consistent with the identification of seven so-called 
'helicase motifs' in the ERCC3 amino acid sequence (Weeda 
et 01., 1990). 
The discovery of the ERCe3~transcription connection 
provided an adequate explanation for several of the mysterious 
observations with respect to this gene, such as its unsolved 
essential function in yeast (Gulyas and Donahue, 1992; Park 
et 01., 1992) and Drosophila (Mounkes et of., 1992) and a 
poorly defined involvement in expression of certain genes. 
In addition to a direct participation of ERCe3 in both 
transcription and repair, this finding opened a second 
possibility 10 explain the ERCC3 -NER connection. When 
the expression of one or more essential NER genes critically 
depends on the functioning of ERCC3, mutations in this 
gene might indirectly result in a NER defect (Gulyas and 
Donahue, 1992; Schaeffer et ai., 1993). The aim of this 
study was to funher define the role of ERCC3 in transcription 
and repair ill ~1~'0 and ill vitro. The work presented here 
has implications for understanding the complex clinical 
picture of XP-B and other foons of NER syndromes and 
provides evidence for the involvement of an additional BIF2 
component in NER. 
Results 
NER function of BTF2 measured by micfolnjecrlon 
The presence of XP-B specific NER correcting activity 
in protein fractions obtained during the purification of 
transcription factor BIF2 was assessed by microinjection 
into living XP-B fibroblasts in culture. The effect of the 
injected proteins on the repair capacity of the cells is 
measured by UV-induced WlSCbeduled DNA synthesis (ODS), 
visualized by ill sim autoradiography and quantified by 
counting sih'er grains above nuclei (De Jonge et 01., 1983). 
Figure IA shows the purification scheme of BIF2 (Gerard 
el 01., 1991) together with the results of the microinjection 
in XP-B and as a control in XP-G. It is apparent that 
BIF2~containjng fractions induce correction in XP-B. The 
multinuclear XP-B cell shown in Figure 1 B has been injected 
with purified BTF2rrFIIH (hydroxyapatite fraction; Gerard 
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A Purification scheme of BTF2(TFIIH) 
BTF2 pllri~cation step Correction 01 NEA-<1efect 
Hela WCE {Man!ey! 
Heparin llitrogel (0 22.(1.4M KC!) 
OEAE-spherode)( (0.Ol-O.17M KCl) 
Sulphopropyl-sPW (O.38M KCJ. pea!.;) 
Phenyl-SPW 
Hydroxyapatite 
glycerol gradient 
B 
(0.2M (NH4)2S04. peak) 
(0.37 M K·Pi. peak) 
in xp-a xp·G 
+ 
NT 
,NT 
+ 
+ 
+ 
+ 
+ 
NT 
NT 
F1g. 1. A~!Th!nt of XP·B correcting activity by BTF2 using 
microooedle inje.;tion. (A) CopurifJcation of XP-B repair correction 
and transcription stimulation of Bin. p.m. f~tio!lS of tfi1ll5Cripti<>n 
~timulatory activity of e.J.ch Bin purification step (for d?taili on the 
BiF2 purifICation soo Gt;rard tI af., 1991) were inje.;ted into the 
C)10pJasm of XP-B or xp·a homopoly~·ons, followed by UV 
irradiation, in.:ubation in the pre~ of [ HJTdR, fixation and 
prlXessing for autoradiography (;00 Materials and mcthods for details). 
The num~r of siJwr grains alxJYe nuclei is a rdlection of the repair 
capacity of the cell. Fractions were scored positi\'e when the injectoo 
cells showoo a level of UDS that was more than ~h'e times ab(we the 
backgrOlJnd of non·inje.;ted neighbouring fibroblasts. WCE: whole cell 
e,tree!. ~ samples of the flISl two purification ~teps were \'ery 
diluted compared with th¢ WCE. (B) Microgl1lph of XP·B fibroblasts 
(XPCSIBA), microinje.;ted with the highly purified fl1lction 12 of the 
HAP chromatogl1lphy column (se>e Figure 2), sho.",ing indLl(:tion of the 
UV de~ndent UDS in the injected multi-nucleate<:! cell (anow) 
wmpared .",ith the Iypkal XP-B residual UDS leYel as ~hown by the 
surrounding uninjected mononudear ceHs. 
el 01., 1991) and shows a level of UDS in the range of 
normal cells. In contrast, the non-injected neighbouring 
mononuclear cells exhibit the very low repair activity 
characteristic of XP-B. However, the correcting activity for 
XP~G fibroblasts, which is present in the whole cell extract 
(WeE), does not copurify with BTF2 (Figure IA). To follow 
more closely the relationship between BTF2 and XP-B 
correction the fractionation profiles of the last two purification 
steps, the hydroxyapatite (HAP) chromatography and the 
glycerol gradient sedimentation were screened in a quantitative 
fashion. Figure 2 shows that there is a direct correlation 
between the repair complementing activity measured as 
. UDS as wel\ as in \ltro and the transcription activation 
detennined in an ill ~llro run-off assay using the adenovirus 
major late promoter with RNA polymerase II and all basal 
transcription factors except BTF2 (Fischer et 01., 1992). In 
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FIg. 2, Co;;hromawgrapby and cosedimentation of BTF2 tranScription 
stimulating and XP-BIERCC) repair-correcting ih.'ti~ities. The 
transcriptionally actiw rrn.~tions that w~re eluted from the phenyl-5PW 
column were sucas.si\-ely applied on a HAP column and a 15-35% 
gl)',ero1 gradient. All fractions were tested for ttanscription stimulation 
in lilTO using the adenoyirus major late promoter. Repair actiyity was 
detenninOO in Iii\? by mkroneOOle injection illto living XP-B 
fibroblasts 300 ill lilTO using a cell-free NER assay. (A) HAP 
purifICation step. The upper part shows the autoradiogram of the 
transcription assay, the middle part presents the mults of grain 
counting (average numbu of grains per nudeus, 50 nudei tounto:d) of 
XP·S c~lIs microinjocled with each fraction and assayed for 
UV-indoced UDS. The lower two ~!s repre.seot the ill }itro NER 
a,tilities of the same fractions in 27-t, a rodent NER deficient c~1l 
strain of comp1enwntation group 3. They sholl' the ~taill<.-xI gel to 
demonstrate equal loading and the autoradiogram to visualize repair 
.')llthesis. The AAF-damaged pla.lmid is indicated '>'>1m '+', the 
undamaged internal control '>'>ith '-'. Fractions 4 and 12 of the HAP 
profile had undergone an eura cycle of fnx'!ing and th.awing prior to 
this test. (8) Glrcerol gradient sedimentation. Transcription (upper 
part) and XP-S in lil'O repair activity (lower pan) of the glycerol 
fra~tioru were as.sJ.yed as aboye. 
previous work it was shown that the transcription stimulation 
of BTFl parallels its helicase activity (Schaeffer et 01., 
1993), Thus, all BTFl activities coincide with the Xp·B 
spedfic NER correction over six purification steps. We 
conclude that microinjected BTFl complex itself and not a 
minor contaminant causes restoration of the repair defect in 
living Xp·B cells, 
NER function of BTF2 in an In vitro repair assay 
The results of the microinjection experiments do not exclude 
the possibility that ERCC3 is only indirectly involved in 
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Fig, J. BTF2 rorrects NER defect of n:xknt complementation group J 
ill Ii/TO. (A) In 1";1'0 wmplernentation of NER def¢;t in CHO mutants 
of rodent complementation group5 3 (mutant 27-1) and 4 (mutant 
UV47). Re.'lclions contained a d:uruged plasmid fpBKS, 3.0 kb) and a 
non-damagoo intwul. control pla.lmid (pHMI4, 3.7 kb). 250 ng e.'lch. 
Protein con«nrration in all re.'lctiortS was 200 Jig. [n lane 2 100 "g of 
protein of e.'lch mutant e.\traci were mhed. After incubation in the 
presence of Illp]dATP to permIt repair, DNA was isolated. linearized 
by restrktion endonuclease treatment and size-fractionlted by agarose 
gel ele.."trOphoresis. (B) In }ilro correction of NER ddecl of rodent 
wmp!eiTh!ntation group 3 (mutant 27-1) by purified BTF2 (fractions 4 
and 12 of the HAP chromatography slKmn in Figure 2). Unes I and 
2 contained 200 I'g protein, lanes J and 4 100 "g of ntract Wa.l used. 
The amount of protein contributed by the BTF2 HAP fractions is 
negligible. 
, 
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NER. It is feasible that introduced BTF2 corrects expression 
of one or more critical NER genes whose transcription is 
abolished by the ERCC2 mutation in XP·B. Therefore. we 
also measured correction of the XP-B defect in an ill vitrQ 
NER system (Wood el af., 1988) where transcription and 
translation cannot occur. Figure 3B shows the outcome of 
administration of highly purified BTF2 (fraction 12 of the 
HAP chromatography) to ceH·free extracts of CHO mutant 
27·1. This mutant is a member of rodent complementation 
group 3, the equivalent of XP·B (Weeda et 01., 1990). In 
the presence of purified BTFl. repair synthesis in the damaged 
plasmid reaches a level similar to that achieved by mixing 
a complementing extract (Figure 3A). No such correction is 
observed with fraclion 4 of the HAP eluate, which does not 
contain BTF2 activity. In further testing all fractions eluted 
from this column in the ill vitro NER assay we find that the 
repair and transcription profiles are again superimposable, 
as they were using the microinjection assay (Figure 2A, 
lower panel). These experiments demonstrate that ERCC3 
has a direct involvement in both transcription and NER. 
Configuration of ERCC3 in the NER reBction 
To detemnne whether the ERCCt correcting activity in a 
whole cell extract resides in a BTF1(·like) configuration 
antibody depletion experiments were conducted. A repair 
proficient HeLa cell extract was incubated with a monoclonal 
antibody against the p62 component of BTFl (1-.1ab3C9), 
immobilized on protein A ~sepharose beads. After removal 
of the beads by centrifugation the remainder of the extract 
was tested for repair capacity ill vitro. Figure 4 shows 
that removal of p62 causes a clear antilxKly dependent 
reduction in repair activity (lane 3, compared with lane t) 
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rig. 4. Monoclonal antibodies against p62 deplete a repaiHomp.:lent 
He1.3 ntract from repair and ERCC3 activity. HeLa cell·frw <,.\tract 
(ISO 1'& protein) was incubated with Mab3C9 agalltit tre p62 BTF2 
~ubunit immobilized on protein A-~pharosc CL-4B beaoli. After 
centrifugation 10 TemQVe the bound proteins the ~upematant was tested 
for its repair and complementing a,th'ities u_Iing the ill lim, NER 
M5..l.y. Uifl¢ I. HeLa extract (undepJeled 100 "g); lane 2, !lela e,tract 
treatoo with protein A ocads alone (SO fig); lane J, HeLa ,'\tracl 
depleted with Mab3C9 (SO pg); lane 4, Mab3C9·ueated HeLa ('''(;lei 
(40 pg) mi_led \\ith ("(!act of CHO mutant UVIJ5 (romplelTh"Jltalion 
group 5, 100 1'8); larw 5, UVJ35 extract alone (lOO I'g); lane 6, 
MabJe9·treated lIela extract (40 1'8) mhro with e,Ir.K! of CliO 
mutant 27·' (oompkmentation group 3, 100 I'g); lane 7, 27-1 C\tract 
alone {lOO pg). 
suggesting that p62 is also involved in NER. To see whether 
ERCC3 activity is still present the treated extract was 
mixed with an extract ofCHO group 3. It is apparent from 
Figure 4 that the (p62)~<r~(tcJ-HeLa extract had also lost the 
ability to complement the group 3 (lane 6) but not the group 
5 defect (lane 4), which is equivalent to XP-G (O'Donovan 
and Wo<Xl, 1993; Scheely el af., 1993). These findings 
indicate that ERCC3 correcting activity in a repair-
competent HeL'I whole cell extract is associated with p62 
and that the ERCC5IXP-G factor is not tightly bound to 
the p62 - ERCC3 complex. 
Effect of ((ee ERCC3 protein 
The purified BIF2 complex is quite stable, at le.ast in \'ilrO, 
as the proteins invoh'ed remain .associated even in I M KCI 
(Schaeffer et af., 1993). To find out whether the ERCC3 
protein can only function in NER when offered in the foml 
of the BTF2 complex we tested the .ability of ERCC3 protein 
overproduced in E.coli to complement the XP-B defect. 
Figure 5 shows a glutathione-agarose bound fraction 
containing the GST - ERCC3 fusion protein after SOS-
PAGE (lane I) and the partially purified ERec3 gene 
product released from the GST fusion protein after cleavage 
by thrombin (lane 3). The results summarized in Table I 
(lower part) demonstrate that the recombinant GST - ERCC3 
fusion protein as well as free ERCC3 induce significant 
correction soon (within 4 h) after microinjection into XP-B 
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Fig. 5, SDS- PAGE analysis of r=bin.mt·prooure.:! ERCCJ fusion 
protein. Rocombinanl-proollCed fusion. protein of GST-ERCCJ (uling 
\'e<;lor pGEX2n \las p;1nly purified on. gIUt3.lhione-agaro5e beads and 
eluted with 5 mM rerlucoo glutathione ilan¢ I). Lane 2, eluted 
proreif\S, after dige>!io!l \\ith thrombin; lane J, proteins releawd after 
thrombin deasage from immobilizoo fusion pro{eiru on GSH beads. 
Arrows irKlicate the n:wmbinant ERCC) proteins. OIMr bands pre;;enl 
in the Coomassie sta~d gd are prot-ably duil·oo from C-Ierminal 
degradllion prOOucts of GST-ERCC3 and oonlami[l.lting £.(011 
protein,. 
fibroblasts. The fact that ERCC3 in the context of the 
BTF2 complex as well as free ERCC3 exerts correction must 
mean that the ERCC3 subunit is exchangeable. The notion 
that the correction by BTF2 is more rapid (within 2 h) and 
reaches wild-type level is consistent with the ide.a that 
this complex rather than the free protein is involved in the 
NER reaction. Apparently, the N-terrninal GST extension 
does not seriously interfere with ERCe3 functioning in 
the BTF2 complex. 
Consequence o( Interference with ERCC3 functioning 
for NER and transcript/on 
The involvement of ERCC3 in transcription is derived from 
results using an ill l1tro transCription assay and a limited set 
of promoters (Gerard el at., 1991). It is important to verifY 
whether the protein performs such a function ill li\"o as well. 
Therefore. we assessed the effect of antibody injection on 
RNA synthesis (determined by incorporation of eHluridine) 
and on NER (as detemtined by the level of UV-induced 
[3H1TdR incorporation) into normal fibroblasts, As a 
control, cells on the same slide were injected with preimmuJle 
serum of the same rabbit and with antibodies against the 
ERce I protein, a NER component not residing in the BTF2 
complex. Previously, we presented the specificity of the 
antibodies (Schaeffer et af., 1993; van Vuuren el af., 1993). 
The results are summarized in Table I (upper part). The 
ERCC3 preinunune serum has no significant effect on the 
number of grains derived from transcription or NER. The 
ERCCl control serum induces a total inhibition of excision 
repair, demonstrating that this protein is indispensable for 
NER. However, no reduction of general transcription is 
observed, demonstrating that transcription does not drop as 
a non·spe.c;ific consequence of the inhibition of repair. The 
ERCC3 serum causes a significant but incomplete repression 
of transcription as well as repair synthesis. The partial effC{:t 
can be explained in several ways. The antibodies cannot 
reach or block the activity of all EReC3 molecules. e.g. 
because the antigenic sites are not accessible. Alternatively, 
Table I, ~liC[1)inje.;lion of ERCC3 pfl}{dn, antibodies and DNA corut.nKts in human cells 
Injwed suh,tances" Hours after % inhibitiml of % inhibitioa of NER activilY in XP-8 
(UDS in % of rKlnnal) inje.;tion 
Ami-ERCCI (476) 24 
Anti·ERCC3 (lIS\) 24 
Preimmune 1151 24 
K346 _ R ERCO 
1046 - R ERCO 22 
K346 - R ERCO ]0 
K346 _ R ERCe3 48 
\\'.1. ERCe3 ]0 
Roc. GST-ERCC3" '-6 
Roc. ERCC3' 4-6 
No injection 
NERb 
97 
" 2 
0 
74 
93 
98 
10 
RNA sym~sisb 
0 
48 
5 
0 
10 
78 
95 
5 
39 
" II 
'PoiFional rabbit S<l'Ilm (476, anli-ERCCI; !lSI, anli-ERCC3; preirnmune US!), ERCe3 eDNA in the mammalian e_~pre$Sion vector pSVL 
(wild'lype and K346 _ R mutant of ERCe3); aSH-purified r",-"-Ombinam fu.\iQn protein of GST -ERCC) and thrombin..:ut fusion protein of 
GST -ERCeJ on GSH column (sox Figure 5). 
t-compare..J v,j\h uninjeclOO cells present on the =e ~!ide. 
'Estimatoo protein corx:entration O.05-0.ll'glm.l. 
the protein is only involved in part of the transcription and 
NER reactions in the cell. 
As an alternative manner of interfering with ERCC3 
functioning ill lim a DNA construct was designed carrying 
a mutation that is expected to have only a subtle effect on 
the tertiary structure of the protein but a drastic effect on 
its activity. For this the conserved lysine 346 in the nucleotide 
binding box (Weeda et 01 .• 1990) was selected and replaced 
by arginine. thereby preserving the positive charge. It is 
known from other ATPases and helicases with GKT -type 
nucleotide binding domains that substitution of the invariant 
lysine reduces or completely abolishes ATP hydrolysis but 
does not necessarily afiect ATP binding as such (Azzaria 
et of .• 1989; Reinstein et 01 •• 1990; Tijan et of .• 1990). In 
the yeast RAD3 repair helicase it has been demonstrated that 
a similar K - R replacement does not interfere with 
ATP binding but blocked the hydrolysis step and helicase 
activity (Sung et of., 1988). Transfection of the mUlant 
ERCC3 cDNA into the UV-sensitive. repair-deficient rodent 
group 3 cell line 27-\ demonstrated that the K346 - R 
protein was unable to restore the repair defect (L.l\-fa. 
A.Westbroek, A.G.Jochemsen. G.Weeda. D.Bootsm:l. 
LH.J.Hoeijmakers and A.J. van der Eb. manuscript 
submitted). An analogous mutation in the yeast homologue 
of ERCC3, RAD25. showed that the essential function of 
the protein was also inactivated (Park et of., 1992), To 
see whether this mutation exerts a dominant effect the 
K346 - R ERCC3 cDNA was microinjected into 
repair-competent fibroblasts. As a control the wild-type 
cDNA in the same vector was injected into cells on the same 
slide. Although at different time points some heterogeneity 
was seen in the magnitude of the effects, presumably due 
to differences in the level of expression. a sharp drop in UDS 
was registered within 22 h which was total by 48 h (see 
Figure 6D-F and for quantitative results Table I, middle 
part). Concomitantly, transcription fell down to undetectable 
levels (Figure 6A-C. Table I). This was closely followed 
by a dramatic change in nuclear morphology. At fIrSt (22 h) 
the nucleoli increased in size and became less densely 
stained. At later tinles the entire Giemsa-stainable chromatin 
material clumped in a small area. leaving the remainder of 
the nucleus empty. In contrast. the cytoplasm stayed 
remarkably normal in morphology (sec Figure 6). None of 
these effects were observed in the cells injected with the 
wild-type cDNA construct which even exerts correction of 
the repair defect when injected into XP-B fibroblasts (Weeda 
et af .• 1990). We conclude that the K346 - R substitution 
confers a dominant-negative effect on both transcription and 
NER and induces a dramatic chromatin collapse. 
Discussion 
The findmgs reported here demonstrate that the ERCC3 gene 
product functions directly in two quite different aspects of 
nucleic acid metabolism: basal transcription and nucleotide 
excision repair. 1hls confirms and ex.1ends earlier observations 
by Egly and coworkers who identified the ERCC3 protein as 
one of the components of the BTF2ffFllH complex required 
for proper transcription initiation of RNA polymerase II 
ill ~'itro (Schaeffer et of .• 1993). Thus these results rule out 
the theoretical possibility raised by these and other remarkable 
observations with respect to the ERCC3 gene in the yeast 
and Drosophila systems. namely that the ERCC3-NER 
connection could be indirect. i.e. ERCC3 might control the 
expression of one or more (real) NER genes without being 
involved itself in this process (Gulyas and Donahue. 1992; 
.J\-lounkes et of., 1992; Schaeffer et of .• 1993). In addition. 
this work establishes that the ERCC3 protein participates 
in the transcription machinery ill v/'l'o; the evidence for this 
was hitherto only based on an ill I'itro transcription assay. 
Finally, this paper reveals the dramatic consequences of 
interfering with proper ERCC3 functioning ill vil'o via 
overexpression of dominant-negative ERCC3 mutant protein 
or by antibody injections. Our findings have direct 
implications for the functioning of ERCC3 at the molecular 
level and for the interpretation of some of the clinical 
manifestations of the associated human syndrome. 
Involvement of BTF2 in NER 
In what configuration does ERCC3 function in NER? The 
fact that purified BTF2 is able to correct the XP-Blrodent 
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Eg. 6. Eff.:.:t of 10.\6 ~ R ERCe) mutant on. transcription and NER. Mkrographs A, B and C ,how the time dependem effect on. RNA synthesis, 
a5$aYoo by pulw labelling with [lHluridine. in control (wild·type) fibroblasu injected with the ERCC3 eDNA encoding the 1046 - R mutatoo 
pilXein. Minographs D, E and F delOOrut .. lte the effect 011 NER, as rewaloo by UV-indu,c<J UDS. A and D w~re ass3.)'e<J 22 b, B and E 30 h and 
C aod F 48 h after microinje.."tion. Injech!d polykal)'ons (arrow,) delOOnstrate a complete inhibition. of RNA s)'owsis (no incorporatioll of 
eH]uridine) as wen as NER (abs.;:oce of UDS in injoc!i:d pol)'klll)'ons) and a dramatic chronutin. collapse. 
group 3 repair defect ill vim and ill \1/ro suggests, but does 
not prove, that the complex as a whole participates in the 
NER process. It is, however, not excluded that the ERCC3 
subunit dissociates from the complex and either functions 
alone or in a different complex in the NER reaclion 
mechanism, An argument in favour of the involvement of 
BTF2 in NER is our finding that monoclonal antibodies 
against p62 are able to deprive a HeLl WCE of its NER 
capability and all detectable ERCC3 activity. This suggests 
that at least the p62 subunit of BTF2/TFIIH is tightly 
associated with the majority of the ERCC3 molecules that 
are required for ill vitro NER. A second inference from 
this observation is that the p62 protein may be yet another 
NER factor. Whether the same holds for the entire BIF2 
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complex has to be established. The dual involvement of 
ERCC3 extends the emerging notion that the eukaryotic NER 
system recruits man)' factors from other systems that operate 
in the nucleus. From parallels with yeast it is likely that the 
recently discovered ERCCt, ERCC4, ERCCII and XPFC 
complex functions simultaneously in NER and in a mitotic 
recombination pathway (Schiesti and Prakash, 1990; Bailly 
et at,. 1992; Bardwell e/ af., 1992; Biggerstaff et at"~ 1993; 
van Vuuren et at"~ 1993), Using the in ~1tro NER assay 
Wood and coworkers have shown that the replication factors 
PCNA and HSSB (RPA) also participate in the post-incision 
stages of the NER reaction (Coverley el af" 1992; Shivji 
et al., 1992) in addition to DNA polymerase 0 or f and ligase 
I. The dual usage of these proteins for different processes 
may be for economical reasons. Alternatively. it may be a 
reflection of the tight links of excision repair with other 
processes in the nucleus. 
Possible role of ERCC3 In NER 
What can be the role of ERCC3 and BTFl in transcription 
initiation and NER? From the foregoing it is most logical 
to search for a common functional step for ERCC3 and 
perhaps the entire BTF2/TPIIH complex in both processes. 
It has been demonstrated that the human BTF2/TFIIH 
complex as well as the rat counterpart exhibit two activities: 
a protein kinase that is able to phosphorylate the C-tenninal 
domain of the large subunit of RNA polymerase II (Lu el al .• 
1992; Serizawa el al .• 1993a.b) and a helicase activity 
(Schaeffer el af., 1993). The latter is likely to be associated 
with the p89 ERCC3 subunit. In this light at least two 
possibilities (or a combination) can be envisaged for a 
common catalytic function of ERCC3 in transcription and 
NER. (i) Induction of a locally melted DNA confornlation 
for RNA polymerase to be loaded onto the template. In the 
context of NER a similar function can be imagined for putting 
a scanning complex onto the DNA or the incision complex 
at the site of a lesion. (ii) Unwinding of the helix as part 
of the translocation of the transcription or NER scanning 
complex along the chromatin. as suggested for the UvrA1B 
complex in E.coli NER (Grossman and Thiagalingam, 
(993). In both cases the ERCC3 protein or the BTF2 factor 
has to interact with components of the transcription as well 
as the NER machinery. Mutations in the ERCC3 protein 
found in XP-B patients (such as alteration of the C-tenninus: 
Weeda et al .• 1990) primarily inactivate NER. It is tempting 
to speculate that these regions are specifically involved in 
the interaction with other NER components. 
Interference with ERCC3 functioning 
Microinjection of the K346 ~ R ERCC3 mutant construct 
induces a strong reduction or even a complete blockage of 
NER and general transcription. A similar effect-although 
quantitntiyely not as pronounced-was seen with anti·ERCC3 
antibodies. Selective inhibition of NER is not the reason for 
the dramatic decline of transcription, because antibodies 
against the ERCCt protein also cause a total blockage of 
NER but have no measurable impact on transcription. The 
inhibition of NER and transcription by K346 ~ R ERCC3 
occurs with similar kinetics. indicating that both processes 
are disturbed in an analogous fashion. f'urthennore. it is 
observed relatively shortly after microinjection when taking 
into account that the injected gene has to be transcribed. the 
mRNA translated and the protein incorporated in a sufficient 
number of BTF2 complexes to exert the observed effect. 
For many genes expression is first registered 16-24 h after 
injection. Also the correction of the XP-B repair defect by 
injection of the purified ERCC3 protein is a quite rapid 
phenomenon: significant increase in UDS is seen within 4 h 
after injection. This suggests that exogenous ERCC3 is able 
to exchange with endogenous ERCC3 in BTF2 complexes 
in a relatively fast manner. One possibility is that the BTF2 
complex disassembles and reassembles at regular times as 
part of its reaction cycle and in this way incorporates new 
exogenous ERCC3 protein. For the dominant effect of 
mutant ERCC3 the following scenario seems most plausible. 
The conservative K346 ~ R mutation is not expected to 
perturb dramatically the tertiary conformation and fitting of 
the protein into the BTF2 complex. After incorporation into 
BTF2 and assembly of the pre initiation complex the reaction 
proceeds up to the stage in which the ATPase activity of 
ERCC3 is required. At this point the system is paralysed. 
frustrating the nonnal progression of both transcription and 
NER. When a critical threshold of poisoned transcription 
units is reached this process culminates in a complete and 
irreversible inhibition of transcription. Ironically. this 
catastrophic event will also shut down the expression of the 
injected ERCC3 mutant construct itself. 
BTFl has Ix"en demonstrated to be involved in transcription 
by RNA polymerase n (Gerard et al., 1991). It is not 
!mown whether it is implicated in RNA polymerase I and 
ill transcription as weU. The effects of the dominant-negative 
ERCC3 mutant indicates that total RNA synthesis becomes 
impaired. This does not necessarily mean that ERCC3 
participates directly in all three modes of transcription. It 
is possible that the inhibition of e.g. RNA polymerase I is 
an indirect result of the blockage of RNA polymerase U. 
The time-resolved consequences of selective inhibition of 
transcription by RNA polymerase U have hitherto escaped 
detection because se\'ere mutants in this process are obviously 
not viable. In our transient microinjection system the most 
dramatic and earliest morphological effects concern the 
nucleus where the nucleolus seems to swell first and eventually 
all chromatin appears to become clumped in one or a few 
regions. leaving the remainder of the nucleus empty. These 
alterations initiate already at a stage when inhibition of 
transcription is still not complete suggesting that the 
chromatin structure critically depends on ongoing transcription 
and functioning ERCC3. Probably all cellular processes 
which require proteins with a high turnover and a short 
mRNA half-life will be affected first. Morphologically, the 
afiected cells show features resembling an early stage of 
apoptosis. However. further studies are warranted to establish 
a relationship with apoptosis. 
Consequences for tho clinical features of XP-B 
The very rare XP-B complementation group exhibits a 
number of clinical characteristics that are atypical for a 
NER defect and difficult to rationalize on the basis of a 
DNA repair problem. This includes many of the features 
these patients share with Cockayne's syndrome. such as 
neurcxlysmyelination, immature sexual development. absence 
of subcutaneous fat and a general grO\vth deficiency (Cleaver 
and Kraemer. 1989; Scott et al .• 1993; Venneulen et al .• 
1994). In view of the additional function of ERCC3 it is 
tempting to assign at least some of these features to a subtle 
impainnent of transcription. In mouse models evidence has 
been collected that the production of the myelin sheet is 
strongly determined by the amount of mRNA for myelin basic 
protein (Popko et af .• 1987). Thus the neurodysmyelination 
may be related to a reduced expression of this protein. Viable 
mutations in the Drosophila homologue of ERCC3 designated 
• haywire' display sterility which is likely to be caused 
by reduced expression of I.Hubulin. required for spindle 
formation in meiosis (MoUllkes et al .• 1992). Perhaps 
lhe immature sexual development in XP-B could be due to 
the same problem. Recent findings in the field of basic 
transcription support the notion that the requirement of 
transcription factors may vary from promoter to promoter. 
depending on the sequence around the initiation site. the 
topological state of the DNA and perhaps other factors such 
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as the local chromatin structure (see Stanway, 1993 and 
references therein). This may explain the above fealures and 
the poor general development characteristic of this form of 
XP. In fact two other XP complementation groups, XP-D 
and XP-G, also display the remarkable clinical features of 
XP-B (Vemleulen et al., 1993). As demonstrated here the 
XP-G factor is not present in the BIF2 complex. If it is 
involved in transcription it is either present in another 
complex or it is only loosely associated with components 
of BTF2 and not essential for transcription, The latter idea 
is in agreement with the notion that the yeast homologue 
ofXP-G, RAD2 (Scherly el al., 1993) is also not an essential 
gene (Madura and Prakash, 1986). As noted before, XP-D 
and the corresponding gene ERCC2 have many parallels with 
XP-B and ERCC3. This has prompted the idea that the 
ERCC3 and ERCC2 proteins may iflteract and have a similar 
function (Weeda el al., 1990). Clinical heterogeneity in 
XP-O is eyen more pronounced than in XP-B and includes 
the peculiar brittle hair symptoms of lricholhiodystrophy. 
We have recently obtained evidence that Ihe functional 
overlap between repair and transcription also includes 
ERCC2, This is consistent with the idea that some of the 
clinical features of these rare pleiotropic disorders are due 
to basal transcription problems, 
Materials and methods 
Genelef procedllreS 
Purificllion of nudd: a-cids. restrictioo ~lIZ)me digestion, gel d;:ctrophoresis 
ofnudeic adds and p(1}(eins, transformation of E.roli, etc ..... ere p:rformed 
a~ording to nandard procedures (Sambrook et al .. [9S9). 
PiJrif{ca/fon of BTF2/TFIIH 
The purifk.~tio<lofBTF2 and all other generaJ. transcription fa(tors required 
for the ttall5cription assay using the adeno,·il1.ls 2 m~jor bte promot~r as 
template 1'035 p:rformOO >Urting from HeLa cells as !k..<cn"M earlier (Geran.! 
€l al., 1991). 
MlcronalXila {niecr/on and assay (or RNA syn!has{s and 
UV-Induced unschedllled DNA syn!hasis 
Microneed[e injwion of XP·B fibroblasts as well 35 control ,~JIs (C5RO) 
was IXlformed a, descnbed (Vermeulen U 01.. 1994). Briell)" at kast 3 
day., prior to microinjKtion cells w'ele fused with the aid of inaCli.'ated 
S.:rl<hi virus, seeded onlO cowrslips and cultured in Ham's F-!O medium, 
supplemented with 12% fetal calf serum and anulJiOlics. After inj;:ction 
!)f at [cast 50 homopolykaryons c',:Us were incubated for th:- desired lime 
in normal culture medium before being a,sayed. NER octivity was 
dcunnined after UV·C tight irr.ldiation with 15 JIm!, incub.l.tion for 2 h 
in [lHlthymidine (10 pCilm!; I.a.: 50 Cifmmol)-containing culture 
medium. fhation and e.\posure to autoradiography. Grain.> above the nuclei 
(> (00) were counted and represent a qu.mtilatil"e IT\eJ.5Ure for NER ac-
tivity. RNA synthesis was determined a\s.o by counting autoradiographic 
grains above the nuclei of inje.=:ted cells, after labe[ling v,ith ellJuridine 
(10 j.<Ci1ml; I.a.: 50 Cilnuno\) during a puis<: labelling period of I h in 
normal culture medium. Protein preparations (induding antisera) were in-
j.:cted into the C)toplaID1, cDNAs were microinjected into one of the nucld 
of pol)·kar)·on.l. 
In vitlO DNA (epair assay 
Plasmids pBKS (3.0 J..b) and pHM!4 (3,1 !..b) weN: isolated from £.roli 
and e~temiwly purified as closed dn:ula.r DNA (Higgerslaff et al., 1991). 
pBKS was treated with O. [ fIlM N-a,e!0.,y-2-acet)"[aminonuor~ne (AAf-) 
(a kind gift of R.Baan, TNO, Rij,v.ijk), inducing mainly N-(guanine-
8-)'i)-AAF adducts. AAF-modifled plasmid> were colle.;t~d by repeated 
di-eth)"[-eiller e~lfi!.ctions and elh.mol predpltatioo (Lande gent (/ al., (934) 
and repurified on a neutral ~ucrose gradient. pHMI4 was mock-treated in 
p.ua\[el. Thae are [5-20 AAF-guaninc 2ddu.::t5 per dmuged plasmid. 
Repair·proficient cell lines: HeLa, Chines<: hamster ova!)' (CHO) cell 
~tra.in CH09 and cno NER mUWlt<;: 21-[ (comple~ntation group 3), 
UV47 (CG 4) and UVI3S KG 5) \\er~ cultured in a I: 1 mhture of Ham"s 
F·!O and D~!EM rnediwn IGlIx:o) supplemented with 10% fetal calf serum 
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and antibiotics. Cells were h.l.Iyested and e.\tr"a(ts were prepared from 
2-5 ml ofpao:ked cell p:llet by the m~thod of Manley 35 rood.ifioo by Wood 
(Manley f( al., 1983; Woof a af .• (983). li'\.trao.""tS were dialysed in 25 mM 
HEPES-KOH, pH 7.8, 0.1 M KCI. 12 mM MgCI!, 1 mM EDTA, 
2 mM OIT and [7~ (\'1\") glycerol and stored at -8O'e. 
The reaction mhtore (50 j.<1) ,onlained 250 ng of both dan13ged and 
non-d1rrugo:! plasmid DNA. 45 ruM HEPES-KOH (pH 7.8), 70 m.\1 KO, 
7.4 mM MgCl2, 0,9 m..\.f OIT, 0.4 mM EDTA, 20 "M e<!ch of dCTP, 
dGTP and TIP, 8 j.<M dATP, 74 kBq of [,,_J2 PldATP, 2 m.M. ATP, 
40 m.\I pho;;pbocre<!tine, 2.5 j.<g creatine pMsphokil1.1S<), 3.45% glycerol, 
[8 j.<g bo.ine serum albumin aoo 200 "g of cell·free e.\tr;!ct. The reaction 
was inrubated for 3 hat JOoc, afterwards the plasrnid DNAs were isolated, 
linearize>! and separated on an aga.rose gel el~trophor~is, Dala were 
anal)'sed via autoradiography and quantified by scintillation counting of 
e'Cis.ed DNA bands. 
For microinj;:ction and :lntilxxl)' depletion e~periment<;, the foHowing 
antisera were us.:d: (i) a rabbit polyclon.ll anti-ERCel antiserum rahed 
against a ubiquitin-ERCC[ fu.l!on procein and chara<;terized as previously 
<k.scnb:d {van Vuuren (I a1., 1993): (il) a p;:>lycJonal ~nJlll raised again>t 
a GST - ERCC3 fusion protein conl.1ining an internal part (amino acids 
82-480) of ERCC3: (iii) a monodon.ll anu"body (Mab3C9) against the 
62 kDa polypeptide, a compon.::nt of BlF!, med in depletion e~perilT\ents 
was published. earlier (F~~r tt a1., 1992). 
To deplete [50 "g of repair-proficient HeLa ntract, anti·p62 anulJodi~ 
(3 "I of ascites fluidl We£<: immobi[iud on pr{)(ein A -Sepharos<: CL· .. m 
beads; after incubation .... ilh Helaemact and centrifugation the SUpW\l.tant 
was used as a depleted Hela e.\lfact and tested for repair activity in >llfO 
as detailoo abo.·e (Hn Vuuren et 0/., 1993). 
OVelproduction and purification o( (acombfnent ERCC3 plotein 
ECCRJ eDNA doned in pGEXlT was transferred. to E.coli main BUI 
and gene e.lpre"ion was inducoo during 3 h by IPTG. Cells were 
homogenized in PBS (containing 2 mM PMSF and 15% glycerol) by 
sonication and e~tracts w~re ckared. by centrifugation. Fusion protein was 
purified by p.1SIing the eel[ homogenate through a glulathione-agarose 
containing column. proteins were eluted. with 5 mM reduced glutathione 
{in 50 mM Tris, pH 8.0). Alternatively r;:combinant ERCC3 .... as clMved 
from the GST part by llxubating the immobilized fusion protein (on 
the glutathione-agarore beads) with thrombin (I-2 nglpg protein) for 
45 min at 20'C. 
Sile-dil8cted mutagenesIs 
Mutations in the ERCCJ eDNA sequeno:e were made u.ling the 
oligonucleotide dir.:c!ed. uracil-DNA melhod (Kunkel €I al., 1987). An 
internal fragment of £RCC3 was insercai in a MiJ >-eaor, and after mUlation 
induction used to replace the wild-type fra~nt in the parental plasmid 
pE3-\VT. Th~ de,ired mutation was verified by sequ~nce ana[y,is. 
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Chapter 5 
Three unusual repair deficiencies associated with transcription 
factor BTF2(TFIIH). Evidence for the existence of a 
transcription syndrome. 
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To counteract the deleterious effects of DNA 
damage a sophisticated network of DNA repair 
systems has evolved, which is essential for gene-
tic stability and prevention of carcinogenesis. 
Nucleotide excision repair (NER), one of the 
main repair pathways can remove a wide range 
of lesions from the DNA by a complex multi-step 
reaction (for a recent review see Hoeijmakers, 
1993). Two subpathways are recognized in NER: 
a rapid 'transcription-coupled' repair and the less 
efficient global genome repair (Bohr 1991; Hana-
walt and MeHon 1993). The consequences of 
inborn errors in NER are highlighted by the 
prototype repair syndrome xeroderma pigmento-
sum (XP), an autosomal recessive condition, dis-
playing sun (UV) sensitivity, pigmentationabnor-
malities, predisposition to skin cancer and often 
progressive neurodegeneration (Cleaver and 
Kraemer 1994). Two other excision repair dis-
orders have been recognized, Cockayne syndro-
me (CS) and trichothiodystrophy (TID), which 
present different clinical features. These are, 
besides sunsensitivity, neurodysmyelination, 
impaired physical and sexual development, dental 
caries (in CS and TTD), ichthyosis and sulphur-
deficient brittle hair and nails (in TTD)(Lehmann 
1987; Nance and Berry 1992), which are difficult 
to rationalize on the basis of defective NER only. 
The N ER syndromes are genetically heterogene-
ous and comprise at least 10 different comple-
mentation groups: 7 in XP (XP-A to XP-G), 5 in 
CS (CS-A, CS-B, XP-B, XP-D and XP-G) and 2 
for TID (TIDA and XP-D) (Hoeijmakers 1993; 
Stefanini et al. 1993b). Thus, considerable 
overlap and clinical heterogeneity are associated 
with a selected subset of complementation 
groups, of which XP-D is the most extreme, 
harboring patients with XP only, or combined 
XP and CS, or TID (Johnson and Squires 1992). 
Recently it was discovered that the DNA 
repair helicase encoded by the ERCC3 gene (Roy 
et al. 1994), which is mutated in XP-B (Weeda 
et al. 1990), is identical to the p89 subunit of the 
transcription factor BTF2/TFIIH (Schaeffer et al. 
1993). ERCC3 in the context ofTPIIH, is direct-
ly involved in NER and transcription ill vitro as 
well as ill vivo (van Vuuren et al. 1994). Further-
more, another repair helicase, XPD/ERCC2 was 
recognized to be associated with TFIIH (Schaef-
fer et a!. 1994), and it was shown that a partially 
purified TFIIH fraction is able to correct the 
NER-deficiency of XP-D ill vitro (Drapkin et a!. 
1994). These results reveal a link between two 
distinct DNA-metabolizing processes: repair and 
transcription. 
Initiation of transcription is believed to require 
the formation of an elongation-competent protein 
complex in a highly ordered cascade of reactions. 
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A preinitiation (DAB) complex is formed by the 
binding of the multisubunit TFIlD factor to the 
TAT A box element of core promoters, stabilized 
by TFIIA and followed by the association of 
TFIIB. The DAB intermediate stimulates the 
entry of RNA polymerase II mediated by TFIIF. 
Initiation is completed by the ordered association 
of TFIIE, TFIIHIBTF2 and TFIIJ (Drapkin et al. 
1993; Gill and Tjian 1992; Roeder 1991). T-
FIIHIBTF2 is thought to be involved in the con-
version of a closed to an open initiation complex 
by local melting of the transcriptional start site 
and phosphorylation of the C-terminal repeat of 
the large subunit of RNA polymerase II (Lu et 
al. 1992; Schaeffer et a!. 1993; Serizawa et al. 
1993), either at the preinitiation stage, or at a 
step between initiation and elongation, referred to 
as promotor clearance (Goodrich and Tjian 
1994). 
Here we report that defects in the XPB/-
ERCC3 subunit define a new TID complementa-
tion group extending the clinical heterogeneity 
associated with ERCC3. Furthermore, we de-
monstrate that probably the entire TFIIH com-
plex has a dual role in transcription and repair, 
as it harbors now at least three NER proteins, all 
associated with the TID and CS symptoms. The 
dual function of TFIIH, and the link between 
mutations in this complex and the pleiotropic 
features ofTTD and CS strongly support the idea 
that part of the clinical manifestations arise from 
defects in the transcription function of TFIIH. 
This provides for the first time a molecular 
explanation for the seemingly unrelated symp-
toms of these disorders and introduces a novel 
clinical entity, a heterogenous 'transcription 
syndrome' complex, that may include many more 
inherited conditions. 
METHODS 
Purification of BTF2ITFIlH. The purification 
of BTF2 starting from HeLa whole cell extract 
and involving sequential chromatography on 
Heparin-Ultragel, DEAE-Spheradex, SP-5PW 
sulfopropyl, and -after ammonium sulphate 
precipitation- Phenyl-5PW Sepharose and hydro-
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xyapatite was essentially as described earlier 
(Gerard et a1. 1991). In some fractions an addi-
tional purification step using heparin chromatog-
raphy was inserted in the standard protocol 
before the Phenyl-5PW column. The ill vitro 
assay for following the transcriptional stimulation 
activity of BTF2 on a AD2MLP promoter con-
taining template involving purified RNA polyme-
rase II and all transcription fators except BTF2/-
TFIIH is described in detail before (Gerard et a1. 
1991). 
Cell lilies alld extracts. The human cell lines 
used for microinjection and for complementation 
analysis were XP25RO and XPllPV (both XP 
group A), XPCSlBA and XPCS2BA (XP-B), 
XP21RO (XP-C), XPI BR, XP3NE and TTD8PV 
(all XP-D), XP2RO (XP-E), XP126LO (XP-F), 
XP2B1 (XP-G) and TID lBR (TID-A) and 
TTD6VI (Stefanini et al. 1993b; Vermeulen et a1. 
1986; Vermeulen et a!. 1994). The primary 
fibroblasts were cultured in Ham's FlO medium 
supplemented with antibiotics and 10-15% fetal 
calf serum. 
For preparing cell-free extracts utilized for the 
ill vitro repair assay the following cell lines were 
used: a SY40-transformed line belonging to 
TID-A (TTDIBRSV), human repair-proficient 
HeLa cells, mutant Chinese hamster cells 43-3B, 
UV5, 27.1, UV41 and UV135 assigned to com-
plementation groups 1,2,3,4 and 5 respectively 
(Busch et a1. 1989). The cells were grown in a 
1: 1 mixture of FlO and DMEM medium, antibio-
tics and 10% fetal calf serum were added. After 
harvesting and washing with phosphate-buffered 
saline (PBS), cell-free extracts were prepared as 
described by others (Manley et al. 1983; Wood 
et al. 1988), dialysed against a buffer containing 
25 mM HEPES/KOH pH 7.8, 0.1 M KCI, 12 
mM MgCI" 1 mM EDTA, 2 mM DTI and 17% 
(v/v) glycerol, and stored at 
- 80°C. 
III vUI'O DNA repair assay. Plasmid pBlue-
script KS+ (3.0 kb) was damaged by treatment 
with 0.1 filM N-acetoxy-2-acetylaminofluorene 
(AAF) (a kind gift of R. Baan, TNO, Rijswijk). 
As a non-damaged control plasmid pHMI4 (3.7 
kb) was used. Circular closed forms of both 
plasmids were isolated and extensively purified 
as described by (Biggerstaff et a1. 1991; van 
Vuuren ct al. 1993). The reaction mixture con-
tained 250 ng each of damaged and non-damaged 
control plasmids, 45 rnM HEPESIKOH pH 7.8, 
70 rnM KCI, 7.4 mM MgCI2, 0.4 mM EDTA, 
0.9 mM DTT, 2 mM ATP, 40 mM 
phosphocreatine, 2.5 Jtg creatine phosphokinase, 
3.5% glycerol, 18 Jtg bovine serum albumin, 20 
I,M eachofdCTP, dGTPand TTP, 8pM dATP, 
74 kBq of ",.32PdATP and 200 pg of cell·free 
extract for the rodent extracts and 100 pg for 
HeLa. After 3 It incubation at 30°C, plasmid 
DNAs were purified from the reaction mixture, 
linearized by restriction and separated by electro-
phoresis on an 0.8 % agarose gel. Results were 
quantified using a LKB Densitometer and B&L 
Phospho-Imager. 
Allti-p62 alltibody depletion of a repail'-proji-
dent extract. Protein A sepharose beads in PBS 
were incubated with monoclonal antibodies 
against the p62 subunit of BTF2 (Mab3C9, 
(Fischer et ai. 1992» or against p89 for I h at 
O°C. The beads were washed with dialysis buffer 
and added to a repair-competent Hela extract or 
a (partially) purified heparin or hydroxyapatite 
BTF2 fraction for 1 It at O°C (van Vuuren et al. 
1993). The bound proteins were removed by 
centrifugation and the supernatant was tested in 
the ill vitro repair assay or for microneedle 
injection. Westernblot analysis following SDS 
polyacrylamide gel electroforesis was carried out 
according 10 standard protocols. (Sambrook el a!. 
1989) 
JlJicroinjection. Microinjection of XP homo-
polykaryolls was preformed as described earlier 
(Vermeulen et al. 1994). Repair activity was 
determined after UV irradiation (15 J/m2), 3H_ 
Thymidine incubation (10 pCi/ml; s.a.: 50 Ci/m 
Complemelltation analysis by cell hybridiza-
tion. Fibroblasts of each fusion partner, were 
labeled with latex beads (0.8 pm or 2.0 pm), 3 
days prior to fusion by adding a suspension of 
beads to the culture medium. Cell fusion was 
performed with the aid of inactivated Sendai 
virus or using Polyethylene glycol, cells were 
seeded onto coverslips and assayed for UV-
induced UDS as described in detail by Ver-
meulen et al. (Stefanini et al. 1993a; Vermeulen 
et al. 1993). 
Olher procedures. Isolation of DNA, subclo-
ning, and ill vitro transcription and translation 
were done using established procedures (Sam-
brook et al. 1989). 
'''C~------------
Fig. 1. Complementation analysis of TTD6VI cells. 
Fibroblasts of TID6VI (labeled with 0.8 pm beads) 
were fused with representatives of different XP and 
TID complementation groups (labeled with 2.0 pm 
beads). After performing the UV-induced UDS assay, 
the average number of autoradiographic grains above 
the nuclei were determined. DNA repair synthesis was 
expressed as the percentage of control UDS (vertical-
axis), observed in normal fibroblasts assayed in paral-
lel. The relative standard errors of the mean are in all 
cases less than 5 %. The different types of binuclear 
cells (homodikaryons of TTD6VI and of the different 
fusion partners, and heterodikaryons) are recognized 
by their different bead content and indicated as such 
in the figure. 
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RESULTS 
Identification of fmiller genetic heterogeneity 
within TID 
In an effort to assess the genetic hetero-
geneity within the class of repair-deficient TID 
patients we have conducted a systematic 
complementation study of a large number of 
photosensitive TTD families by cell fusion and 
microneedle injection of cloned repair genes. 
This resulted recently in the identification of a 
second complementation group among NER-
deficient TID patients (designated TID-A) 
(Stefanini et al. 1993b). Figure 1 shows the 
results of an exhaustive complementation analy-
sis of fibroblasts from one of two siblings 
(TTD6Vl and TTD4VI) with relatively mild 
clinical features of TTD and moderately 
impaired NER characteristics (detailed clinical 
description to be presented elsewhere). Full 
complementation of the repair defect was seen 
when fibroblasts of patient TTD6VI were fused 
with representants of the known TID comple-
mentation groups: XP group 0 (3 cell lines 
tested) and with TTD-A fibroblasts (Fig. I) 
(Stefanini et al. 1993a; Stefanini et al. 1993b). 
This demonstrates that this family defines a new 
TTD complementation group. To see whether 
this group is genetically identical to one of the 
other XP groups not previously associated with 
TID further cell hybridization experiments were 
carried out. No restoration of the deficient UV-
induced unscheduled DNA synthesis (UDS) was 
found when TTD6VI cells were fused with a XP-
B representant (XPCS IBA), whereas normal 
complementation was observed with the other XP 
groups (Fig. 1). This indicates that the repair 
defect in this family resides in the XPBIERCC3 
gene. Although TTD6VI cells appeared excep-
tionally sensitive to nuclear microneedle injection 
of DNA, still a few cells could be found cor-
rected by ERCC3 cDNA, in agreement with the 
assignment by cell fusion. Defects in the TFIlH 
subunit ERCC3 thus extend to the disorder TID, 
increasing the already observed clinical hetero-
geneity among patients carrying mutations in 
94 
B 
/ \ 
c 
'-
. 
-, 
Fig. 2. Microneedle injection of BTF2 in XP-D, 
TTD-A and XP-B fibroblasts. A, B and C, are 
micrographs showing the effect of purified BTF2 
(HAP-fraction 12, containing the highest trans-
criptional activity (Schaeffer et aI. 1993» on NER-
activity of injected XP-D (cell line XPlBR), TTD-A 
(TTDlBR) and XP-B (TTD6VI) fibroblasts respec-
tively. The injected cells (binuclear fibroblasts 
obtained by cell fusion prior to injection) are indicated 
by arrows. As apparent from the number of silver 
grains above their nuclei they exhibit a high (wild 
type) level ofUV-induced UDS when compared to the 
non-injected surrounding cells, which express residual 
UDS levels typical for these complementation groups. 
The heavily labelled fibroblast in panel n is a cell per-
forming S-phase replicative DNA-synthesis at the 
moment of the UDS-assay. 
A 1 2 3 4 5 B 7 2 3 4 5 B B 
Fig. 3, 111 vitro correction of NER defect by purified BTF2. BTF2 HAP-fraction 12 was added to an extract 
of rodent complementation group 2 (mutant UV5, equivalent to XP-D)(A), and to a human TID group A lysate 
(ITDIBRSV)(B), and tested for its capacity to restore the NER defect using an ill vitro cell-free repair assay 
(Wood et a1. 1988), The level of correction of NER activity using purified BTP2 is of the same order (lanes 
6, Fig.2A and B) as the level of complementation reached when the extract of group 2 is mixed with a group 
4 extract (Fig.2A, lane 2) or with the TTD-A exlract (Fig.2B, lane 2). No significant correction is observed 
when the purified BTF2-fraclion is added to rodent complementation group 4 (mutant UV47) exlract (Fig.2A, 
lane 7). The upper panel shows the ethidium-bromide stained DNA gel, the lower panel the autoradiogram of 
the dried gel, the presence of 31p_dATP indicates repair synthesis. The positions of AAF-damaged and non-
damaged DNA substrates, 250 ng each, are indicated by plus (+) and min (-) respectively. Lanes 1-3 contain 
in total 200 JIg of cell-free extract (in complementations JOO J-tg of each extract was used), the otbers lanes 
contain 100 ltg, the protein contribution by the BTF2 fraction is negligible. 
ERCC3 (Vermeulen el al. 1994). 
Systematic screening of TFIIH for NER pro-
teins 
To examine whether besides XPB/ERCC3 
(p89) additional NER factors are hidden in the 
TFIIH/BTF2 complex, we have systematically 
screened the existing human and rodent NER 
mutants for complementation by BTF2. The final 
fractions of TFIIH purification show at least 5 
tightly associated proteins, including p89 (XPB/-
ERCC3), p62, p44, p41, p34 (Gerard el al. 
1991; Schaeffer el al. 1993). A purified BTFl-
fraction (hydroxyapatite chromatography, gel 
pattern and properties see (Gerard et al. 1991)) 
was inserted by microneedle injection into fibro-
blasts of all known excision-deficient XP, XP/CS 
and'TID complementation groups. The injected 
cultures were exposed to UV and incubated with 
tritiated thymidine to pennit visualization of the 
repair synthesis step of NER by ill situ autoradio-
graphy (unscheduled DNA synthesis, UDS). The 
results summarized in Table 1, show that 3 out 
of 8 NER-deficient human complementation 
groups are corrected by the purified BTF2 tran-
scription factor. Figure 2A, Band C show 
micrographs of BTF2 injected multi-nucleated 
fibroblasts of XP group D, TID-A and the new 
XP group B patient with TID symptoms. The 
repair activities in injected cells reach the levels 
of normal fibroblasts assayed in parallel, indica-
ting full correction of the excision defect (see 
also Table 2). 
The restoration of NER could also be ex-
plained by correction of expression of one or 
more critical repair genes whose transcription is 
impaired by mutations in BTF2 subunits. There-
fore, purified BTF2 was checked for its repair 
capacity in an ill vitro repair assay (van Vuuren 
et al. 1993; Wood et al. 1988), where neither 
transcription nor translation can occur, because 
ribonucleotides and aminoacids are lacking. The 
results in Fig. 3 and Table 1 show that the BTF2 
fraction not only corrects the repair defect in 
rodent group 3 (the equivalent of XP-B), as re-
ported earlier (van Vuuren et at. 1994) but also 
the rodent group equivalent to XP-D (CHO 
group 2, defective in ERCC2) (Flejler el al. 
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Fig, 4. Correlation between transcription activation and correction of the NER defect in XP-D/ERCC2 and 
TTD-A mutant cells using different fractions from the HAP chromatography calonm. BTF2-derived ill vivo 
NER-corrccting activity, was quantitatively determined. after microinjection, by counting the grains above the 
nuclei (UV-induced UDS) of injected cells and expressed as % of the UDS-Ievel of repair-proficient control 
cells (C5RO) assayed in parallel (left black bar) (Vermeulen cl aI. 1986). The hatched bars indicate the average 
UDS level (determined by counting grains above 50 nuclei) of multikaryons injected with BTF2. The black bars 
represent UDS in non-injected neigbouring cells. The ill vh'o NER-activity profiles for respectively: XP-B 
(XPCSlBA) (A), XP-D (XPlBR) (B) and TTD-A (TTDlBR) (C) are compared to the ill vitro repair capacity, 
for rodent complementation group 2 (ERCC2 mutant UV5) extracts (D) and to the transcription activity, as 
determined in a BTF2-dependent ill vitro transcription run-off assay using the Adenovirus late promoter (E). 
Note that the UV5 (group 2) extract in panel D (like the XP-D cells in panel B) has a considerable residual 
repair. The lower activity seen in the higher salt fractions (lanes 16-18) is attributed to a inhibition of repair 
incorporation by increased salt (Wood et al. 1988). 
1992) and an extract from a SV40-transformed 
TIDIBR cell line (TID group A). In contrast, 
no significant NER restoration is observed in 
extracts of UV-sensitive mutants from groups I, 
4 and 5 (defective in ERCCI, ERCC4 and 
XPG/ERCC5 respectively). These findings ex-
tend the specificity of the repair-correcting acti-
vity of TFIIH, and confirm the ill vivo results 
obtained by microinjection. Furthermore, they 
demonstrate that besides XPB/ERCC3, also 
XPD/ERCC2 and TTDA must have a direct in-
volvement in NER. The ill vitro and ill vivo 
correction of ERCC2 mutants confirmed the ill 
vitro data of Drapkin et al. who used a partially 
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purified TFlIH preparation (Drapkin et al. 1994). 
However, the TFIIH/BTF2 purified fractions 
used in this study do not contain a XP-C correc-
ting activity, in contrast to the observations made 
by these authors. 
RelationsWp of XPDlERCC2 and TTDA with 
the core of TFIIH 
To further strengthen the link between NER 
and the TFIIH complex, the full elution profile 
of hydroxyapatite chromatography, the final puri-
fication step of BTF2 (Gerard et al. 1991), was 
quantitatively screened for NER-activity by mi-
croinjection as well as by ill vitro complemen-
tat ion, The XP-D and TTD-A correcting activi-
ties coelute with the activities of XP-B correc-
tion and transcription initiation(FigA). Identical 
results were obtained after cosedimentation in 
glycerol gradients (van Vuuren et a1. 1994 and 
unpl. results), 
Independent evidence for a physical associ-
ation of the XPD/ERCC2, XPB/ERCC3 and 
TTD A proteins with each other and with other 
components in the TFIIH complex can be ob-
tained from antibody depletion experiments. A 
crude repair-proficient HeLa extract was incu-
bated with a monoclonal antibody against the 
p62 TFllH subunit (Fischer et al. 1992), immo-
bilized on protein A sepharose beads, and after 
centrifugation to remove bound proteins, the 
extract was tested for remaining repair capacity. 
anti-p62 anti-p89 
110kDa 
~ 
70kDa 
43kDa • 
~ 
28kDa 
.. 
18kO. -
123456 
Fig. S. Western blot mmlysis ofp62 and p89 depletion 
of a repair-proficient HeLa extract. Monoclonal anti-
body (Mab3C9) against the p62 subunit of BTF2(-
TFIIH) coupled to protein-A sepharose beads was 
incubated with a repair-proficient extract prepared 
from HeLa cells. To verify the removal of p62 and 
simultaneous removal of other components of BTF2 
the remaining cell-free extract and the bound fraction 
were analysed by immunoblotting using monoclonal 
antibodies against p62 itself (lanes 1-4) and against the 
p89 (XPB/ERCC3) subunit of BTF2 (lanes 5-6). Lane 
1 contains the protein fraction bound to the anti-p62 
beads, released by SDS (the strong bands at 55 and 25 
kDa represent the heavy and light chains of the 
antibodies released from the beads). Lanes 2 and 5 
HeLa whole cell extract treated with the anti-p62 
beads. Lanes 3 and 6: HeLa whole cell extract treated 
with protein-A beads alone (control). Lane 4 untreated 
BeLa whole cell extract. In lanes 2-6 equal amounts 
of sample were loaded. 
A 
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Fig. 6. Effect of injection of antibodies against 
XPD/ERCC2 on transcription and repair of normal 
cells. Micrograph A demonstrates the effect of injec-
tion of ERCC2 antibodies on UV-induced UDS of 
normal fibroblasts, assayed by a 2 h incubation in JH_ 
thymidine immediately following UV-irradiation. 
Micrograph B shows the effect of injection of XPD/-
ERCC2 antiserum on RNA synthesis of control (wild-
type) fibroblasts assayed by a 1 h pulselabelling with 
3H-Uridine. The UDS and RNA synthesis assays were 
performed 20 h after injection of the antibodies. The 
strong reduction of autoradiographic grains above the 
nuclei of injected dikaryons (arrows) compared to 
non-injected cells indicates a virtually complete 
inhibition of RNA and repair synthesis. The heavily 
labelled nucleus in A is from a ceJl in S-phase at the 
time of incubation. Note that these preparations have 
a higher background labelling than the micrographs 
shown in Fig.I. 
Western blot analysis verified that the amount of 
p62 was strongly reduced (Fig,S). In the in vitro 
correction assay, the p62d~pkW HeLa extract had 
lost most of its repair activity when compared 
with the repair level of mutant extracts alone and 
a mock-treated extract (Table 2, footnote). To 
examine whether other NER factors were co-de-
pleted the treated extract was tested for its com 
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Table 1. Involvement of BTF2 in different human and 
rodent NER-deficient complementation groups 
NER-deficient CorrlXlion of NER defect 
complementation groups by BTF2 
human mutants 
XP25RO XP-A 
XPCSIBA XP-B 
XP2IRO Xp-c 
XPIBR XP-D 
XP2RO XP-E 
XP126LO XP-F 
XP2BI XP-G 
TIDIBR TID-A 
TTDIBRSV TID-A 
rodent Illutants 
43.3B group I 
UV 5 group 2 
27.1 group 3 
UV41 group 4 
UV 135 group 5 
microneedle injlXtion 
+ 
+ 
+ 
ill ~i/ro repair assay 
+ 
+ 
+ 
plementing capacity using both the ill vitro assay 
and the microneedle injection. Previously, we 
have demonstrated that XPB/ERCC3, but not 
XPG/ERCCS, is simultaneously removed with 
p62 (van Vuuren et a1. 1994). Table 2 shows that 
most XPD/ERCC2 and TIDA activities are also 
removed, whereas XPA, ERCC1, ERCC4 and 
XPG/ERCC5 are not significantly eliminated 
(Table 2 and unp. res.). This is confirmed by the 
Westernblot analysis revealing depletion of 
XPB/ERCC3(p89) at the protein level (Fig 5, 
lanes 5-6). The same co-depletion patterns were 
observed with a monoclonal antibody against p89 
(XPB/ERCC3)(table 2). Furthermore, depletion 
experiments using monoclonal antibodies against 
two olher components of TFIIH, p44 (the human 
homolog of yeast SSLl) and p34, revealed tight 
association with repair (Humbert et al. 1994 and 
results not shown). As with crude HeLa extracts, 
antibody depletion of purified BTF2 (Hydroxy 
apatite and heparin purification fractions) using 
p62 monoclonal antibodies resulted in simultane-
ous removal of the XPB/ERCC3, XPD/ERCC2 
and TTDA factors (Table 2). The depletion and 
correction experiments provide strong evidence 
that 3 repair factors are physically associated 
with 3 different TFIIH subunits and, thus, likely 
constitute an integral part of transcription factor 
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BTF2. 
Table 2 also shows that small amounts of 
correcting activities persist in the Anti-p62-
treated extract. This is largely due to incomplete 
removal of p62 (as shown by the \Vestern blot 
analysis in Fig.S). However, it is not fully 
excluded that a small fraction of the ERCC2, 
ERCC3, and TIDA molecules exist dissociated 
from (the p62 part of) TFIIH, or reside in forms 
of TFIIH lacking p62. The same holds for the 
anti-p89 experiments. A somewhat looser associ-
ation between ERCC2 and the p62-ERCC3 core 
of TFIIH is also derived from independent dis-
sociation studies by Schaeffer and coworkers 
(Schaeffer et al. 1994). Further indications for 
exchange of various TFIIH subunits can be 
deduced from the ill w'tro complementation 
between ERCC2- and TTDA-deficient extracts 
shown in Fig 3a (lanes 1-3), each of these 
extracts being defective in a different component 
of the same complex. In line with this also 
extracts defective in XPD/ERCC2 and XPB/-
ERCC3 exhibit complementation ill vitro (van 
Vuuren et al. 1993) and microinjection of free 
(recombinant) ERCC3 protein is able to induce a 
partial but clear correction of the repair defect of 
XP-B cells ill vim (van Vuuren et at. 1994). We 
conclude that a complex containing at least 
XPD/ERCC2, XPB/ERCC3, TTDA and p62 and 
possibly also p44 (SSLl) and p34 is implicated in 
NER and that subunits of this complex can ex-
change ill vivo and to some extent also ill vitro. 
It is plausible that this complex represents the 
entire Illultisubunit TFJIH transcription factor. 
Is TTDA identical to any of the cloned TFIIH 
subwtits? 
A prediction of the findings reported above is 
that one of the components of BTF2 is responsi-
ble for the repair defect in TTD-A for which no 
repair gene has been isolated yet. Therefore, 
cDNAs encoding the cloned TFIIH subunits p62, 
p44 and p34 (Humbert et al. 1994) and XPD-
IERCC2(p80) and XPBIERCC3(p89) were inser-
ted into a mammalian expression vector and 
injected into the nucleus of TID-A fibroblasts. 
Prior to iItiection the eDNA-containing vectors 
were checked for their ability to specify proteins 
of the predicted size. None of these genes (p62, 
p44, p34), nor any of the cloned NER genes 
(ERCCI, XPDIERCC2, XPBIERCC3, CSBI-
ERCC6, XPA, XPC. and (he genes llllR23A and 
B (Masutani et al. 1994» were able to exert 
correction of the repair defect, whereas micro-
injected ERCC2 and ERCC3 were able to restore 
UDS to XP-D and XP-B cells, respectively, in 
the same experiments. It appears that the TTDA 
factor is yet another non-cloned component of 
TFIIH. 
Eyidence for direct involvement of XPD/-
ERCC2 in transcription ill l'ivo. 
The data described thus far tightly link the 
repair protein XPD/ERCC2 with transcription 
factor TFITH/BTF2, however, they do not de-
monstrate that the protein is directly involved in 
transcription. Recently, Schaeffer and coworkers 
(Schaeffer et al. 1994) have shown that a pSO 
protein associated with TFIIH is identical to 
XPD/ERCC2 and that this protein stimulates the 
TFIIH-dependent in vitro transcription reaction. 
In addition Drapkin and coworkers have shown 
that an antibody directed against ERCC2 is able 
to inhibit the in vitro transcription reaction 
(Drapkin et al. 1994). To verify whether the ill 
vitro results can be extrapolated to the ill vim 
situation we have conducted antibody microinjec-
lion experiments into living normal cells. As 
shown in Figure 6A and quantitatively in Table 
3 introduction of antibodies against XPD/ERCC2 
causes a strong inhibition of UV-induced UDS, 
consistent with the direct role of the protein in 
NER (Fig.2 and 3) and similar to the effect 
observed using antibodies against another repair 
protein ERCCt that is not detectably associated 
with purified BTF2 (Table 3). In addition, a 
strong inhibition of general transcription (as 
measured by a Ih tritiated uridine labeling) is 
found (Fig.6B), which is absent in the injections 
with ERCCt antiserum (Table 3). Similar, but 
less pronounced effects on transcription and UDS 
arc exerted by a less powerful serum against the 
XPB/ERCC3 component of TFIIH (Table 3, sec 
also: (van Vuuren et a1. 1994». These results 
indicate that XPD/ERCC2 like XPB/ERCC3 is 
involved in transcription ill vivo. 
Table 2. Effect of inununodepletion of BTF2 components on NER activity 
Repair assay Immullodepleteu 
microneedlt: 
iI*ction 
microneedle 
irijcclion 
ill vi/ro 
n:pair 
material 
crude lIela 
lysate 
8TI'2 
(Heparin 5PW, 
fraction 12) 
crude HeLa 
lysnlel 
Tested cells/extracts 
(campI. group) 
XP25RO (Xp·A) 
XPCS2BA (XP·B) 
XPlBR (XP-D) 
TIDtBR (TID-A) 
XPCS2BA (XP·B) 
TID6Vl (XP-H) 
XPlBR (XP·D) 
TTDtBR ("ITO-A) 
27.1 (group3) 
UV-5 (group2) 
TTDI8R (TrD-A) 
I re5iLlu~1 NER activity; 1II1Iount of repair exhibited by mutatell rclls1cxlr,\cls. 
NER activity (% of control) 
protA anti p62 anti p89 residual ' 
dep!. dcpl. depl. 
99 tOO 9. 2 
(OJ 39 33 t3 
98 4( 39 2t 
t02 29 23 8 
92 37 35 (2 
(00 42 44 44 
9. 37 38 23 
100 35 35 8 
toO 35 ND' 34 
( 00 32 ND 24 
tOO 32 ND 27 
1 p62-dcp!cted crude extraci exhibits a resk!u~l iliCOrpowtiulI of 359;:. compared to a pfotA·ln:n!ed cuntrol e.\tta~t. whirh is dose 
10 incorpofJtioll by mo.t mutant extracts. 
J ND; not d~lennined. 
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Fig. 7. Model for involvement of defects in transcription and repair in human disease. (see text for explanation). 
DISSCUSION 
The findings reported here have implications 
in several directions. At the molecular level the 
identification of at least three repair factors in 
TFIIH endows this complex with a dual functio-
nality and extends the functional overlap between 
two quite different processes, basal transcription 
and NER. At the clinical level the identification 
of a link between TTD and XP/CS group B ex-
tends the association between TFIIH subunits and 
TID and supports the notion that CS, TID and 
some forms of XP represent different manifesta-
tions of one large clinical continuum. The con-
nection between TFIIH and TID provides new 
clues to understand the basis of the complex 
clinical features displayed by these disorders and 
potentially a number of other, strikingly related 
syndromes. 
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Mechanistic implications for transcription and 
repair. 
A minimum of three NER factors is found to 
be associated with transcription factor TFIIH. In 
addition to XPBlERCC3 (Schaeffer et al. 1993), 
we demonSirate Ihat XPD/ERCC2 and TTDA re-
side in this complex. We provide evidence for 
the involvement of the XPD/ERCC2 helicase in 
transcription ill vivo. Circumstantial data support 
the idea that the transcription proteins p62, p44 
and p34 are also implicated in NER (Humbert et 
al. 1994; van Vuuren et al. 1994), (this paper). 
As previously anticipated (Bootsma and Hoeijma-
kers 1993) Ihe human homolog of SSLl, a yeasl 
repair factor which was linked to translation 
before (Yoon et al. 1992) was recently identified 
as the p44 subunit of TFllH (Humbert et al. 
1994). Table 4 summarizes the current evidence 
for the involvement of different human BTF21 
TFIIH and yeast factor b subunits in repair. It is 
possible that the TIDA protein is identical to the 
(non-cloned) p41 BTF2 subunit. Together these 
data suggest that most, if not all, components of 
the transcription complex participate in excision 
repair, converting this complex into a functional 
unit participating in at least two processes. 
It is still difficult to estimate how many 
polypeptides constitute TFIIH. Because of the 
absence of XPD/ERCC2 as a major protein in 
the most pure BTF2 preparation (Schaeffer et al. 
1994, Drapkin, 1994), it is likely that the five 
predominant bands present in the final stages of 
BTF2 purification (Gerard et a!. 1991) are de-
rived from the most tightly associated protein 
fraction constituting the core of the complex. 
Protein profiles of the rat homolog (factor 5) sug~ 
gest the presence of at least eigtlt polypeptides 
(Conaway and Conaway 1989). Thus BTF2 could 
well be considerably larger ill vivo and form a 
"supercomplex" of which the more loosely bound 
factors have a tendency to (partly) dissociate 
during purification. This could also explain the 
absence of a X PC-correcting activity in our 
TFlIH purifications, whereas others found associ-
ation of XPC with TFIIH, but not in the final 
purification fraction (Drapkin et aL 1994). 
Alternatively, it is possible that the XPC-correc-
ting activity represents a spurious copurification 
with TFIIH. Association of XPC with TFIIH is 
somewhat unexpected, since XPC is thought to 
be selectively involved in the global genome 
(transcription-independent) NER pathway (Vene-
ma et a!. 1990). 
BTF2 possesses a bidirectional unwinding acti-
vity involving XPB/ERCC3 and XPD/ERCC2 
(Schaeffer et al. 1994), which may promote 
transition from a closed to an open initiation 
complex. It is likely that TFIIH can be utilized as 
an independent unit in the context of transcription 
and NER; e.g., for loading and/or translocation 
of the preinitiation complex or a NER scan-
ning/incision complex or for the repair synthesis 
step. The TFIIH mutants XP-B, XP-D, and 
TTD-A display defects in both the "transcription-
coupled" as well as the "global genome" NER 
subpathways, so the complex is likely to playa 
role in the core of the NER reaction mechanism 
(Sweder and Hanawalt 1993). 
Clinical heterogeneity and pleiotropy associ-
ated with lIlutations in TFIIH. 
The spectrum of diseases linked with TFIIH is 
heterogeneous and pleiotropic, including seem-
ingly unrelated symptoms, such as photosensi-
tivity, brittle hair and nails, neurodysmyelination, 
impaired sexual development, ichthyosis, and 
dental caries. Both the rare XP group B and the 
more common group D present pronounced clini~ 
cal heterogeneity: classical XP (only in group D), 
atypical combination of XP and CS, and TID 
(Johnson and Squires 1992; Vermeulen et al. 
1994; this paper). The occurrence of patients 
displaying TID symptoms within XP group B, 
extends the parallels between XP group Band D 
and their respective gene products noted before 
(Weeda et al. 1990). Clinical variability in TID 
is even observed within families and also appa-
rent from the close association with at least 7 
disorders (shown in Fig.7) appearing in the 
OMIM database (McKusick 1992). The occur-
rence of TID in 3 NER-deficient complementa-
tion groups argues against a chance association 
between genetic loci separately involved in NER 
and in brittle hair. Consistent with this notion, 
mutations in the XPDIERCC2 gene have been 
detected recently in TTD(XP-D) patients (Broug-
hton et al. 1994). 
How can we rationalize the pleiotropy and 
clinical heterogeneity in the above mentioned 
conditions? The symptoms associated with a sole 
NER defect are displayed by the most common 
XP groups, A (totatly deficient in NER) and C 
(defective in the 'genome overall' repair subpath-
way). Patients in these groups present a relatively 
uniform clinical picture involving photosensiti-
vity, pigmentation abnormalities, predisposition 
to skin cancer and, in the case of XP-A, accele-
rated neurodegeneration (which is not associated 
with neurodysmyelination), but no CS and TID 
symptoms. The gene products affected in these 
groups are not vital and therefore do not appear 
to be essential for basal transcription. 
Obviously, the hallmarks of a pure NER 
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Table 3. Effect of amibody injection on repair and 
transcription 
Injected antiserum % inhibition inhibition of 
of NER[ transcriptionl 
rabbit anti ERCCl l 97 0 
rabbit anti ERCC3 l 43 48 
rabbit and ERCC2 87 85 
p[einmlUne rabbit serum 2 7 
[ compaJed to UDS level observed in uninjected cells on the 
same slide. 
1 compared to transcription level (assayed by Ih pulse labeliing 
with JH·uridine) observed in uninjlXted cells on the same slide. 
l van Vuuren et al. (1994). 
deficiency do not include the salient features of 
CS and TID. It is tempting to link these with the 
additional transcription-related function. Indeed, 
it would be highly unlikely when an mutations in 
the three subunits of this bifunctional complex 
would only affect the repair function and leave 
the inherent transcriptional role entirely intact. 
This interpretation is supported by the haywire 
phenotype of the Drosophila ERCC3 mutant, 
involving UV sensitivity, central nervous system 
abnormalities, and impaired sexual development, 
as found in XP-B (Mounkes et aJ. 1992). Sper-
matogenesis in Drosophila is very sensitive to the 
level of 62 lubulin (Kemphues el al. 1982). 
Mutations in the Drosophila ERCC3 gene seem 
to affect fi tubulin expression, causing male 
sterility (Mounkes et at. 1992). In mammals, 6-
tubulin mRNA is selectively regUlated by a 
unique cotranslational degradation mechanism 
(Theodorakis and Cleveland 1992). It is possible 
that this renders fi-tubulin expression particularly 
sensitive to the level of transcription and thereby 
to subtle mutations in BTF2, resulting in the 
immature sexual development found in TID and 
CS. Similarly, reduced transcription of genes 
encoding ultrahigh sulfur proteins of the hairshaft 
may account for the observed reduced cysteine 
content in the brittle hair of TID patients (Itin 
and Pittelkow 1990). Low expression of the 
myelin basic protein, whose transcription is 
known to be rate-limiting in mouse (Readhead et 
al. 1987), may cause the characteristic neurodys-
myelination of CS and TID (Peserico et al. 
1992; Sasaki et al. 1992). A comparable explana-
tion is proposed for the poor enamelation of teeth 
in CS and TID (McCuaig et al. 1993; Nance and 
102 
Berry 1992). The skin abnormalities typical of 
TID often involve ichthyosis. Various classes of 
ichthyoses show abnormalities in the production 
of filaggrin (Fleckman and Dale 1993). Thus, 
mutations in TFIIH which subtly disturb its 
transcription function may affect a specific subset 
of genes whose functioning critically depends on 
the level or fine-tuning of transcription. Recent 
studies indicate that the requirement for basal 
transcription factors Illay vary from promoter to 
promoter depending on the sequence around the 
initiation site, the topological state of the DNA, 
and the local chromatin structure (Parvin and 
Sharp 1993; Slanway 1993; Timmers 1994). 
These mechanisms can easily explain the pro-
nounced clinical heterogeneity even within fam-
ilies. 
Upon close illspection (Bootsma and Hoeij-
makers 1993), many parallels can be found 
between CS and TID. To a varying degree, CS 
patients exhibit features prominent in TTD, such 
as thin, dry hair and scaly skin (Nance and Berry 
1992). TID has recently been recognized to 
include neurodysmyeIination (Peserico et al. 
1992), bird-like facies, dental caries, and cataract 
(McCuaig el al. 1993), hallmarks normally 
associated with CS. This suggests that CS and 
TID are manifestations of a broad clinical con-
tinuum, consistent with the notion that mutations 
in different subunits of the same (TFIIH) com-
plex give rise to a similar set of phenotypic 
features. In this proposition, defects in the classi-
cal CS genes CSA and ERCC61CSB (Troelslra el 
al. 1992), as well as XPGIERCC5 (Boolsma and 
Hoeijmakers 1993; Vermeulen et al. 1993), are 
expected to somehow affect basal transcription as 
well. 
IHodel for involvement of transcription and 
repair in CS amI TID: deduction of the exis-
tence of transcription syndromes. 
A tentative model proposed for the aetiology 
of the defects in the conglomerate of CS, TID, 
and related disorders is shown in Fig. 7. In this 
model, mutations in BTF2 factors inactivating 
only the NER function result in a XP phenotype 
as observed in the classical XP patients of XP 
Table 4. The NER connection of BTF2/TFIIH 
NER proteins associated NER proteins with Polypeptides identified in 
with BTF2 yeast factor b SDS-PAGE 
XPBlERCC3 RAD25/SSL22 p89 
XPDlERCC2 RAD3l pSO 
TIDA ? ? 
P621 TFBl4 p62 
p441 SSLl4 p44 
? ? p41' 
? ? p34 
Factors for which the involvement in NER is unequivocally demonstrated are in boldface. 
1 NER function based on inference from (presumed) NER involvement of yeast homologs. 
I references: Park (1992); Feaver (1993). 
1 reference: Feaver (1993). 
4 some alleles are UV sensitive, suggesting that they are deficient in NER. 
5 the relationship between p41 and TTDA is no! yet known. 
group D. If, in addition, the transcription func-
tion is subtly affected, the photosensitive forms 
of combined XP/CS and TID are found. Theore-
tically, mutations causing a (still viable) tran-
scription problem without NER impairment are 
predicted. The notion, that the new TID XP-B 
members have only a mild repair defect (see 
table 2), but nevertheless display TID features 
not exhibited by the Illore repair-deficient origi-
nal XP-B cases, fits perfectly into this reasoning. 
Indeed, a significant proportion of TID patients, 
as well as clinically characteristic CS patients, is 
not noticably photosensitive and has normal NER 
(Lehmann 1987; Lehmann et al. 1993; Nance 
and Berry 1992). These findings extend the 
implications to non-repair-defective disorders. 
Therefore, and in view of the pronounced 
heterogeneity inherent to the model, we propose 
that also Ihe Sjogren-Larsson (270200), RUD 
(308200), ICE (146720), OTD (257960), IFAP 
(308205), CAM(F)AK (214550), Rotlullund-
Thompson (268400), and KID (242150) syn-
dromes (for references, see Baden 1991; 
McKusick 1992) also fall within this category. 
Interestingly, some of these diseases show occur-
rence of skin cancer. 
In conclusion, our findings provide evidence 
for the presence of a wide class of disorders that 
we propose to designate collectively as "tran-
scription syndromes". A prediction from our 
modeJ is that these patients carry mutations in 
transcription factors, that do not affect the NER 
process. This proposition is testable. The expla-
nation put forward here for this class of disorders 
would introduce a novel concept into human 
genetics. It can be envisaged that similar pheno-
mena are associated with subtle defects in transla-
tion, implying the potential existence of "transla-
tion syndromes" (as suggested earlier on comple-
tely different grounds; Fisher et al. 1990). 
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P44 and p34 subunits of the BTF21TFIIH transcription factor 
havehomologies with SSLl, a yeast protein involved in DNA 
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Introduction 
BIF2 (TFIIH) is an essential class II transcription factor that 
has recently been shown to playa role in nucleotide excision 
repair (NER) (Schaeffer el at .• 1993). This basal factor 
participates in the fonnation of the preinitiation transcription 
complex. which includes the TFIIA, TFflD, TFIIB. TFIlE, 
and TFIIF basal transcription factors and RNA polymerase 
II (B) onto a minimal promoter (containing the TATA box 
and cap site) (Conaway and Conaway, 1991; Zawel and 
Rcinberg, 1992). BTF2, like its homologs the rat factor 0 
and the yeast factor b, is absolutely required for the basal 
ill ~'itro transcription of most protein coding genes. Little 
is known about the role of BIF2 in the transcription reaction, 
although a kinase activity which is capable of phosphoryla-
ting the carboxy-terminal domain (CTD) of the large subunit 
of RNA polymerase If, and a DNA-dependent ATPase 
activity have been found to be associated with BTF2 and 
its rat and yeast homologs (Bunick et al., 1982; Sawadogo 
and Roeder, 1984; Conaway and Conaway, 1988; Feaver 
et al., 1991~ Dahmus and Dynan, 1992; Lu et at., 1992; 
Serizawa el at., 1992). Ihese two activities may be 
responsible for the obligate ATP hydrolysis required for 
completing transcriptional initiMion. 
A role ofBTF2 in NER was recently suggested when one 
of the ~ubunits (the 89 kDa polypeptide; p89) was identified 
as the ERCC3 gene product, a presumed heIicase associated 
with DNA repair (Weeda el al., 1990; Schaeffer et al., 
1993; van Vuuren el al., 1994). Mutations in this gene 
confer sensitivity to sunlight (UV) and a predisposition to 
skin cancer manifested by xerodenna pigmentosum group 
B (XP-B), a severe fonn of this repair syndrome, which also 
exhibits the clinical hallmarks of another DNA repair 
disorder, namely Cockayne's syndrome. Further experi-
ments, using both an ill ~'il'O microinjection repair assay and 
an ill \'ilro NER system based on cell-free extracts (Wood 
el al., 1988), confirmed that the p89/ERCC3 subunit of 
BTF2 is directly involved in the excision repair reaction (van 
Vuuren el al., 1994). More recent results have shown that 
the ERCC2 80 kDa polypeptide is also associated with the 
BIF2 complex, although not as tightly as p89 (Schaeffer 
el ai., 1994). 
The dual function of BIF2 in these two important, but 
otherwise quite distinct, mechanisms of DNA metabolism 
has r~ently generated some controversy as to whether BTF2 
is indeed a transcription repair cou piing factor, or whether 
components of DTF2 function independently in each of the 
two processes (Sweder el al., 1993). A means to resolve 
this disparity lies in the cloning of aU subunits of BTF2, 
which will permit the elucidation of their individual roles 
and that of the entire complex in DNA repair and 
transcription. As a step toward this goal, we report here the 
cloning of two additional subunits of this multifunctional 
complex. Analysis of these components provides indications 
that BTF2 may be involved in yet another basic cellular 
process: translation. 
Results 
Cloning and expression of the p44 end p34 
polypeptides of BTF2/TFIIH 
The BTF2 (TFIIH) transcription factor was purified as 
previously described (Gerard el at., 1991). A concentrated 
hydroxyapatite fraction was subjected to SDS- PAGE and 
elcctrotransferred onto a PVDF membrane. The 44 kDa 
(p44) and the 34 kDa (p34) polypeptides were then 
individually digested with trypsin, before being resolved by 
reversed phase chromatography. Amino acid sequences 
obtained from tryptic digests of p44 or p34 were used to 
synthesize degenerate oligonucleotides for screening a HeLa 
}.ZAPII eDNA librar),. Multiple positive clones were 
obtained, and sequencing revealed that for each, one clone 
contained the entire open reading frame (ORF). The p44 
and p34 cDNAs (Figure I) possess ORFs of 1185 and 
909 bp respectively that encode proteins of 395 and 303 
amino acids, with calculated mol. wts of 44 451 and 33 920 
Da respectively, which is in good agreement with the 
previously estimated mol. wt of the purified protein on an 
SDS gel (43 and 35 kDa respectively; Gerard et al., 1991). 
~10reo\'er. when overexpressed in Escherichia coli. both 
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Fig. I. Seque",~s of p-14 (A) and p34 (B) BTF2 ~l)"peptides. and 
alignments with SSLI fA and C). Positions of the amioo acids are 
inJic.l.ted on the !eft. The peptide; trut were mkrosequenc~-.:I from the 
purified .U and 34 lDa polyp.:ptide.s are underlined. The lir.c fingw 
motifs in pM and p34 are bo~eJ or in bold characters (see te~t). The 
SSLI ~equenc.: has been aligned \\ith the p44 sequen.:e and 
homologies are indicated by I (threshold I), : (thre,hold 0.5) or • 
(threshold 0.11. Th<: nudOOlide seqWfl(es of p44 and p34 subunits C.l.J\ 
be found in tho: G.:nBank database under the accession numbers 
D0094 and Z)OO9). resp.:.:tiwly. 
recombinant polypeptides (rp44 and rp34) exhibit the same 
electrophoretic mobility on 80S-PAGE as the endogeneous 
BTFl p44 and p34 polypeptides according to immunoblotting 
experiments depicted in Figure 2A (compare lane I with 
lanes 2 and 3 respectively). In both cases the microsequenced 
peplides were observed in the deduced amino acid sequences 
confirming the identity of the clones (Figure IA and B). 
Searches in DNA and protein databases revealed a 
significant overall homology between p44 and the yeast 
protein SSLI (Figure IA). SSLI is a yeast zinc finger protein 
previously identified as the product of a stem-loop 
suppressor gene associated with initiation of translation 
(Yoon et al., 1992). At the amino acid level, p44 and SSLI 
have a 58% similarity and a 40% identity. p44 as well as 
SSLl contains the motif Tyr-X-Cys-XrCys+XrPhe-
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Xg-His-XrLeu-His (amino acids 358-380) characteristic 
of TFIIIA-like zinc finger proteir.s that have been 
demonstrated to interact with DNA (Jacobs, 1992; Berg, 
1993). We also noticed in p44 as well as SSLi, a repeat 
of the motif Cys-X2-CyS-X4-Cys/His-Xs-CyS+Xl-CyS 
interrupted by a Cys-XrCys+Xu/X21-Cys-XrCys domain. 
Surprisingly, the first type is also present in p34. Alignment 
of the three sequences in this region (Figure 1 C) highlights 
the conservation of the cysteine residues among the three 
polypeptides. which also suggests that p44 and p34 must 
share some common function, e.g. in the interaction with 
the DNA template. Preliminary results suggest that p44 
indeed interacts with the DNA promoter (unpublished 
results). No other known motifs were found. but we noticed 
that the p34 is rich in leucine and isoleucine residues (20% 
over the entire sequence) which confers a very hydrophobic 
character to the polypeptide. 
The p44 and p34 polypeptides are bona (Ide subunits 
of BTF2 
When overexpressed in E.coli, the p44 and p34 polypeptides 
remained in an insoluble form (up to 98%) and were 
therefore subjected to denaturation -renaturation with 
guanidium hydrochloride. In this condition a small part of 
the proteins was recovered in a soluble form that was used 
in the following experiments. 
The recombinant polypeptides p44 and p34 did not 
substitute for the BTF2 activity when added either alone or 
in combination with the two other bacterially expressed BTF2 
subunits (p62 and p89) in a BTF2-dependent ill vitro 
transcription system {data not shown}. Indeed, Ihis was 
expected since our purification evidenced at least an 
additional polypeptide in BTF2 (Gerard et al., 1991). 
Human BTF2 (TFIIH), the rat factor {j and the yeast b 
factor have been found to contain several activities including 
a DNA-dependent ATPase (Roy el al., (994), a CTO kinase 
capable of phosphorylating the CTD of the largest subunit 
of RNA polymerase II (Feaver et al., 1991; Lu et al., 1992; 
Serizawa et til., 1992) and a helicase (Schaeffer et 01., (993), 
thus suggesting the presence of putative helicase motifs, 
ATP-binding sites, or kinase motifs in the various BTF2 
subunits. None of the above motifs was detected in either 
p44 or p34 and no kinase, ATPase or helicase activities could 
be found associated with p44 or p34 when tested in the three 
enzymatic assays under the conditions used for the native 
BTF2 complex (data not shown). Furthermore, no 
stimulation of any of these activities was observed upon 
addition of p44 or p34. 
Despite our inability to detect any of the aforementioned 
biological activities associated with the two polypeptides, 
several lines of evidence indicate that both p44 and p34 are 
indeed subunits of BTFl (TFIIH). First, monoclonal 
antibodies raised against the p44 (Ab-p44) and p34 (Ab-p34) 
polypeptides recognized the 44 and 34 kDa polypeptides 
(Figure 2B, middle panel) that cofractionated with BTF2 
transcription activity (upper panel) and the heHcase activity 
(lower panel) through the HAP chromatography (sixth step 
of the purification; Gerard et 01., 1991) as well as on the 
glycerol gradient sedimentation step (data not shown; see 
also Figure 38, upper panel). Furthermore, both p44 and 
p34 perfectly coelute with the previously described p62 and 
p89 (lanes 1O~ 14) that have previously been shown to 
belong to BTF2 transcription factor (Fischer el 01., 1992; 
Schaeffer etal., 1993); the crD kinase and the ONA-
dependent ATPase activities were also found 10 coelute with 
the four BTF2 subunits (unpublished results; Roy et 01., 
(994). Identical results were also observed with the phenyl 
fractions (fifth step of our purification procedure; Gerard 
et al., 1991), Thus. in the three last steps of the purification 
scheme (using three different separation techniques based 
either on the hydrophobic character, the charge or the 
sedimentation constant of the BTF2 complex), p44 and p34 
are always found tightly associated with the various activities 
and polypeptides characteristic of BTF2. In addition. when 
the BTF2 multisubunit complex is treated with I M KCl 
before glycerol gradient sedimentation. the four polypeptides 
cosediment in a region corresponding to -200-250 kDa 
(unpublished results). 
Second, to confinn that p44 and p34 belong to the BTF2 
multisubunit complex, two additional sets of experiments 
were performed: an inullunoprecipitation (Figure 3A) and 
a glycerol gradient shift (Figure 38) in which either of the 
two previousl)' described monoclonal antibodies was used 
to precipitate or to shift all the BTF2 subunits. A partially 
purified BTF2 fraction eluted from the heparin column 
(Gerard eta!., 1991), was incubated either with protein 
A ~agarose beads alone (- Ab, lanes 3 and 7) or with 
protein A ~agarose beads to which anti-pM (lane 2) or anti-
p34 (lane 6) antibodies or an antibody against an unrelated 
polypeptide (Ab control, lanes 4 and 8) were bound. After 
extensive washing with a buffer containing 0.15 M KCI, the 
remaining proteins were analyzed by SOS-PAGE (Figure 
3A). The anti-pM or anti-p34 :mtibodies immunoprecipitate 
both p34 and p·H in addition 10 p62 and p89 (Janes 2 and 
6. re~pecti\'el}'), while the protein A ~agarose, either alone 
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Fig. 3. The mooodonal antilxxlks raised Jgairut pM or p34 
imrnunoprecipitatc BTF2 (A) and displac.: !his compk1: in a g1yoxrol 
gradient (B). (A) 50 "I of t/w: BTF..! h¢parin HPLC fraction lIen: 
irK"ut>ate.i for ..1: h at 4 'C v.ith either 00 anlibody (lanes J and 7), anti· 
pM antibody {lane 2), anti-pM antibody (lane 6), or an unrebted 
mntro! antibody (1:111<!S 4 and 8). The~ mhrures wue iOCIlNled with 
protein A-Sepharose. The beads v.ere washed and loaded {Into an 
SDS-potyacl)'lamide get. After e!e.;:trophoresis an;! transfer onw 
nitrocdlulo~, the various BTF:2 subunits (as indkated by arroll;; on 
the Idt) were detocted with the corresponding amibody. J...anes I and 
5: 2 1'1 of BIF2 heparin HPLC fractioll. (B) [00 1'1 of heparin IiPLC 
BTF2 fraction wen: inruootoo for 2 hat 4'C with either no antibody 
(up~r panel), anti·pM antIbody (middle panel) or anti-p34 antibody 
(lower plnd). After centrifugation for 12 h .'II 300 000 g on a 
10-30% glycerol gradient, 15 fractions were wlle,too and analyzed 
by Western blotting ming anti·p62, anti-pM and and·pJ4 antibodie.s. 
The arrows irldicJte the position of the four BIF2 suburU15. The hea~y 
(H) and light chain (L) subunilS of the antibody an: also iliumiru.lro by 
the socond anti-mouse antibody. 
or coupled to the control antibody, precipitated none or 
negligible amounts of p89, p62, p44 and p34 polypeptides 
(lanes 3, 4, 7 and 8). Thus, both of the antibodies raised 
against either p44 or p34 are able to coprecipitate p62 as 
well as p89 in addition to their corresponding antigenic p44 
and p34 subunits. No transcription activity was recovered 
either from the protein A -agarose beads on which Ab-p44 
or Ab-pJ4 were immobilized or from their corresponding 
III 
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Fig. 4. Inhibition of ill lil'o tran$o:ription by anti·p44 or antj-pJ4 
antibodies. The BTFl heparin HPLC fraction (10 pI) was prein.::ublted 
for 2 h at 4°C with eitil<!r 00 antibody (laII<! I), increasing amounts of 
anti-p44 (lane> 2~4). anti-p34 (1mes 7-9) or control (lan~s 12 and 
13) antibodies, or with a 100% inlullltol)' amount of anti-p44 (lanes 5 
and 6, and 14 and 15) or anti-p3-t (lanes 10 and II. and 16 and 17) 
antibodies. The reaction was then compkm<:nted with the other basal 
transcription factors, RNA p;>lrmerase II, DNA template and as 
indicated, increasing amounts of either BTFl hydro.\yaP""li\e fra.."1ion 
(1an?S 5 and 6, and 10 and 11), rp44 (Imes 14 and 15) or rpJ4, (lan.!> 
[6 and 17). After 15 min of incubltio[J at 25·C, the mlCkotidc, were 
added and transcription was allowed to proce.eJ for 45 min at 25'C. 
The tfilllS(ripts were analyzed as previously rep;:lrtoo. The aITOw 
indicates the 309 nuclootide long spednc transcript, 
supematants due to the inhibitory effect of the antibody (see 
also below), 
In another sel of experiments, BTF2 was preincubated 
either alone (BTF2) or with either Ab-p44 (BTF2 + Ab-
p44) or Ab·p34 (BTF2 + Ab-p34) before glycerol gradient 
centrifugation (Figure 3B). In both cases, and thus 
independent of the nature of the antibody, p44 and p34 were 
shifted from fractions 7 -9 in the absence of antibody (upper 
panel) to fractions 8 - I I in the presence of either antibody 
(middle and lower panels). The p62 subunit as well as the 
p89 subunit (see Figure 3D) fonowed p44 and p34, thus 
demonstrating that the antibodies were able to displace the 
other subunits of BTF2. Altogether, these data demonstrate 
that p44 and p34 are strongly associated with the previously 
characterized p62 and p89 BTF2 subunits as well as with 
all the enzymatic activities exhibited by BTF2, 
Finally, the antibodies were tested for their ability to 
prevent BTF2 transcription acth'it)' in an ill \1lro transcription 
assay (Figure 4). Increasing amounts of either purified Ab-
p44, Ab-p34 or Ab-control were incubated for I hat 4"C, 
with a fixed amount of partially purified BTF2 (heparin 
HPLC fraction; Gerard et 01., 1991). The mixture was then 
added to the il/ \itro transcription system containing RNA 
polymerase II, the Ad2 MLP template and all basal 
transcription factors except BTF2, before addition of 
nucleotides. As shown in Figure 4, transcription was reduced 
as a function of the concentration of Ab-p44 and Ab-p34, 
whereas transcription was not inhibited when increasing 
amounts of the control antibody were added (compare lanes 
2-4 and lanes 7-9 with lanes 12~13, respectively), To 
establish further that inhibition resulted from the specific 
interaction between the two antibodies and BTF2, increasing 
amounts of BTF2 were added to an in \11ro transcription 
reaction that was previously 100% inhibited after addition 
of each of the Iwo antibodies, In both cases, we were able 
to restore the transcription activity as shown by the synthesis 
of a specific transcript of 309 nucleotides (see lanes 5 and 
6 and lanes JO and II, respectively). Increasing amOUniS 
of rp44 or rp34 did not restore BTF2 transcription activity 
(lanes 14~ 17). In conclusion all of the above data 
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fig, S. Inhibition of iT! lil'O NER aaivity_ MOl1();:[oruJ anlibodl~s 
against pJ4, deplete a repair-proficient HeLa e.\tract from rep3lr 
caP""city. A cell-free Hela e~tract was lncublted 'with anti-p34 
antibOOy immobilized on protein A~Sepharose CL .. m bc-.ads. After 
removal of the pMeiru bound to the antibody by centrifugation, the 
supernatant \\as tested in an in I;ITV NER assay for rep3ir and 
complementati<m activities (Wood el af.. 1988). Th~ in lilfO NER 
assay contained 250 ng AAT-damagoo plilsmid (+) and an equal 
amount of oon.<famaged plamud (~). The upper pan.el (autoradio) 
detoXtoo th¢ [a-J1 PJdATP irK:orporation that indicates th¢ repair 
~clivilY and the lower panel (EtBr) ~hows th¢ ethidium bromide stained 
DNA gel. Lane I: lieLa e~tract (H) treated \\ith protein A beads as a 
(l()n-d~plet.:d (Qntro!. Lan.: 2: Hela e.\lract d~plelcd with Ah--pJ4 
{dH). The depleted HeLa e.\tract was mhoo (1:1) with ewacts of 
rodent complementation group 3 (ERCCJ-: lane J), group 2 
(ERCC2-: lane 5) or group 4 (ERCC4-; lane 7). Th~ e,\tracts were 
also tested in the absence of BeLa e.maCI, group J (lane 4), group 2 
(lane 6) and group 4 (lane 8)_ Lane 9: detection of complememation 
acti",ity using two unrelatoo e.\tract.s (groups 3 and 4). 
unambiguously demonstrate the participation of both p44 and 
p34 in BTF2 transcription activity, 
Inhibition of In vitro NER activity by antl-p44 or antl-
p34 ant/bod/as 
Since the antibodies were able 10 immunoprecipilate the 
DTF2 complex, we have tested their effects on NER activity. 
Antibody depletion experiments were thus perfornled using 
an ill vitro NER system (Wood et 01., 1988; van Vuuren 
et al., 1993). Repair-proficient HeLa whole cell extracts 
were incubated with anti-p34 antibody that was immobilized 
on protein A -Sepharose beads. After.removal of the beads 
by centrifugation, the sUpernatant was tested for its repair 
capacity. The anti-p34 depleted HeLa extract (Figure 5, 
lane 2) showed a clear reduction in repair activity in 
comparison with the non---depleted HeLa extract (lane 1). 
Furthermore. Western blot analyses confioned the depletion 
of p44 and p34 (data not shown). In order to determine 
whether additional NER factors were simultaneously 
removed, the treated extract was mixed with rodent repair-
deficient extracts of complementation group 2, 3 or 4. The 
depleted HeLa extract had lost the ability to restore repair 
aclivity for ERCC2 (lane 5) and ERCC3 (lane 3) but not 
ERCC4 (lane 7). These findings indicate that the anti-p34 
antibody not only removed p89 (ERCC3), but also ERCC2, 
a 80 kDa polypeptide that we recently found associated with 
BTF2 (Schaeffer et al., 1990.1-), which is in agreement with 
immunoprecipitation experiments using the heparin fraction 
(van Vuuren et al., 1994). Similar results were obtained 
using the anti-p44 antibody (data not shown). 
Discussion 
Here, we report the cloning and characterization of two 
additional subunits of BTFl that appear to be intimately 
associated with the p62 subunit which shares homology with 
the 74 kDa subunit (fFB I) of yeast transcription factor b 
(Gileadi et al., 1992) and the pS9 subunit that corresponds 
to the product of the ERCC3 gene (Schaeffer el al., 1993). 
All our data demonstrate unequivocally that both poly-
peptides are subunits of BTF2. First, p44 and p34 copurified 
no! only with the other identified subunits of BTF2 (pS9 and 
p62) but also with the previously characterized enzymatic 
activities of BTF2 (helicase, DNA-dependent ATPase and 
cro kinase). Second, all subunits can be immuno-
precipitated or shifted on a glycerol gradient with monoclonal 
antibodies raised against p44 or p34 (or p62: not shown). 
Third, the latter antibodies inhibit an ill ~1tro transcription 
assay, and this inhibition can be relieved by addition of 
purified BTF2. 
Preliminary experiments to reconstitute the transcription 
activity using the four recombinants subunits of BIF2 (pS9, 
p62, p44 and p34) either alone or in combination were not 
successful. This may be due to the lack of correct folding 
of the protein in E.cofi, but also, and most likely, to the 
absence of some other component(s) oflhe BIF2 factor. It 
also remains possible that additional polypeptides that are 
not strongly associated with BTF2 (three other polypeptides 
were found 10 coeime with the five polypeptides of BIF2: 
Fischer et af., 1992) can modulate the function of the 'core' 
BTF2 to select its implication in either transcription or NER 
but it is still unclear which ones constitute the transcriptional 
'core' or the repair function of BIF2. In a similar context, 
we also noticed that the most purified fraction of the 0 factor. 
the rat homolog of BTF2, contains at least seven polypeptides 
(Conaway and Conaway, 1989). Although we have demon-
strated that the recombinant ERCC3. the p89 subunit of 
BTFl, contains a DNA helicase activity (Schaeffer et al., 
1993), we were unable to detcct any enzymatic activity such 
an ATPase. or CTD kinase associated with p44 or p34. In 
fact, none of the characteristic motifs for such function were 
obvious when considering their amino acid sequence. 
Instead. both proteins contain various zinc finger motifs, such 
as Cys-Xr Cys-X12-His-X}-His, or Cys-XrCys-Xw·Cys· 
XrCys, that may mediate the binding of BTF2 to the DNA 
template. More interesting is the observation that there is 
some common zinc finger 10 both p44 and p34 proteins that 
may suggest some similarity in their function. It will be 
interesting to determine which of the identified zinc fingers 
is reponsible for the DNA binding and if so, if such a 
polypeptide displays sequence specificity. 
The dual role of BTF2 in NER as well as in transcription 
initially suggested by the identification of ERCC3 as one 
subunit of BTF2, is further strengthened by the following 
observations. First, antibodies against p44 or p34 were able 
to deplete both the in l11ro NER system and in vilro 
transcription. This strongly suggests that p44 and/or p34 are 
either directly involved or are associated with one or more 
polypeptides of the BTF2 protein complex that are absolutely 
required for either of the two reactions. Secondly, p44 has 
significant homology (58% similarity) with SSLI, a protein 
that has been shown to playa role in UV resistance in yeast 
as well as translational initiation (Yoon et al., 1992). Thus, 
p44 is most likely the human homolog of SSLI. 
The relationship between p44 and the function of SSLl 
is difficult to rationalize with the observations reported by 
Yoon et af. (1992) who strongly assert that SSLl acts at the 
translation initiation level. SSLl was identified in a search 
for screening for suppressors of an artificial stem -loop in 
the 5'UTR of the selectable HIS4 mRNA that is assumed 
to block translation. The role of SSLl in translation was 
further confirmed by the fact that an extract of ts- SSLl 
suppressor strains presents a decrease of protein synthesis 
from exogenously added roRNA in a cell-free ill vitro 
translation system. In the sante search for suppressors, they 
isolated SSL2, the yeast counterpart ofERCC3fp89 (Gulyas 
and Donahue, 1992). Thus, our findings link a second 
presumed translation regulating protein with the basal 
transcription factor BTFl. This is consistent with the genetic 
cross studies of Gulyas and Donahue (1992) who showed 
that SSLl and SSLl interact with each other. This interaction 
likely occurs in the yeast homolog ofBTF2, the transcription 
factor b, which also contains the TFB1 subunit (Gileadi 
et al., 1992; p62 BTF2 homolog), and suggests that SSLl 
is a component of the yeast factor b. The reported ro!e of 
the SSLlfp44 protein in translation (Yoon et al., 1992) and 
the claimed involvement of the SSL2fpS9 subunit (Gulyas 
and Donahue, 1992) in this process, when correct, would 
extend the multiple functioning of BIF2 from repair and 
transcription to protein synthesis. BTF2 was shown to 
contain ERCC3, a 3'-5' helicase, and to be associated with 
the ERCC2 5'-3' helicase (Schaeffer et al.. 1993, 1994). 
This bidirectional unwinding capacity would allow reading 
of the coding strand in transcription initiation, removal of 
the damaged sequence in DNA repair and ribosomal 
bindingfscanning of the mRNA in translation. In light of all 
lhese data, it appears now that at least two subunits of BTF2, 
i.e. pS9 (ERCC3) and p44 (SSLl), may be involved in 
several essential functions of the cell such as transcription, 
DNA repair and translation. The further characterization of 
BTF2 and the reconstitution of the whole complex will 
represent a major step towards the understanding of its role 
in eukaI),otic gene expression. 
Materials and methods 
Isoralton and sequence of cDNA clones 
Microsequencing of the po!ypeptid~, ~reening of the Hd.a eDNA tibrruy 
ron>truclW in the AZAPil vectOr (S""ugene) and sequ<:ncing of the po,ili>e 
clones were as d~ml::>OO (Fischer el al .• t992). The t.2 kb pM eDNA 
was generated by PCR using the following oligonucleotides: 
5'· TGAAACATA TGGATGAAGAACCTGT AAAGAACT-3' and 
5'..(lACCGGATCcrCAAACACCIGAAGGAGCTGGA-3'. Theresulum 
PCR fragment was inserted into the Ndd-&zmHI site of pEnta 
(Novagene). 
To subdoO¢ the p34 ORF, the pETJd plasmid (Novagen.::) CUI by 
, ... ·col ~&zmH( was ligated 10 an N(ol-BSlE11~BamHI adaptor. The tOJ8 
bp Nwl-8slEli fragment containing the entire ORF of pJ4 was <toned 
in the modified pETId digested by Ncot and BHEIL 
Expul$sion of f8combfnant p44 and p34 
E.coli strain BL2t(DP.3) (NoYligene) ronlaining the pETlla-p44 or pET3d-
1'34 plasmlds were grown in LB rn.:dium SlJppkmentoo ",ith ampicillin 
(100 "glml) at 31"C. Culture; were induced with isoprop)·l-/l·[)-
thillgalil{top)'rano~ide (OA IllM) at an optical density al roJ nm of 0.6. After 
2: h at 37'C. the cells were collected by centrifugation and the pellet was 
r~uspended in 50 mM Tris~Ha pH 8. I m.\! EDTA pH 8. 100 m.\1. 
KCL The celts were then fwzen. thawed and tysed by wnication un iu. 
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Soluble and lI{)o·wluble fractioru were collected after centrifugation. 
Renaturation oftlw recombi!1.lJlt polypeplliks was perforITh!d as describOO 
(Hager and Burgm, 19&0). 
Product/on of antibodlas 
The annb:;dies again:;t rp44 (I HS) and rpJ4 (2B1) were proJuced as <ieocnD.xi 
(Fischer (I af., 1992). The p-M antibody was raised to a polypeptide from 
amino adds I to 17. for p34, the entire protein that was oyere.~press.ed 
in E.coli was used. The anti·p62 and anti·p89 monoclonal antibodies wue 
as d~nD.xi in FIscherel aL (1992) and Sdudfer et al. (993) respxtiwly. 
The monoclonal antibodies w-ere purified from ascile fluids by caprilic acid 
and ammonium sulfate precipitations. 
Immunopr8c;pitetfon 
The BIF2 heparin frdCtion lIas incubated for 2 h at 4"C .... ith the antibodies 
and then for 1 h "ith protein A-Sephaime FF (Phannad3) in TGIOEKI5O 
(50m11 Tris-HClpH7.9, 10% glycerol, 0.1 m.\f EDTA, 150mM KCI) 
containing I mgfml BSA. Beads were washed twice I"ith TGIOEKI50 
containing 0.1% NNO and I mgfml BSA and once with TGiOEKI50 
containing 0.15% NNO, and resuspended in SDS-PAGE loo.ding buffer. 
Aftu SDS- PAGE and trarufer to nitrocellulose, the various polypep!id~s 
were detected "ith the corre,ponding antibodies. 
Other techniques 
The purification of BTF2 and all the basK: transcription factors required 
for the transcription run-off assay wue as preliously describOO (G~rard 
€l aL, 1991). The iJl Ijlm NER assay was as <ieocnD.xi (Woo:Ia el aI., 1990). 
Mutaru5 27.1 (ERCCJ-) and UVI40 (ERCC4-) are as descnD.xi by WOOO 
and Burki (I982) and Busch el al. (1994) respectively. 
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Summary 
A network of DNA repair processes protects the genetic information of organisms 
from accumulation of deleterious mutations. Alterations in DNA can be due to chemical 
instability intrinsic to the DNA itself or to exposure to genotoxic agents. Nucleotide excision 
repair (NER) is one of the most important repair mechanisms in the cell that removes a broad 
range of stmcturally unrelated lesions, for instance lesions induced by UV -light. If not 
repaired, lesions may disturb essential c~llular processes as transcription, recombination, 
replication, or lead to mutations. This might result in malfunction of the cell, inborn defects 
or even onset of carcinogenesis. The consequences of a NER-defect in man are illustrated 
by three hereditary disorders: xeroderma pigmentosum (XP), Cockayne's syndrome (CS), 
and a photosensitive form of trichothiodystrophy (TID). A wide variety of clinical symptoms 
are associated with these disorders. XP patients show an extreme sensitivity to sun(UV)light 
and an elevated risk to develop skin cancer. CS and TTD patients display a milder sensitivity 
to UV-irradiation than XP patients and do not exhibit a predisposition to skin tumours. In 
addition, they show distinct features as growth abnormalities, mental retardation, and, a 
specific halhnark of TID, brittle hair and nails. Genetic heterogeneity has been defined by 
identification of at least 10 different complementation groups defective in NER, seven in XP 
(XP-A to XP-G), two in CS (CS-A and CS-B), and one in TID (TID-A). In rodent cell 
lines at least 11 groups have been found, which show extensive overlap with the human 
groups. The clinical picture is even more confusing, since certain XP patients belonging to 
group B, D, and G show combined features of XP and CS, wltile some TTD patients have 
been classified into XP groups Band D. 
To understand in more detail the complex molecular mechanism of NER, it is 
necessary to isolate and identify the genes involved and their encoded products. The work 
described in this thesis focuses on the characterization of different repair proteins. The 
development of a 'bona fide' ill vitro NER assay has been essential to study the function 
andlor interaction of distinct repair components. The assay is based on damaged DNA 
substrates and protein extracts of rodent or human cells. The repair enzymes recognize the 
damage and remove the damage-containing patch, and the remaining gap is filled by de novo 
DNA synthesis. This last step can be detected by autoradiography when ["P)-Iabelled 
nucleotides are included in the reaction mixture. The assay can be used to purify biologically 
active repair factors; for example XPA, XPG, and XPC/HHR23B complex have been 
isolated from extracts of repair-proficient cells. 
The first evidence of a mammalian repair protein complex is described in Chapter 2. 
Complementation groups have been defined as correction of the repair defect when two 
different cells were fused ill vivo. Analysis in vitro of repair-deficient extracts revealed 
results, which do not correlate with data observed in vivo. When two extracts of different 
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rodent complementation groups 1,4, 11, or human XP-F were mixed, they could not restore 
the repair synthesis to normal levels. However, when they are mixed with extracts of rodent 
groups 2, 3, 5, or human XP-A, correction to wild-type levels is found. This is the first 
indication that repair proteins ERCC1, ERCC4, ERCC11, and XPF affect each other. A 
possible explanation for the differences between the ;'1 vivo and ill vitro findings is, that 
proper complex formation is only possible in vivo, while ill vitro subunits of the complex 
cannot be exchanged. A repair-proficient HeLl extract depleted for ERCCI also lost the 
activity to correct extracts of rodent groups 4, 11 and human XP-F, but not the activity to 
complement the repair defects of rodent groups 2, 3, 5, and human XP-A. The inununo-
depletion studies confirm the hypothesis of such a repair complex. Since the ERCC4 and 
ERCCll genes have not been cloned yet, it cannot be excluded that one of these genes 
corrects the human XP-F deficiency. 
Chapter 3 describes the partial characterization of the ERCCII4/11/XPF complex. A 
subunit of approximately 120 kDa could specifically be immunoprecipitated, suggesting that 
at least one additional subunit of the ERCCI complex still has to be identified. The ERCCI 
complex displays DNA-binding affinity without pronounced preference for single-stranded, 
double-stranded, or UV-damaged DNA. Using non-denaturing gradient gels the molecular 
mass of the complex was measured as - 280 kDa, much larger than previously observed by 
glycerol gradient sedinlentation studies (-120 kDa). The size of 280 kDa for the complex 
would better acconmlOdate the presence of ERCCI (33 kDa), the precipitated subunit (120 
kDa), and at least one additional component. 
An unexpected link between NER and transcription initiation is reported in Chapters 
4 and 5. The experiments were done in collaboration with the group of Dr. I.M. Egly 
(Strasbourg). Purified fractions of basal transcription initiation factor TFIlH were found to 
correct the repair defects of complementation groups XP-B, XP-D, and TID-A, both in an 
in vivo microinjection repair assay and in an in vitro NER assay. Immunodepietion studies 
suggest that probably the entire TFIlH complex is directly implicated in excision repair. 
Expression of an ERCC3 mutant containing a Lys~Arg replacement in the ATP-binding 
domain, which is expected to have lost all helicase activity, displays a dominant-negative 
effect on DNA repair as well as on transcription, after injection into repair-proficient 
fibroblasts. Antisemm against XPB and XPD injected into normal cells causes also a strong 
inhibition of both repair and transcription activities. These data indicate that XPB and XPD 
are involved in transcription ill vivo, extending the evidence for involvement of these subunits 
in transcription in vitro as observed by Dr. I.M. Egly and coworkers. Furthennore, cell 
fusion experiments established the existence of a new TID complementation group, since the 
repair defect in patient TID6VI is identified as a defect in XP group B. The specific 
association between at least three TFIlH subunits and TID supports the idea that TID, and 
those fOlms of XP with combined XP/CS features belong to one broad clinical entity. 
Probably some clinical symptoms that are atypical for a NER defect, such as 
neurodysmyeliniaton, impaired sexual development, brittle hair, and growth abnorn1alities, 
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can be explained by subtle mutations, that affect the transcriptional role of TFIIH. 
Two other subunits, p44 and p34, of TFIIH have been cloned (Chapter 6). The gene 
encoding p44 appeared to be the human homolog of yeast SSLI. Both proteins p44 en p34 
contain certain zinc-finger domains, which might bind TFIlH to the DNA template. 
Antibodies against p44 and p34 are able to precipitate p62 and XPB, other subunits of 
TFIIH, and inhibit the tral15cription reaction ill vitro. Again innnunodepletion of repair-
proficient extracts reduces repair activity to mutant levels. This depleted extract cannot 
complement the repair defect of rodent groups 2 and 3, which are the equivalents of human 
groups XP-D and XP-B respectively. 
The dual role of TFIIH in DNA repair and transcription might explain the diverse 
phenotypes found, when a subunit of TFIlH is impaired. For instance, mutatiol15 can 
influence only the NER function, resulting in a classical XP-phenotype as observed in some 
patients of XP group D. If in addition the transcriptional role of TFIIH is subtly affected, 
combined XP/CS features and photosensitive forms of TTD can be expected. These findings 
support the hypothesis that mutations can cause viable transcriptional problems without any 
NER impairment. Indeed, several TID and CS patients with no photosensitivity and normal 
NER have been described, providing evidence for the existence of a new class of disorders 
that can be designated as 'tral15cription syndromes'. However, this proposition has to be 
confirmed in the future. 
119 
Samenvatting 
Een netwerk van DNA herstelprocessen beschermt de genetische informatie van 
organismen tegen de accumulatie vall schadelijke mutaties. Veranderingen in het DNA 
kunnen veroorzaakt worden door de chemische instabiliteit van het DNA zelf of door 
blootstelling aan genotoxische agentia. Nucleotide excisie herstel (verder afgekort als NER 
afkomstig van de Engelse uitdrukking "Nucleotide excision repair") is cen zeer belangrijk 
herstelproces in de eel en verwijdert cen variatie aan lesies, bijvoorbeeld lesies geinduceerd 
door ultraviolet licht. Wanneer lesies in DNA niet hersteld worden, kUlmen ze mutaties 
veroorzaken of andere essentiele processen in de eel verstoren, zoals transcriptie, 
recombinatie of replicatie, met als mogelijk gevolg afwijkingen bij de geboorte of de 
ontwikkeling van kanker. De consequenties van een hersteldefect in de mens worden 
gelllustreerd door drie erfelijke ziektebeelden: xeroderma pigmentosum (XP), Cockayne's 
syndroom (CS) en trichothiodystrophy (TTD). Naast TID-patienten die overgevoelig zijn 
voor ultraviolet lieht be staat er een groep van TID-patienten die niet sensitief is Vaal' Hellt. 
Deze laatste groep heeft geen defect in het NER-proces. Een brede variatie aan klinische 
symptomen wordt geassocieerd met deze ziektebeelden. XP patienten vertonen een zeer 
extreme gevoeligheid voor ultraviolette straling en hebben een sterk verhoogde kans op de 
ontwikkeling van huidkanker. CS en TTD patienten zijn in tegenstelling tot XP veel minder 
gevoelig voor ultraviolet licht en hebben geen verhoogde kans op huidtumoren, maar zij 
vertonen andere kenmerken zoals groei- en ontwikkelingsstoornissen. Specifieke symptomen 
van TTD patienten zijn braze haren en nagels. Tenminste 10 verschillende genen betrokken 
bij DNA herstel zijn tot nu toe gei'dentificeerd in de mens: 7 in XP (XPA tot XPG), 2 in CS 
(CSA en CSB) en 1 in TID (TIDA). In knaagdieren zijn al 11 herstelgenen gevonden, 
waarvan sommige identiek zijn aan de humane genen. Het klinisch beeld is echter 
ingewikkelder dan geschetst, omdat sommige XP patienten ingedeeld in groep B, D en G 
gecombineerde XP/CS kenmerken vertonen en er TTD patienten zonder een verhoogd risico 
op huidkanker bestaan met een hersteldefect in XPB of XPD. 
Om dit complexe mechanisme van DNA herstel te begrijpen is het noodzakelijk om 
aIle genen, betrokken bij dit proces, en de eiwitprodukten afgeschreven van deze genen te 
isoleren. Het werk beschreven in dit proefschrift concentreert zich op het karakteriseren van 
verschillende DNA hersteleiwitten. De ontwikkeling van een 'bona fide' ill vitro 
herstelmethode heeft belangrijk bijgedragen aan de analyse van de functies en/of interacties 
van de verschillende herstelfactoren. Deze methode is gebaseerd op het gebmik van een 
beschadigd DNA substraat en eiwitextracten uit gekweekte knaagdier- of menselijke cellen. 
De hersteleiwitten herkennen de schade in het DNA en verwijderen het stukje DNA met de 
lesie. Daarna wordt de enkelstrengs opening opgevuld door normale DNA synthese. Dit 
nieuw gesynthetiseerde DNA kan met behulp van autoradiografie gedetecteerd worden, indien 
radio-actief gelabelde nucleotiden aanwezig zijn in het reactiemengsel. Deze ill vitro methode 
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is ook erg nuttig bij het zuiveren van biologisch aktieve herstelfactoren uit normale cellen. 
Op deze manier zijn XPA, XPG en het XPCIHHR23B eiwitcomplex gelsoleerd. 
De eerste aanwijzing dat hersteleiwitten een complex vormen in zoogdieren wordt 
beschreven in Hoofdstuk 2. Wanneer cellen uit twee verschillende patienten na fusie elkaars 
defect kunnen corrigeren ill vivo, worden ze gedefinieerd als verschillende complementatie 
groepen. Analyse van herstel-deficiente extracten toont in bepaalde comb ina ties een verschil 
in de ill vivo en ill vitro respons aan. Wanneer twee extracten van de compiementatie groepen 
1, 4, 11 of XP-F gemengd worden kunnen ze elkaars defect niet corrigeren. Al deze 
extracten kunnen echter wei het defect repareren van de groepen 2, 3, 5 en XP-A. Dit is de 
eerste aanwijzing dat de hersteleiwitten ERCCI, ERCC4, ERCC11 en XPF elkaar 
bei'Ilvloeden, waarschijn1ijk door de Yorming van een complex ill vivo waarin de individuele 
componenten ruet uitgewisseld kunnen worden in vitro. Na verwijdering van EReCl uit cen 
extract van herstel-competente HeLa cellen is dit extract niet meer in staat tot correctie van 
groepen 1, 4, 11 en XP-F, terwijl de aktiviteit om extracten van groepen 2, 3, 5 en XP-A 
te compiementeren nog steeds aanwezig is. De aanwijzing dat hersteleiwitten cen complex 
vormen wordt versterkt door de resultaten van deze immuundepletie studies. Aangezien de 
ERCC4 en ERCCll genen nog niet gekioneerd zijn, is het niet uitgesloten dat eon van deze 
genen het defect in XP groep F kan complementeren. 
Hoofdstuk 3 beschrijft de partiele karakterisering van het ERCC1I4/lllXPF complex. 
Een component met een massa van - 120 kDa kan specifiek geprecipiteerd worden. Het feit 
dat ERCC4 of ERCCll identiek zou kunnen zijn aan XPF suggereert dat ten minste nog eon 
component van het ERCCI-complex geldentificeerd moet worden. Het ERCC1-complex kan 
binden aan DNA zonder voorkeur voor enkelstrengs, dubbelstrengs ofUV-beschadigd DNA. 
Met behulp van een niet-denaturende gradient gel is de massa van het complex bepaald op 
-280 kDa; dit is echter groter dan het eerder gevonden resultaat met glycerol gradient 
sedimentatie (-120 kDa). De massa van 280 kDa zou betel' de aanwezigheid van' ERCC1 
(33 kDa), de hier geidentificeerde component (120 kDa) en ten minst nog eon additionele 
component kUImen herbergen. 
Een onverwachte relatie tussen DNA herstel en transcriptie wordt besproken in de 
Hoofdstukken 4 en 5. Deze experimenten zijn uitgevoerd in samenwerking met de 
onderzoeksgroep van Dr. J.M. Egly (Straatsburg). Gezuiverde fracties van de basale 
transcriptie initiatie factor TFIIH corrigeren het defect van de complementatie groepen XP-B, 
XP-D en TTD-A, zowel in de ill vitro methode als in een ill vivo methode door middel van 
microinjectie in cellen. Immuundepletie studies suggereren dat mogelijk het gehele TFIIH-
complex direct betrokken is bij excisie herstel. Expressie van een ERCC3 mutant, waarin het 
aminozuur lysine is vervangen door arginine in het ATP-bindings domein met als gevolg 
verlies van helicase aktiviteit, vertoont een dominant negatief effect zowel op DNA herstel 
als op transcriptie na microinjectie in normale fibroblasten. Injectie van antiserum gericht 
tegen XPB of XPD remt in sterke mate beide processen, DNA herstel en transcriptie, in 
normale cell en. Deze gegevens geven een indicatie dat beide eiwitten XPB en XPD betrokken 
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zijn bij transcriptie in vivo, terwijl deze betrokkenheid in vitro al gevonden is door Dr. Egly 
en medewerkers. Verder bevestigen celfusie experimenten het bestaan van een nieuwe 
complementatie groep voor TTD patienten. Het hersteldefect in patient TTD6VI is 
geldentificeerd als een defect in XP groep B. De relatie tussen tenminste drie componenten 
van het TFIIH-complex, namelijk XPB, XPD en TIDA, en TID versterkt de veronder-
stelling dat zowel TTD als de XP vormen met gecombineerde XP/CS kenmerken tot een 
breed klinisch ziektebeeld behoren. Sormnige klinische symptomen, die ongewoon zijn voor 
een hersteldefect, zoals de afbraak van de myeline schede hetgeen neurologische afwijkingen 
in CS patienten veroorzaakt, en groei- en ontwikkelingsafwijkingen, zijn mogelijk 
geassocieerd met mutaties die de functie van TFIIH in transcriptie subtiel belnvloeden. 
Twee andere componenten van TFIIH, p44 en p34 zijn gekloneerd (Hoofdstuk 6). Het 
gen dat codeert voor p44 blijkt de humane homoloog te zijn van SSLl in gist. Beide eiwitten 
p44 en p34 bevatten bepaalde zink-vinger domeinen, die mogelijk belangrijk zijn bij de 
binding van TFIIH aan DNA. Antilichamen gericht tegen p44 en p34 zijn in staat andere 
componenten van TFIIH, p62 en XPB, te precipiteren en remmen de transcriptie ill vitro. 
NOlmale extracten waamit p44 of p34 verwijderd zijn met antilichamen, vertonen een 
duidelijke reductie van de herstelaktiviteit tot het niveau van herstel-deficH:!nte cellen. 
Tegelijkertijd heef! dit extract de mogelijkheid verloren om de knaagdier complementatie 
groepen 2 en 3 te complementeren, welke homoloog zijn aan XP-D en XP-B. 
De functie van TFIIH in zowel DNA herstel en transcriptie verklaart mogelijk de 
diverse fenotypes, die gevonden worden als cen component van dit complex defect is. 
Mutaties knnnen bijvoorbeeld enkel de functie in DNA-herstel belnvloeden met als gevolg 
een klassiek XP fenotype zoals gevonden in sonunige patienten van XP groep D. Warmeer 
tegelijkertijd de rol van TFIIH in transcriptie subtiel is aangetast knnnen gecombineerde 
XP/CS kenmerken en lichtgevoelige vormen van TID verwacht worden. Deze bevindingen 
versterken de hypothese dat mutaties subtiele problemen in transcriptie knrmen veroorzaken 
zonder dat het DNA-herstelproces wordt beschadigd. Inderdaad zijn er TID en CS patienten 
beschreven, die niet gevoelig zijn voor ultraviolet licht en lesies in het DNA normaal knnnen 
herstellen. Het klinisch beeld van deze patienten verschaft aanwijzingen voor het bestaan van 
een nieuwe klasse van ziektebeelden, die aangeduid kan worden als 'transcriptie syndromen', 
maar het bewijs voor deze verondersteIling moet nag gevonden worden. 
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